<SEC-DOCUMENT>0001193125-25-138898.txt : 20250611
<SEC-HEADER>0001193125-25-138898.hdr.sgml : 20250611
<ACCEPTANCE-DATETIME>20250611110748
ACCESSION NUMBER:		0001193125-25-138898
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20250611
DATE AS OF CHANGE:		20250611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Air Products & Chemicals, Inc.
		CENTRAL INDEX KEY:			0000002969
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INORGANIC CHEMICALS [2810]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				231274455
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275663
		FILM NUMBER:		251039256

	BUSINESS ADDRESS:	
		STREET 1:		1940 AIR PRODUCTS BLVD.
		CITY:			ALLENTOWN
		STATE:			PA
		ZIP:			18106-5500
		BUSINESS PHONE:		6104814911

	MAIL ADDRESS:	
		STREET 1:		1940 AIR PRODUCTS BLVD.
		CITY:			ALLENTOWN
		STATE:			PA
		ZIP:			18106-5500

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AIR PRODUCTS & CHEMICALS, INC.
		DATE OF NAME CHANGE:	20220408

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AIR PRODUCTS & CHEMICALS INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>d942740d424b2.htm
<DESCRIPTION>424B2
<TEXT>
<HTML><HEAD>
<TITLE>424B2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(2)<BR> Registration No. 333-275663 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Prospectus Supplement </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To prospectus dated November&nbsp;20, 2023) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>&#128;500,000,000 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g942740g01k01.jpg" ALT="LOGO" STYLE="width:2.0702in;height:0.468639in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Air Products and Chemicals, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>3.250% Notes due 2032 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are offering &#128;500,000,000 aggregate principal amount of 3.250% Notes due 2032 (the &#147;Notes&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will bear interest at the rate of 3.250% per year. We will pay interest on the Notes on June 16 of each year, beginning on June 16,
2026. The Notes will mature on June 16, 2032. We may redeem the Notes prior to their maturity, in whole or in part, as described in this prospectus supplement. We may also redeem all, but not part, of the Notes at a price equal to 100% of the
principal amount plus accrued and unpaid interest upon the occurrence of certain changes in U.S. tax law, as described in this prospectus supplement under &#147;<I>Description of Notes&#151;Redemption for Tax Reasons.</I>&#148; In addition, if a
change of control triggering event occurs as described under &#147;<I>Description of Notes&#151;Change of Control and Ratings Decline</I>,&#148; we will be required to offer to repurchase the Notes from their holders at a purchase price equal to
101% of the principal amount thereof plus accrued and unpaid interest to, but excluding, the date of repurchase. The Notes will be issued in book-entry form only, in minimum denominations of &#128;100,000 and integral multiples of &#128;1,000 in
excess thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are a new issue of securities with no established trading market. We intend to apply to list the Notes on the
New York Stock Exchange (the &#147;NYSE&#148;), and we expect trading in the Notes on the NYSE to begin within 30 days after the initial issuance of the Notes. We will have no obligation to maintain the listing of the Notes, and we may delist the
Notes at any time. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in the Notes involves risks. See &#147;</B><B><I><A HREF="#supptx942740_4">Risk Factors</A></I></B><B>&#148; beginning on page <FONT
STYLE="white-space:nowrap">S-5</FONT> of this prospectus supplement, as well as the section entitled &#147;</B><B><I>Risk Factors</I></B><B>&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
September&nbsp;30, 2024. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Public&nbsp;Offering<BR>Price<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Underwriting<BR>Discount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proceeds&nbsp;to&nbsp;Us,<BR>Before&nbsp;Expenses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Per Note</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99.661</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.400</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99.261</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">498,305,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">496,305,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Plus accrued interest, if any, from June 16, 2025, if settlement occurs after that date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission has approved or disapproved of the
Notes or determined if this prospectus supplement or the accompanying prospectus is accurate or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters expect to deliver the Notes in book-entry form only through the facilities of the Euroclear System (&#147;Euroclear&#148;)
and Clearstream Banking S.A. (&#147;Clearstream&#148;), on or about June 16, 2025, against payment in immediately available funds. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint Book-Running Managers </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top" NOWRAP><B>Barclays</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>Cr&eacute;dit&nbsp;Agricole&nbsp;CIB</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>Deutsche&nbsp;Bank</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><B>Standard&nbsp;Chartered&nbsp;Bank</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus supplement is June&nbsp;10, 2025. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_2">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-iv</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_3">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_5">CURRENCY CONVERSION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_7">DESCRIPTION OF NOTES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_8">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_9">UNDERWRITING (CONFLICTS OF INTEREST)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_10">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_11">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx942740_12">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_3">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_6">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_7">DESCRIPTION OF PREFERRED STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_8">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_9">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_10">DESCRIPTION OF DEPOSITARY SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_10a">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_11">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering, the Notes
and matters relating to us. The second part is the accompanying prospectus, which provides a more general description of the terms and conditions of the various securities we may offer under our registration statement, some of which does not apply
to this offering or to the Notes. In this prospectus supplement and the accompanying prospectus, references to &#147;<I>Air Products</I>,&#148; the &#147;<I>Company</I>,&#148; &#147;<I>we</I>,&#148; &#147;<I>us</I>&#148; and &#147;<I>our</I>&#148;
refer to Air Products and Chemicals, Inc. and, unless the context otherwise requires, its consolidated subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>We have not, and
the underwriters have not, authorized anyone to provide any information that is different or in addition to that contained or incorporated by reference in this prospectus supplement, the accompanying prospectus and in any free writing prospectus
prepared by us or on our behalf to which we have referred you, and we take no responsibility for, and we cannot provide any assurance as to the reliability of, any other information that others may give you. We are not, and the underwriters are not,
making an offer to sell the Notes in any jurisdiction where the offer or sale is not permitted. Further, you should assume that the information appearing in this prospectus supplement, the accompanying prospectus, and the documents incorporated by
reference herein and therein, and any free writing prospectus, is accurate only as of the respective dates of those documents in which the information is contained. Our business, financial condition, results of operations and prospects may have
changed since those dates. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is important for you to read and consider carefully all information contained or incorporated by
reference in this prospectus supplement, the accompanying prospectus and any permitted free writing prospectuses we have authorized for use with respect to this offering prior to making a decision to invest in the Notes. See &#147;<I>Where You Can
Find More Information</I><I>&#148;</I> for additional information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References herein to &#147;$,&#148; &#147;U.S. $,&#148;
&#147;dollars&#148; and &#147;U.S. dollars&#148; are to the lawful currency of the United States of America; and references to &#147;&#128;&#148; and &#147;euros&#148; are to the lawful currency of the member states of the European Monetary Union
that have adopted the euro as their currency. The financial information presented or incorporated by reference in this prospectus supplement and accompanying prospectus have been prepared, unless otherwise noted, in accordance with generally
accepted accounting principles in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN CONNECTION WITH THIS OFFER OF NOTES, J.P. MORGAN SECURITIES PLC, AS STABILIZING
MANAGER (OR ANY OTHER PERSON ACTING ON ITS BEHALF), MAY OVER-ALLOT NOTES OR EFFECT TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICE OF THE NOTES AT LEVELS WHICH MIGHT NOT OTHERWISE PREVAIL. THIS STABILIZING, IF COMMENCED, MAY BE
DISCONTINUED AT ANY TIME AND WILL BE CARRIED OUT IN COMPLIANCE WITH ALL APPLICABLE LAWS AND RULES. ANY STABILIZATION ACTION MAY BEGIN ON OR AFTER THE DATE ON WHICH ADEQUATE PUBLIC DISCLOSURE OF THE TERMS OF THE OFFER OF THE NOTES IS MADE AND, IF
BEGUN, MAY BE ENDED AT ANY TIME, BUT IT MUST END NO LATER THAN THE EARLIER OF 30 CALENDAR DAYS AFTER THE ISSUE DATE OF THE NOTES AND NO LATER THAN 60 DAYS AFTER THE DATE OF THE ALLOTMENT OF THE NOTES. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are being offered only for sale in jurisdictions where it is lawful to make such offers. The distribution of this prospectus
supplement and the accompanying prospectus does not constitute, and may not be used in connection with, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or in which the person making such
offer or solicitation is not authorized or qualified to do so or to any person to whom it is unlawful to make such offer or solicitation. The Notes have been accepted for clearance through Euroclear and Clearstream and have been assigned Common Code
Number 309536797 and International Security Identification Number (&#147;ISIN&#148;) XS3095367978. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prohibition of Sales to Retail Investors in the European Economic Area (&#147;EEA&#148;) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to
any retail investor in the EEA. For these purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended, &#147;MiFID II&#148;); (ii) a
customer within the meaning of Directive (EU) 2016/97 (as amended, the &#147;Insurance Distribution Directive&#148;), where that customer would not qualify as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II; or
(iii)&nbsp;not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the &#147;Prospectus Regulation&#148;). Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the &#147;PRIIPs
Regulation&#148;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA
may be unlawful under the PRIIPs Regulation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prohibition of Sales to Retail Investors in the U.K. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to
any retail investor in the U.K. For these purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No.&nbsp;2017/565 as it forms part of domestic law by
virtue of the European Union (Withdrawal) Act 2018 (&#147;EUWA&#148;); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (as amended, &#147;FSMA&#148;) and any rules or regulations made under the
FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No.&nbsp;600/2014 as it forms part of domestic law by virtue of
the EUWA; or (iii)&nbsp;not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA (the &#147;U.K. Prospectus Regulation&#148;). Consequently, no key information document
required by Regulation (EU) No.&nbsp;1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#147;U.K. PRIIPs Regulation&#148;) for offering or selling the Notes or otherwise making them available to retail investors in the U.K. has
been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the U.K. may be unlawful under the U.K. PRIIPs Regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MiFID II Product Governance/Professional Investors and Eligible Counter Parties (&#147;ECPS&#148;) Only Target Market </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solely for the purposes of the manufacturer&#146;s product approval process, the target market assessment in respect of the Notes has led to
the conclusion that: (i)&nbsp;the target market for the Notes is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii)&nbsp;all channels for distribution of the Notes to eligible counterparties and professional
clients are appropriate. Any person subsequently offering, selling or recommending the Notes (an &#147;EU distributor&#148;) should take into consideration the manufacturer&#146;s target market assessment; however, an EU distributor subject to MiFID
II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturer&#146;s target market assessment) and determining appropriate distribution channels. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.K. MiFIR Product Governance/Professional Investors and ECPS Only Target Market </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solely for the purposes of each manufacturer&#146;s product approval process, the target market assessment in respect of the Notes has led to
the conclusion that: (i)&nbsp;the target market for the Notes is only eligible counterparties, as defined in the FCA Handbook Conduct of Business Sourcebook (COBS), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part
of domestic law of the U.K. by virtue of the EUWA (&#147;UK MiFIR&#148;); and (ii)&nbsp;all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or
recommending the Notes (a &#147;U.K. distributor&#148;) should take into consideration the manufacturers&#146; target market assessment; however, a U.K. distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook
(the &#147;UK MiFIR Product Governance Rules&#148;) is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers&#146; target market assessment) and determining appropriate
distribution channels. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_2"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus and the information included or incorporated by reference herein and therein include
&#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange
Act&#148;), and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can generally
be identified by words such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;forecast,&#148; &#147;future,&#148; &#147;goal,&#148; &#147;intend,&#148; &#147;may,&#148;
&#147;outlook,&#148; &#147;plan,&#148; &#147;positioned,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would,&#148; and similar expressions or variations
thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on management&#146;s expectations and assumptions as of the date they are made and are not guarantees
of future performance. You are cautioned not to place undue reliance on our forward-looking statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements may
relate to a number of matters, including the expected timetable and benefits related to this offering; expectations regarding revenue, margins, expenses, earnings, tax provisions, cash flows, pension obligations, share repurchases or other
statements regarding economic conditions or our business outlook; statements regarding capital expenditures and plans, projects, strategies and objectives for our future operations, including our ability to win new projects and execute the projects
in our backlog; and statements regarding our expectations with respect to pending legal claims or disputes. While forward-looking statements are made in good faith and based on assumptions, expectations and projections that management believes are
reasonable based on currently available information, actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors, including, without limitation:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in global or regional economic conditions, inflation, and supply and demand dynamics in the market
segments we serve, including demand for technologies and projects to limit the impact of global climate change; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the financial markets that may affect the availability and terms on which we may obtain financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to execute agreements with customers and implement price increases to offset cost increases;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruptions to our supply chain and related distribution delays and cost increases; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with having extensive international operations, including political risks, risks associated with
unanticipated government actions and risks of investing in developing markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">project delays, scope changes, cost escalations, contract terminations, customer cancellations, or postponement
of projects and sales; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to safely develop, operate, and manage costs of large-scale and technically complex projects;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the future financial and operating performance of major customers, joint ventures, and equity affiliates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop, implement, and operate new technologies and to market products produced utilizing new
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to execute the projects in our backlog and refresh our pipeline of new projects;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">tariffs, economic sanctions and regulatory activities in jurisdictions in which we and our affiliates and joint
ventures operate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of environmental, tax, safety, or other legislation, as well as regulations and other public policy
initiatives affecting our business and the business of our affiliates and related compliance requirements, including legislation, regulations, or policies intended to address global climate change; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in tax rates and other changes in tax law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safety incidents relating to our operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing, impact, and other uncertainties relating to acquisitions, divestitures, and joint venture activities,
as well as our ability to integrate acquisitions and separate divested businesses, respectively; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to cybersecurity incidents, including risks from the interruption, failure or compromise of our
information systems or those of our business partners or service providers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">catastrophic events, such as natural disasters and extreme weather events, pandemics and other public health
crises, acts of war, including Russia&#146;s invasion of Ukraine and new and ongoing conflicts in the Middle East, or terrorism; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on our business and customers of price fluctuations in oil and natural gas and disruptions in markets
and the economy due to oil and natural gas price volatility; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs and outcomes of legal or regulatory proceedings and investigations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">asset impairments due to economic conditions or specific events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant fluctuations in inflation, interest rates and foreign currency exchange rates from those currently
anticipated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">damage to facilities, pipelines or delivery systems, including those we are constructing or that we own or
operate for third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability and cost of electric power, natural gas, and other raw materials; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement and success of any productivity and operational improvement programs. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should carefully read the factors described in <I>Risk Factors,</I> <I>Management&#146;s Discussion and Analysis of Financial Condition
and Results of Operations,</I> <I>Quantitative and Qualitative Disclosures about Market Risk </I>and other cautionary statements in this prospectus supplement, the accompanying prospectus and/or in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended September&nbsp;30, 2024, our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended December&nbsp;31, 2024 and March&nbsp;31, 2025, and our other
filings with the SEC that are incorporated by reference into this prospectus supplement or the accompanying prospectus for a description of certain risks that could, among other things, cause our actual results to differ from these forward-looking
statements. Any of these factors, as well as those not currently anticipated by management, could cause our results of operations, financial condition or liquidity to differ materially from what is expressed or implied by any forward-looking
statement. Except as required by law, we disclaim any obligation or undertaking to update or revise any forward-looking statements contained or incorporated by reference herein to reflect any change in assumptions, beliefs, or expectations or any
change in events, conditions, or circumstances upon which any such forward-looking statements are based. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_3"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary provides a brief overview of certain information appearing elsewhere in this prospectus supplement and the documents
incorporated by reference herein, which are described under &#147;Where You Can Find More Information.&#148; Because it is abbreviated, this summary does not contain all of the information that you should consider before making an investment in the
Notes. We encourage you to read the entire prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein carefully, including the &#147;Risk Factors&#148; section, the audited consolidated
financial statements contained in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended September&nbsp;30, 2024 and the unaudited consolidated financial statements contained in our Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended December&nbsp;31, 2024 and March&nbsp;31, 2025 and the notes to those financial statements, before making an investment decision. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Air Products and
Chemicals, Inc., a Delaware corporation originally founded in 1940, is a world-leading industrial gases company that has built a reputation for its innovative culture, operational excellence, and commitment to safety and the environment. We are
focused on serving energy, environmental, and emerging markets and on generating a cleaner future by offering products and services that enable our customers to improve their environmental performance, product quality, and productivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our regional industrial gases business provides essential gases, related equipment, and applications expertise to customers in dozens of
industries, including refining, chemicals, metals, electronics, manufacturing, medical, and food. As the leading global supplier of hydrogen, we also develop, engineer, build, own, and operate some of the world&#146;s largest clean hydrogen
projects, supporting the transition to <FONT STYLE="white-space:nowrap">low-</FONT> and <FONT STYLE="white-space:nowrap">zero-carbon</FONT> energy in the industrial and heavy-duty transportation sectors. Through our sale of equipment businesses, we
also provide turbomachinery, membrane systems, and cryogenic containers globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate offices are located at 1940 Air Products
Boulevard, Allentown, Pennsylvania 18106-5500. Our telephone number is (610) <FONT STYLE="white-space:nowrap">481-4911,</FONT> and our website is www.airproducts.com. The information contained in, or that can be accessed through, our website is not
a part of, or incorporated by reference in, this prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concurrent Offering of USD Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;9, 2025, we priced an offering of $600&nbsp;million aggregate principal amount of our 4.300% Notes due 2028 and $500&nbsp;million
aggregate principal amount of our 4.900% Notes due 2032 (together, the &#147;USD Notes&#148;), by means of a separate prospectus supplement. This prospectus supplement is not an offer of any securities of the Company other than the Notes. The
completion of this offering is not contingent on the completion of the concurrent offering, and the completion of the concurrent offering is not contingent on the completion of this offering. Accordingly, you should not assume that the concurrent
offering will be consummated on the terms described in this prospectus supplement, if at all. We expect to use any net proceeds received from the concurrent offering, together with the net proceeds from this offering, as detailed herein under
&#147;<I>Use of Proceeds</I>.&#148; </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following is a brief summary of the terms and conditions of this offering. It does not contain all of the information that you need to
consider in making your investment decision. To understand all of the terms and conditions of the offering and the Notes, you should carefully read this prospectus supplement, as well as the accompanying prospectus and the documents incorporated by
reference that are described under &#147;Where You Can Find More Information.&#148; </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Issuer </P></TD>
<TD>Air Products and Chemicals, Inc. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Securities Offered </P></TD>
<TD>&#128;500,000,000 aggregate principal amount of 3.250% Notes due 2032. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Maturity Dates </P></TD>
<TD>The Notes will mature on June&nbsp;16, 2032. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Interest and Payment Dates </P></TD>
<TD>The Notes will bear interest at the annual rate of 3.250%. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Interest on the Notes will accrue from the date of issuance and be payable annually on June&nbsp;16, commencing on&nbsp;June&nbsp;16, 2026, to the persons in whose names such Notes are registered at the close of
business on the calendar day prior to the interest payment date. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Currency of Payment </P></TD>
<TD>The initial investors in the Notes will be required to pay for the Notes in euros. All payments of principal and interest, including payments made upon any redemption of the Notes, will be made in euros. If the euro is unavailable to us due to
the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of
transactions by public institutions of or within the international banking community, then all payments in respect of the Notes will be made in U.S. dollars until the euro is again available to us or so used. See &#147;<I>Description of
Notes&#151;Issuance in Euros</I>.&#148; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Priority </P></TD>
<TD>The Notes will be our unsubordinated unsecured obligations and will rank equally in right of payment with all of our existing and future unsubordinated indebtedness. The Notes will be effectively junior to any of the secured debt that we may
incur, to the extent of the value of the assets securing such debt. In addition, the Notes will be structurally subordinated to all liabilities of our subsidiaries, including trade payables. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Optional Redemption </P></TD>
<TD>At our option, we may redeem any or all of the Notes, in whole at any time or in part from time to time, at the redemption price described under &#147;<I>Description of Notes&#151;Optional Redemption</I>&#148; in this prospectus supplement, plus
accrued and unpaid interest thereon to, but excluding, the redemption date. If we redeem all or any part of the Notes on or after the Par Call Date, we will pay a redemption price equal to 100% of the principal amount of Notes being redeemed, plus
accrued and unpaid interest thereto to, but excluding, the redemption date. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Par Call Date </P></TD>
<TD>April&nbsp;16, 2032. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Redemption of Notes for Tax Reasons </P></TD>
<TD> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may redeem in whole, but not in part, the Notes upon the occurrence of certain tax events described under &#147;<I>Description of</I>
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman">
<I>Notes&#151;Redemption for Tax Reasons</I>&#148; in this prospectus supplement at a redemption price equal to 100% of their principal amount, together with accrued and unpaid interest on the
Notes to, but excluding, the date fixed for redemption. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Change of Control Triggering Event </P></TD>
<TD>If a Change of Control Triggering Event (as defined herein) occurs, each holder of the Notes may require us to repurchase some or all of the Notes at a purchase price equal to 101% of the principal amount of the Notes, plus accrued and unpaid
interest thereon to, but excluding, the date of repurchase. A Change of Control Triggering Event means the occurrence of both a change of control and a Ratings Decline (as defined herein). See &#147;<I>Description of Notes&#151;Change of Control and
Ratings Decline</I>.&#148; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>We intend to use the net proceeds from the sale of the Notes and from the concurrent offering of USD Notes for general corporate purposes and to repay a portion of our outstanding commercial paper obligations. As of June&nbsp;6, 2025, we had
approximately $1,464&nbsp;million of commercial paper outstanding with a weighted average interest rate of 4.48% (on a bond equivalent yield basis) and a weighted average maturity of 16 days. See &#147;<I>Use of Proceeds</I>&#148; beginning on page
S-10 of this prospectus supplement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Conflicts of Interest </P></TD>
<TD>Certain of the underwriters and/or their respective affiliates may hold our commercial paper, which we intend to repay in part with the net proceeds of this offering. Accordingly, such underwriters or their respective affiliates may receive at
least 5% of the net proceeds of this offering, not including underwriting compensation, thus creating a &#147;conflict of interest&#148; within the meaning of Rule 5121 of the Financial Industry Regulation Authority, Inc. (&#147;FINRA Rule
5121&#148;). Accordingly, this offering is being made in compliance with the requirements of FINRA Rule 5121. See &#147;<I>Underwriting (Conflicts of Interest)</I>&#148; beginning on page&nbsp;S-27 of this prospectus supplement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD>You should consider carefully the specific factors set forth under &#147;<I>Risk Factors</I>&#148; beginning on page <FONT STYLE="white-space:nowrap">S-5</FONT> of this prospectus supplement as well as the information and data included elsewhere
or incorporated by reference in this prospectus supplement and the accompanying prospectus, before making an investment decision. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Additional Issues </P></TD>
<TD>We may from time to time, without notice to or consent from the holders of the Notes, create and issue additional notes ranking equally and ratably with the Notes. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Book-Entry; Form and Denominations </P></TD>
<TD>The Notes will be issued only in book-entry form, in minimum denominations of &#128;100,000 and integral multiples of &#128;1,000 above that amount, through the facilities of Euroclear Bank SA/NV, as operator of Euroclear, and Clearstream.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Listing </P></TD>
<TD>We intend to apply to list the Notes on the NYSE. We will have no obligation to maintain the listing of the Notes, and we may delist the Notes at any time. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Trustee </P></TD>
<TD>The Bank of New York Mellon Trust Company, N.A. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Paying Agent </P></TD>
<TD>The Bank of New York Mellon, London Branch. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Governing Law </P></TD>
<TD>State of New York. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Legal Entity Identifier </P></TD>
<TD>7QEON6Y1RL5XR3R1W237. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Your investment in the Notes involves risks. You should consider carefully the risks described below and those discussed under the section
captioned &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September&nbsp;30, 2024. Each of the risks described in these documents could materially and adversely affect our
business, financial condition, results of operations and prospects, and could result in a partial or complete loss of your investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The
Notes are subject to prior claims of any of our secured creditors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are our unsubordinated general obligations, ranking
equally in right of payment with other unsubordinated debt, but will be effectively junior to any secured debt that we may incur to the extent of the value of the collateral securing such debt. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An active trading market for the Notes may not develop, which could limit their market prices or your ability to sell them. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes constitute a new issue of debt securities for which there currently is no trading market. As a result, we cannot provide any
assurance that any market will develop for the Notes or that you will be able to sell your Notes. Although we expect the Notes to be listed for trading on the NYSE, we cannot provide any assurance that the Notes will become or remain listed, that a
trading market for the Notes will develop or of the price at which investors may be able to sell the Notes, if at all. In addition, we will have no obligation to maintain, and may terminate, any listing of the Notes on the NYSE without the consent
of the holders of the Notes. If any of the Notes are traded after their initial issuance, they may trade at discounts from their initial offering prices depending on prevailing interest rates, the markets for similar securities, general economic
conditions, fluctuations in exchange rates with the euro, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the Notes, but they are not obligated to do so and
may discontinue any market-making at any time without notice. Accordingly, we cannot assure you that a liquid trading market will develop for the Notes, that you will be able to sell your Notes or that the prices you receive when you sell will be
favorable. To the extent an active trading market does not develop, the liquidity and trading price for the Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the Notes for an indefinite period of
time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The indenture does not restrict the amount of additional debt that we may incur or taking other actions that could negatively impact holders
of the Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be able to incur substantially more debt in the future, and have commenced an offering for the USD Notes
concurrently with this offering. The Notes and indenture governing the Notes will not limit us or our subsidiaries from incurring debt or additional liabilities. As of March&nbsp;31, 2025, we had outstanding long-term debt to third parties and
related parties of approximately $14.2&nbsp;billion (inclusive of approximately $4.0&nbsp;billion of <FONT STYLE="white-space:nowrap">non-recourse</FONT> long-term debt). Our incurrence of additional debt may have important consequences for holders
of the Notes, including making it more difficult for us to satisfy our obligations with respect to the Notes, a loss in the trading value of the Notes, if any, and a risk that the credit ratings of the Notes are lowered or withdrawn. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Structural subordination of the Notes to indebtedness of our subsidiaries and to the claims of secured creditors may reduce amounts available for
payment of the Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will not be guaranteed by any of our subsidiaries. As a result, the Notes will be structurally
subordinated to the indebtedness and other liabilities of our subsidiaries. Except to the extent that we are a creditor with recognized claims against our subsidiaries, all claims of creditors (including trade creditors) and holders of preferred
stock, if any, of our subsidiaries will have priority with respect to the assets of such subsidiaries over our claims (and therefore the claims of our creditors, including holders of the Notes). As of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
March&nbsp;31, 2025, our subsidiaries had debt of approximately $4.8&nbsp;billion (inclusive of approximately $4.0&nbsp;billion of <FONT STYLE="white-space:nowrap">non-recourse</FONT> long-term
debt). The Notes will not be secured by any of our assets, and as a result will be effectively junior to any secured debt that we or our subsidiaries may incur in the future, to the extent of the value of the assets securing such debt. Excluding any
of our consolidated subsidiaries, Air Products and Chemicals, Inc. had no secured indebtedness as of March&nbsp;31, 2025. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of the Notes will
receive payments solely in euros, except under limited circumstances, and investments in a currency other than the currency in which a holder of the Notes resides entails significant risks. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial investors in the Notes will be required to pay for the Notes in euros. All payments of principal, premium, if any, and interest in
respect of the Notes and any redemption prices for the Notes, will be paid in euros subject to certain limited exceptions. None of the Company, the underwriters, the trustee or the paying agent will be obligated to assist the initial investors in
obtaining euros or in converting other currencies into euros to facilitate the payment of the purchase price for the Notes or in converting payments of interest, principal, premium or any redemption price in euros made with respect to the Notes into
U.S. dollars or any other currency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in the Notes by a holder whose home currency is not the euro entails significant risks
not associated with a similar investment in a security denominated in the investor&#146;s home currency. In the case of the Notes offered hereby, these risks may include the possibility of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant changes in rates of exchange between the euro and the investor&#146;s home currency;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the imposition or subsequent modification of any foreign exchange gains results from an investment in the Notes;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the imposition or modification of foreign exchange controls or tax consequences with respect to the euro or the
investor&#146;s home currency; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">currency exchange risk in connection with any judgment that is entered with respect to payment on the Notes.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These risks depend on factors over which we have no control, such as economic, financial and political events and the
supply of and demand for the relevant currencies. In recent years, rates of exchange between the euro and certain currencies have been highly volatile, and each holder should be aware that volatility may be expected to continue in the future.
Fluctuations in any particular rate of exchange that have occurred in the past, however, are not necessarily indicative of fluctuations in the rate that may occur during the term of the Notes. Depreciation of the euro against the holder&#146;s
functional currency would result in a decrease in the effective yield of the Notes below the coupon rate and, in certain circumstances, could result in a loss to the holder. See &#147;<I>Currency Conversion.</I>&#148; If you are a beneficial owner
of Notes subject to U.S. federal income tax, see &#147;<I>Material United States Federal Income Tax Considerations</I>&#148; for certain U.S. federal income tax consequences related to the Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Notes permit us to make payments in U.S. dollars if we are unable to obtain euros. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no
longer being used by the then-member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, all payments in
respect of the Notes will be made in U.S. dollars until the euro is again available to us or so used. The amount payable on any date in euros will be converted into U.S. dollars in accordance with the indenture governing the Notes. Any payment in
respect of the Notes so made in U.S. dollars will not constitute an event of default under the Notes or the indenture governing the Notes. We cannot provide any assurance that this exchange rate will be as favorable to holders of Notes as the
exchange rate otherwise determined by applicable law or the exchange rate that might have been used had that rate been determined as of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a specific date or with reference to a specific publication or other source of exchange rate data. These potential developments, or market perceptions concerning these and related issues, could
materially adversely affect the value of the Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to repurchase the Notes upon a Change of Control Triggering Event.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a Change of Control Triggering Event, we will be required to make an offer to each holder of the Notes to
repurchase all or any part of that holder&#146;s Notes at a purchase price equal to 101% of the aggregate principal amount thereof, together with accrued and unpaid interest thereon to, but excluding, the date of repurchase. It is possible that we
will not have sufficient funds at the time of any Change of Control Triggering Event to make the required repurchases. In order to obtain sufficient funds to pay the purchase price of the outstanding Notes, we may need to refinance the Notes. We
cannot assure you that we would be able to refinance the Notes on reasonable terms, or at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Credit ratings of the Notes may change and affect
the market prices and marketability of the Notes or not reflect all risks of an investment in the Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit ratings are
limited in scope, and do not address all material risks relating to an investment in the Notes, but rather reflect only the view of each rating agency at the time the rating is issued. An explanation of the significance of such rating may be
obtained from such rating agency. We cannot provide any assurance that such credit ratings will remain in effect for any given period of time or that a rating will not be lowered, suspended or withdrawn entirely by the applicable rating agencies,
if, in such rating agency&#146;s judgment, circumstances so warrant. Each agency&#146;s rating should be evaluated independently of any other agency&#146;s rating. Agency credit ratings are not a recommendation to buy, sell or hold any security.
Actual or anticipated changes or downgrades in our credit ratings, including any announcement that our ratings are under review for a downgrade, could affect the market prices or marketability of the Notes and increase our corporate borrowing costs.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Redemption prior to maturity may adversely affect your return on the Notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since the Notes are redeemable at our option, we may choose to redeem your Notes at times when prevailing interest rates are relatively low. As
a result, you generally will not be able to reinvest the redemption proceeds in a comparable security at effective interest rates as high as the interest rates on your Notes being redeemed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An increase in market interest rates could result in a decrease in the market value of the Notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, as market interest rates rise, debt securities bearing interest at fixed rates of interest decline in value. Consequently, if you
purchase Notes and market interest rates increase, the market value of those Notes may decline. We cannot predict the future level of market interest rates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Trading in the clearing system is subject to minimum denomination requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Notes provide that Notes will be issued with a minimum denomination of &#128;100,000 and multiples of &#128;1,000 in excess
thereof. It is possible that the clearing systems may process trades that could result in amounts being held in denominations smaller than the minimum denominations. If definitive Notes are required to be issued in relation to such Notes in
accordance with the provisions of the relevant global note, a holder who does not have the minimum denomination or a multiple of &#128;1,000 in excess thereof in its account with the relevant clearing system at the relevant time may not receive all
of its entitlement in the form of definitive Notes unless and until such time as its holding satisfies the minimum denomination requirement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Proposed legislation could result in higher rates of tax imposed on Non-U.S. Holders (as defined
herein) that are resident in countries imposing &#147;unfair taxes.&#148; </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>Legislation is being considered by the U.S.
Congress that could affect the rates of U.S. federal income taxes imposed on holders of Notes. In particular, one proposal is being considered that could substantially increase certain U.S. tax rates applicable to payments made to residents of
countries that impose &#147;unfair foreign taxes.&#148; For that purpose, under the currently proposed version of Section&nbsp;899 of the U.S. Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), digital services taxes imposed by
countries aiming to tax the revenues of large technology companies derived from consumers within their borders, undertaxed profits rule taxes designed to ensure that multinational enterprises pay a minimum level of tax globally, and diverted profits
taxes targeting multinational companies that divert profits away from countries where the economic activities occur are deemed to be unfair foreign taxes. It is uncertain whether this legislation will pass in its current form or will be dropped
altogether from proposed legislation. Non-U.S. Holders should consult their tax advisors regarding the legislative proposals under consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_5"></A>CURRENCY CONVERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investors will be required to pay for the Notes in euros. All payments of principal, premium, if any, and interest on the Notes, including
payments made upon any redemption, and any other amounts that may be payable with respect to the Notes, will be payable in euros. If, however, the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our
control, or if the euro is no longer being used by the then-member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking
community, then all payments in respect of the Notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euros will be converted into U.S. dollars as determined by
a paying agent appointed by us and shall be equal to the sum obtained by converting euros into U.S. dollars at the exchange rate on the second business day preceding such interest payment date or the second business day preceding the maturity of an
installment of principal, as the case may be, or if no rate is quoted for euros, the last date such rate is quoted, all in accordance with the terms in the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investors will be subject to foreign exchange risks as to payments on the Notes that may have important economic and tax consequences to them.
See &#147;<I>Risk Factors.</I>&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of 9:00 a.m. (London Time) on June 10, 2025, the euro/U.S. dollar rate of exchange as reported by
Bloomberg was &#128;1/U.S.$1.1392. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from the sale of the Notes will be approximately &#128;495 million after deduction of the underwriting
discounts and estimated expenses related to the offering. We intend to use the net proceeds from the sale of the Notes and from the concurrent offering of USD Notes for general corporate purposes and to repay a portion of our outstanding commercial
paper obligations. As of June&nbsp;6, 2025, we had approximately $1,464&nbsp;million of commercial paper outstanding with a weighted average interest rate of 4.48% (on a bond equivalent yield basis) and a weighted average maturity of 16 days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of the underwriters and/or their respective affiliates may hold our commercial paper, which we intend to repay in part with the net
proceeds of this offering. Accordingly, such underwriters or their respective affiliates may receive at least 5% of the net proceeds of this offering, not including underwriting compensation, thus creating a &#147;conflict of interest&#148; within
the meaning of FINRA Rule 5121. Accordingly, this offering is being made in compliance with the requirements of FINRA Rule 5121. See &#147;<I>Underwriting (Conflicts of Interest)&#151;Conflicts of Interest</I>&#148; beginning on page S-27 of this
prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_7"></A>DESCRIPTION OF NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description of the particular terms of the 3.250% Notes due 2032 (the &#147;Notes&#148;) offered hereby supplements the
description of the general terms and provisions of the debt securities included in the accompanying prospectus. The following summary of the Notes is qualified in its entirety by reference in the accompanying prospectus to the description of the
indenture, dated as of April&nbsp;30, 2020 (the &#147;Indenture&#148;), entered into between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will issue &#128;500,000,000
aggregate principal amount of 3.250% Notes due 2032. The Notes will mature on June 16, 2032. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will constitute part of the senior
debt of the Company and will rank <I>pari passu </I>in right of payment with all other unsubordinated indebtedness of the Company. The Notes will be issued in fully registered form only, in denominations of &#128;100,000 and additional multiples of
&#128;1,000 above that amount, through the facilities of Euroclear and Clearstream, and sales in book-entry form may be effected only through participants in Euroclear or Clearstream. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will bear interest at the annual rate of 3.250%. Interest on the Notes will accrue from the date of issuance and be payable annually
on&nbsp;June 16, commencing on June 16, 2026, to the persons in whose names such Notes are registered at the close of business on the calendar day prior to the payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest payable at the maturity of the Notes will be payable to registered holders of the Notes to whom principal is payable. Interest will
be computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the Notes (or from June 16, 2025, if no interest
has been paid on the Notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as ACTUAL/ACTUAL (ICMA) as defined in the rulebook of the International Capital Markets Association. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any interest payment date falls on a day that is not a Business Day (as defined herein), the interest payment will be postponed to the next
day that is a Business Day, and no interest on such payment will accrue for the period from and after such interest payment date. If the maturity date of the Notes falls on a day that is not a Business Day, the payment of interest and principal
shall be made on the next succeeding Business Day, and no interest on such payment will accrue for the period from and after the maturity date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest payments for the Notes will include accrued interest from and including the date of issue or from and including the last date in
respect of which interest has been paid, as the case may be, to, but excluding, the interest payment date or the date of maturity, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the trustee nor the paying agent shall act as the exchange rate agent or have any responsibility for effecting any foreign currency
conversions or calculations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will constitute a single series of debt securities under the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may, without the consent of the holders of the Notes, issue additional Notes having the same priority and the same interest rate,
maturity and other terms (except for the issue date and public offering price and, if applicable, the initial interest payment date) as the Notes. Any additional Notes having such similar terms, together with the Notes, will constitute a single
series of debt securities under the Indenture. No additional Notes having such similar terms may be issued if an Event of Default has occurred and is continuing with respect to such Notes. In the event that any additional Notes are not fungible with
the Notes offered hereby for U.S. federal income tax purposes, such additional Notes will have a separate CUSIP, ISIN, or other identifying number so that they are distinguishable from the Notes offered hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this prospectus supplement, &#147;<I>Business Day</I>&#148; means any day, other
than a Saturday or Sunday, (i)&nbsp;that is neither a legal holiday nor a day on which banking institutions are authorized or required by law or regulation to close in The City of New York or London, and (ii)&nbsp;on which the Trans-European
Automated Real-Time Gross settlement Express Transfer system (the T2 System) or any successor thereto, is open. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issuance in Euros </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial investors in the Notes will be required to pay for the Notes in euros. Principal and interest payments of the Notes are payable by
us in euros. If, on or after the date of this prospectus supplement, the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then-member states
of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the Notes will be made in U.S.
dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euros will be converted into U.S. dollars in accordance with the Indenture. See &#147;<I>Currency Conversion.</I>&#148; Any payment
in respect of the Notes so made in U.S. dollars will not constitute an event of default under the Notes or the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investors will
be subject to foreign exchange risks as to payments of principal and interest that may have important economic and tax consequences to them. See &#147;<I>Risk Factors.</I>&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Optional Redemption </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our option, we
may redeem the Notes, in whole or in part, at any time or from time to time as described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we redeem all or any part of the Notes
prior to the Par Call Date (as defined herein), we will pay a redemption price equal to the greater of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">100% of the principal amount of the Notes being redeemed; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the sum of the present values of the remaining scheduled payments of principal and interest of the Notes being
redeemed, that would be due if the Notes matured on the Par Call Date (in each case, not including the amount, if any, of accrued and unpaid interest to, but excluding, the redemption date) discounted to the redemption date on an annual basis
(ACTUAL/ACTUAL (ICMA)) using a discount rate equal to the Comparable Government Bond Rate plus 15 basis points; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>plus</I>, in each case, any accrued and unpaid interest to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we redeem all or any part of the Notes on or after the Par Call Date, we will pay a redemption price equal to 100% of the principal amount
of the Notes being redeemed plus accrued and unpaid interest thereon. The redemption price shall be calculated by the Company. The Trustee shall have no responsibility to calculate the redemption price or determine the Comparable Government Bond
Rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Comparable Government Bond</I>&#148; means, in relation to any Comparable Government Bond Rate calculation, at the
discretion of an independent investment bank selected by us, a German <I>Bundesanleihe </I>security whose maturity is closest to the maturity of the Notes being redeemed (assuming that the Notes to be redeemed matured on the Par Call Date), or if
such independent investment bank in its discretion considers that such similar bond is not in issue, such other German <I>Bundesanleihe</I> security as such independent investment bank may, with the advice of three brokers of, or market makers in,
German <I>Bundesanleihe </I>securities selected by such independent investment bank, determine to be appropriate for determining the Comparable Government Bond Rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Comparable Government Bond Rate</I>&#148; means the price, expressed as a percentage (rounded to three decimal places, 0.0005 being
rounded upwards), at which the gross redemption yield on the Notes being redeemed, if they </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
were to be purchased at such price prior to the Par Call Date on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day
of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11:00 a.m. (London time) on such business day as determined by an independent investment bank selected by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Par Call Date</I>&#148; means April 16, 2032 (two months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption for Tax Reasons </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as a
result of any change in, or amendment to, the laws of the United States or the official interpretation thereof that is announced or becomes effective on or after the date of this prospectus supplement, we become obligated, or, based upon a written
opinion of nationally recognized independent counsel selected by us, there is a substantial probability that we will become obligated within 90 days to pay additional amounts as described herein under &#147;&#151; <I>Payment of Additional
Amounts&#148; </I>with respect to the Notes, then we may at any time at our option redeem, in whole, but not in part, the Notes on not less than 30 nor more than 60 days&#146; prior notice, at a redemption price equal to 100% of the principal amount
of the Notes being redeemed, together with accrued and unpaid interest on the Notes to, but excluding, the date fixed for redemption. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Change of
Control and Ratings Decline </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a Change of Control Triggering Event, we will be required to make an offer (a
&#147;Change of Control Offer&#148;) to each holder of the Notes to repurchase all or any part (equal to &#128;100,000 or an integral multiple of &#128;1,000 in excess thereof) of such holder&#146;s Notes at a purchase price equal to 101% of the
aggregate principal amount thereof, together with accrued and unpaid interest thereon to, but excluding, the date of repurchase (the &#147;Change of Control Payment&#148;). Within 30 days following any Change of Control Triggering Event, we will be
required to mail (or otherwise transmit in accordance with DTC procedures) a notice to each holder stating: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Change of Control Offer is being made pursuant to the covenant entitled &#147;Change of Control and
Ratings Decline&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the purchase price and the purchase date, which shall be no earlier than 30 days nor later than 45 days after
the date such notice is mailed (the &#147;Change of Control Payment Date&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that any Notes that are not tendered will continue to accrue interest in accordance with the terms of the
Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that, unless we default in the payment of the Change of Control Payment, all Notes that are accepted for
payment pursuant to the Change of Control Offer will cease to accrue interest after the Change of Control Payment Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that holders will be entitled to withdraw their election if the paying agent receives, not later than the close
of business on the fifth business day preceding the Change of Control Payment Date, a facsimile transmission or letter setting forth the name of the holder, the principal amount of Notes delivered for purchase, and a statement that such holder is
unconditionally withdrawing its election to have such Notes purchased; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that holders whose Notes are being purchased only in part will be issued new Notes that are equal in principal
amount to the unpurchased portion of the Notes that are surrendered, which unpurchased portion must be equal to &#128;100,000 in principal amount or an integral multiple of &#128;1,000 in excess thereof. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not be required to make a Change of Control Offer with respect to the Notes following a Change of Control Triggering Event if a third
party makes a Change of Control Offer for the Notes in the manner, at the times and otherwise in compliance with the requirements set forth in the form of Notes applicable to a Change of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Control Offer made by the Company and purchases all of the Notes that are validly tendered and not withdrawn under such Change of Control Offer. Notwithstanding anything to the contrary herein, a
Change of Control Offer may be made in advance of a Change of Control Triggering Event, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control at the time of making the Change of Control Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as described above with respect to a Change of Control Triggering Event, neither the Indenture nor the Notes contain any provisions
that permit the holders of the Notes to require that we repurchase or redeem the Notes in the event of a takeover, recapitalization or similar transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Capital Stock</I>&#148; means any and all shares, interests, participations, rights or other equivalents, however designated, of
corporate stock or partnership or membership interests, whether common or preferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Change of Control</I>&#148; means the
occurrence of any one of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the consummation of any transaction (including without limitation, any merger or consolidation) the result of
which is that any person (including any &#147;person&#148; (as that term is used in Section&nbsp;13(d)(3) of the Exchange Act) other than us or one of our subsidiaries) becomes the &#147;beneficial owner&#148; (as defined in Rules <FONT
STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act), directly or indirectly, of more than 50% of the Company&#146;s outstanding Voting Stock, measured by voting power rather than number
of shares; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the adoption of a plan relating to the liquidation or dissolution of the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;we become a direct or indirect
wholly owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of our Voting Stock immediately prior
to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of
such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Change of Control Triggering Event</I>&#148; means the occurrence of both a Change of Control and a
Ratings Decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Investment Grade</I>&#148; means a rating of Baa3 or better by Moody&#146;s (or its equivalent under any
successor rating category of Moody&#146;s) and a rating of <FONT STYLE="white-space:nowrap">BBB-</FONT> or better by S&amp;P (or its equivalent under any successor rating category of S&amp;P). In the event that we shall select any other Rating
Agency, the equivalent of such ratings by such Rating Agency shall be used. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Moody&#146;s</I>&#148; means Moody&#146;s Investors
Service, Inc., a subsidiary of Moody&#146;s Corporation, and its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Rating Agency</I>&#148; means each of Moody&#146;s
and S&amp;P and any other Rating Agency appointed by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Ratings Decline</I>&#148; means, with respect to the Notes,
within 60 days after the earlier of (i)&nbsp;the occurrence of a Change of Control or (ii)&nbsp;public notice of the occurrence of a Change of Control or the intention by the Company to effect a Change of Control (which period shall be extended so
long as the rating of the Notes is under publicly announced consideration for a possible downgrade by any of the Rating Agencies) (the &#147;Trigger Period&#148;), (a) if two or more Rating Agencies are providing a rating for the Notes at the
commencement of any Trigger Period, the rating of the Notes shall be reduced by at least two Rating Agencies and the Notes shall be rated below Investment Grade by each of such Rating Agencies or (b)&nbsp;if only one Rating Agency is providing a
rating for the Notes at the commencement of any Trigger Period, the rating of the Notes shall be reduced by such Rating Agency and the Notes shall be rated below Investment Grade by such Rating Agency. Neither the trustee nor the paying agent shall
be responsible for monitoring our Investment Grade status or determining whether a Ratings Decline has occurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>S&amp;P</I>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc.,
and its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Voting Stock</I>&#148; with respect to any person, means securities of any class of Capital Stock of such
person entitling the holders thereof (whether at all times or only so long as no senior class of stock or other relevant equity interest has voting power by reason of any contingency) to vote in the election of members of the board of directors of
such person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will comply in all material respects with the requirements of Regulation 14E under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any such
securities laws or regulations conflict with the Change of Control Offer provisions of the Notes, the Company will comply with those securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control
Offer provisions of the Notes by virtue of any such conflict. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discharge and Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of the Indenture described in the accompanying prospectus under &#147;<I>Description of Debt Securities&#151;Discharge and
Defeasance</I>&#148; will apply to the Notes. In addition, as a condition to defeasance, we must deliver to the trustee an opinion of counsel to the effect that the beneficial owners of the Notes will not recognize income, gain, or loss for U.S.
federal income tax purposes as a result of such defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such defeasance had not occurred. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Payment of Additional Amounts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will,
subject to the exceptions and limitations set forth below, pay as additional interest on the Notes such additional amounts as are necessary in order that the net payment by us or the applicable withholding agent of the principal of and interest on
the Notes with respect to a payee that is not a United States person (as defined herein), after withholding or deduction for any present or future tax, assessment or other governmental charge imposed by the United States or a taxing authority in the
United States, will not be less than the amount provided in the Notes to be then due and payable; provided, however, that the foregoing obligation to pay additional amounts shall not apply: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge that would not have been imposed but for the holder, a
fiduciary, settlor, beneficiary, member or shareholder of the holder, or a person holding a power over an estate or trust administered by a fiduciary holder, being treated as: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">being or having been engaged in a trade or business in the United States, or having or having had a permanent
establishment in the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">having a current or former connection with the United States (other than a connection arising solely as a
result of the ownership of the Notes, the receipt of any payment in respect of the Notes or the enforcement of any rights under the Indenture), including being or having been a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">being or having been a personal holding company, a passive foreign investment company or a controlled foreign
corporation for U.S. federal income tax purposes, a foreign tax exempt organization, or a corporation that has accumulated earnings to avoid United States federal income tax; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">being or having been a <FONT STYLE="white-space:nowrap">&#147;10-percent</FONT> shareholder&#148; of the
Company, as defined in Section&nbsp;871(h)(3) of the Code, or any successor provision; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the
ordinary course of its trade or business, within the meaning of Section&nbsp;881(c)(3) of the Code or any successor provision; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any holder that is not the sole beneficial owner of the Notes, or a portion of the Notes, or that is a
fiduciary, partnership or limited liability company, but only to the extent that a beneficiary or settlor with respect to the fiduciary, a beneficial owner or member of the partnership or limited liability company would not have been entitled to the
payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge that would not have been imposed but for the failure of the
holder or beneficial owner to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the Notes, if
compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other
governmental charge; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding from the
payment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge that would not have been imposed but for a change in law,
regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any estate, inheritance, gift, sales, excise, transfer, wealth, capital gains or personal property tax or
similar tax, assessment or other governmental charge; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge required to be withheld by any paying agent from any
payment of principal of or interest on any Note, if such payment can be made without such withholding by any other paying agent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge that would not have been imposed but for presentation by
the holder of any Note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any tax, assessment or other governmental charge required to be withheld or deducted that is imposed on a
payment pursuant to Sections 1471 through 1474 of the Code (or any amended or successor version of such Sections that is substantively comparable and not materially more onerous to comply with), any Treasury Regulations promulgated thereunder, or
any other official interpretations thereof, any agreement (including any intergovernmental agreement) entered into in connection therewith, or any law, regulation or other official guidance enacted in any jurisdiction implementing FATCA (as defined
herein) or an intergovernmental agreement in respect of FATCA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any combination of items (1), (2), (3), (4), (5), (6), (7), (8), and (9). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as specifically provided under this heading &#147;&#151;<I>Payment of Additional Amounts,&#148;</I> we will not be required to pay
additional amounts in respect of any tax, assessment or other governmental charge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used under this &#147;&#151;<I>Payment of
Additional Amounts&#148;</I> and under &#147;&#151;<I>Redemption for Tax Reasons,&#148;</I> the term &#147;United States&#148; means the United States of America, any state thereof, and the District of Columbia, and the term &#147;United States
person&#148; means (i)&nbsp;any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii)&nbsp;a corporation, partnership or other entity created or organized in or under the laws of the United States,
any state thereof or the District of Columbia (other than a partnership that is not treated as a United States person for U.S. federal income tax purposes) or treated as a domestic corporation under </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;7874(b) of the Code, (iii)&nbsp;any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv)&nbsp;any trust if a U.S. court can
exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to apply to list the
Notes on the NYSE, and we expect trading in the Notes on the NYSE to begin within 30 days after the initial issuance of the Notes. We will have no obligation to maintain the listing of the Notes, and we may delist the Notes at any time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-Entry System </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will be
issued in the form of one or more fully registered global notes and will be deposited with a common depositary for, and in respect of interests held through, Euroclear Bank SA/NV, as operator of Euroclear, and Clearstream. Except as described
herein, certificates will not be issued in exchange for beneficial interests in the global notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have obtained the information in
this section concerning Clearstream and Euroclear Bank SA/NV, or its successor, as operator of Euroclear, and their book-entry systems and procedures from sources that we believe to be reliable. We take no responsibility for an accurate portrayal of
this information. In addition, the description of the clearing systems in this section reflects our understanding of the rules and procedures of Clearstream and Euroclear as they are currently in effect. Those clearing systems could change their
rules and procedures at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will initially be represented by one or more fully registered global notes. Each such global
note will be deposited with, or on behalf of, a common depositary, and registered in the name of the nominee of the common depositary for the accounts of Clearstream and Euroclear. Except as set forth below, the global notes may be transferred, in
whole and not in part, only to Euroclear or Clearstream or their respective nominees. You may hold your interests in the global notes in Europe through Clearstream or Euroclear, either as a participant in such systems or indirectly through
organizations which are participants in such systems. Clearstream and Euroclear will hold interests in the global notes on behalf of their respective participating organizations or customers through customers&#146; securities accounts in
Clearstream&#146;s or Euroclear&#146;s names on the books of their respective depositaries. Book-entry interests in the Notes and all transfers relating to the Notes will be reflected in the book-entry records of Clearstream and Euroclear. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The distribution of the Notes will be cleared through Clearstream and Euroclear. Any secondary market trading of book-entry interests in the
Notes will take place through Clearstream and Euroclear participants and will settle in <FONT STYLE="white-space:nowrap">same-day</FONT> funds. Owners of book-entry interests in the Notes will receive payments relating to their Notes in euros. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clearstream and Euroclear have established electronic securities and payment transfer, processing, depositary and custodial links among
themselves and others, either directly or through custodians and depositaries. These links allow book-entry interests in the Notes to be issued, held and transferred among the clearing systems without the physical transfer of certificates. Special
procedures to facilitate clearance and settlement have been established among these clearing systems to trade securities across borders in the secondary market. The policies of Clearstream and Euroclear will govern payments, transfers, exchanges and
other matters relating to the investor&#146;s interest in the Notes held by them. We have no responsibility for any aspect of the records kept by Clearstream or Euroclear or any of their direct or indirect participants. We also do not supervise
these systems in any way. Clearstream and Euroclear and their participants perform these clearance and settlement functions under agreements they have made with one another or with their customers. You should be aware that they are not obligated to
perform or continue to perform these procedures and may modify them or discontinue them at any time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided below, owners of beneficial interests in the Notes will not be entitled
to have the Notes registered in their names, will not receive or be entitled to receive physical delivery of the Notes in definitive form and will not be considered the owners or holders of the Notes under the Indenture, including for purposes of
receiving any reports delivered by us or the trustee pursuant to the Indenture. Accordingly, each person owning a beneficial interest in a Note must rely on the procedures of the depositary and, if such person is not a participant, on the procedures
of the participant through which such person owns its interest, in order to exercise any rights of a holder of Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Clearstream </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clearstream advises that it is incorporated under the laws of Luxembourg as a professional depositary. Clearstream holds securities for its
participating organizations (&#147;Clearstream Participants&#148;). Clearstream facilitates the clearance and settlement of securities transactions between Clearstream Participants through electronic book-entry changes in accounts of Clearstream
Participants, thereby eliminating the need for physical movement of certificates. Clearstream provides to Clearstream Participants, among other things, services for safekeeping, administration, clearance and settlement of internationally traded
securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries. As a professional depositary, Clearstream is subject to regulation by the Luxembourg Commission for the Supervision of the Financial
Sector (<I>Commission de Surveillance du Secteur Financier</I>). Clearstream Participants are recognized financial institutions around the world, including underwriters, securities brokers and dealers, banks, trust companies, clearing corporations
and certain other organizations and may include the underwriters. Indirect access to Clearstream is also available to others, such as banks, brokers, dealers and trust companies, that clear through or maintain a custodial relationship with a
Clearstream Participant, either directly or indirectly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions with respect to interests in the Notes held beneficially through
Clearstream will be credited to the cash accounts of Clearstream Participants in accordance with its rules and procedures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Euroclear </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Euroclear advises that it was created in 1968 to hold securities for participants of Euroclear (&#147;Euroclear Participants&#148;) and to
clear and settle transactions between Euroclear Participants through simultaneous electronic book-entry delivery against payment, thereby eliminating the need for physical movement of certificates and any risk from lack of simultaneous transfers of
securities and cash. Euroclear includes various other services, including securities lending and borrowing and interfaces with domestic markets in several countries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Euroclear is operated by Euroclear Bank SA/NV (the &#147;Euroclear Operator&#148;). All operations are conducted by the Euroclear Operator,
and all Euroclear securities clearance accounts and Euroclear cash accounts are accounts with the Euroclear Operator. Euroclear Participants include banks (including central banks), securities brokers and dealers and other professional financial
intermediaries and may include the underwriters. Indirect access to Euroclear is also available to other firms that clear through or maintain a custodial relationship with a Euroclear Participant, either directly or indirectly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Terms and Conditions Governing Use of Euroclear and the related Operating Procedures of the Euroclear System, or the Euroclear Terms and
Conditions, and applicable Belgian law govern securities clearance accounts and cash accounts with the Euroclear Operator. Specifically, these terms and conditions govern transfers of securities and cash within Euroclear, withdrawal of securities
and cash from Euroclear, and receipt of payments with respect to securities in Euroclear. All securities in Euroclear are held on a fungible basis without attribution of specific certificates to specific securities clearance accounts. The Euroclear
Operator acts under the terms and conditions only on behalf of Euroclear Participants, and has no record of or relationship with persons holding securities through Euroclear Participants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions with respect to interests in the Notes held beneficially through Euroclear will be credited to the cash accounts of Euroclear
Participants in accordance with the Euroclear Terms and Conditions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Clearance and Settlement Procedures </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We understand that investors that hold their Notes through Clearstream or Euroclear accounts will follow the settlement procedures that are
applicable to conventional eurobonds in registered form. Notes will be credited to the securities custody accounts of Clearstream and Euroclear participants on the business day following the settlement date, for value on the settlement date. They
will be credited either free of payment or against payment for value on the settlement date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We understand that secondary market trading
between Clearstream and/or Euroclear participants will occur in the ordinary way following the applicable rules and operating procedures of Clearstream and Euroclear. Secondary market trading will be settled using procedures applicable to
conventional eurobonds in registered form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should be aware that investors will only be able to make and receive deliveries, payments
and other communications involving the Notes through Clearstream and Euroclear on days when those systems are open for business. Those systems may not be open for business on days when banks, brokers and other institutions are open for business in
the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, because of time-zone differences, there may be problems with completing transactions involving
Clearstream and Euroclear on the same business day as in the United States. U.S. investors who wish to transfer their interests in the Notes, or to make or receive a payment or delivery of the Notes, on a particular day, may find that the
transactions will not be performed until the next business day in Luxembourg or Brussels, depending on whether Clearstream or Euroclear is used. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clearstream or Euroclear will credit payments to the cash accounts of Clearstream customers or Euroclear participants, as applicable, in
accordance with the relevant system&#146;s rules and procedures, to the extent received by its depositary. Clearstream or the Euroclear Operator, as the case may be, will take any other action permitted to be taken by a holder under the Indenture on
behalf of a Clearstream customer or Euroclear participant only in accordance with its relevant rules and procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clearstream and
Euroclear have agreed to the foregoing procedures in order to facilitate transfers of interests in the Notes among participants of Clearstream and Euroclear. However, they are under no obligation to perform or continue to perform those procedures,
and they may discontinue those procedures at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certificated Notes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Notes represented by the global notes are exchangeable for certificated Notes in definitive form of like
tenor in minimum denominations of &#128;100,000 principal amount and multiples of &#128;1,000 in excess thereof if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the common depositary (A)&nbsp;notifies us that it is unwilling or unable to continue as depositary for the
global notes or (B)&nbsp;has ceased to be a clearing agency registered under the Exchange Act and, in each case, a successor depositary is not appointed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">we, at our option, notify the trustee in writing that we elect to cause the issuance of certificated Notes; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there has occurred and is continuing an Event of Default with respect to the Notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In all cases, certificated Notes delivered in exchange for any global note will be registered in the names, and issued in any approved
denominations, requested by or on behalf of the common depositary (in accordance with its customary procedures). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments (including
principal, premium and interest) and transfers with respect to Notes in certificated form may be executed at the office or agency maintained for such purpose in London (initially the office of the paying
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agent maintained for such purpose) or, at our option, by check mailed to the holders thereof at the respective addresses set forth in the register of holders of the Notes, provided that all
payments (including principal, premium and interest) on Notes in certificated form, for which the holders thereof have given wire transfer instructions, will be required to be made by wire transfer of immediately available funds to the accounts
specified by the holders thereof. No service charge will be made for any registration of transfer, but payment of a sum sufficient to cover any tax or governmental charge payable in connection with that registration may be required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Euroclear and Clearstream Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of Air Products, any agent or any underwriter or any affiliate of any of the above or any person by whom any of the above is controlled
(as such term is defined in the Securities Act), have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in the global notes or for maintaining, supervising or
reviewing any records relating to such beneficial ownership interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because Euroclear and Clearstream can only act on behalf of
participants, who in turn act on behalf of indirect participants, the ability of a person having an interest in the global notes to pledge such interest to persons or entities which do not participate in the relevant clearing system, or otherwise
take actions in respect of such interest, may be affected by the lack of a physical certificate in respect of such interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trustee, Registrar and
Paying Agent </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Bank of New York Mellon Trust Company, N.A. is the trustee under the Indenture. We may maintain deposit accounts and
conduct other banking transactions with the trustee or an affiliate of the trustee in the ordinary course of business. The Trustee will also initially be the registrar for the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The paying agent for the Notes will initially be The Bank of New York Mellon, London Branch. Upon notice to the trustee, we may change the
paying agent at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture is, and the Notes will be, governed by and construed in accordance with the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_8"></A>MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
discussion summarizes material U.S. federal income tax consequences generally applicable to the purchase, ownership and disposition of the Notes for cash in the original issue and at the Notes&#146; &#147;issue price&#148; within the meaning of the
Code (<I>i.e.</I>, the first price at which a substantial amount of Notes is sold for cash to persons other than bond houses, brokers or similar persons or organizations acting in the capacity of underwriters, placement agents, or wholesalers). This
summary is for general information purposes only and does not purport to consider all aspects of U.S. federal income taxation that might be relevant to a holder of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is based on the Code, U.S. Treasury Department regulations thereunder (&#147;Treasury Regulations&#148;), rulings,
administrative pronouncements and judicial decisions, all as in effect on the date of this prospectus supplement and all of which are subject to change or differing interpretations, possibly with retroactive effect. Any such change or differing
interpretation may alter the U.S. federal income tax consequences described herein. Accordingly, the discussion below neither binds the Internal Revenue Service (the &#147;IRS&#148;) nor precludes it from adopting a contrary position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion addresses only holders that hold the Notes as capital assets (within the meaning of the Code). It does not address any tax
consequences applicable to holders that are subject to special rules, including persons that own (or are deemed to own) 10% or more of the total combined voting power of all classes of our stock entitled to vote, &#147;controlled foreign
corporations,&#148; holders that are dealers in securities or foreign currency, financial institutions or insurance companies, mutual funds, regulated investment companies, holders that hold the Notes through individual retirement or other <FONT
STYLE="white-space:nowrap">tax-deferred</FONT> accounts, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations, partnerships (or arrangements treated as partnerships for U.S. federal income tax purposes), real estate investment trusts, S
corporations and other pass-through entities, U.S. Holders (as defined herein) whose functional currency is not the U.S. dollar, holders that hold the Notes as part of an integrated investment (including a straddle, constructive sale or conversion
transaction) comprised of the Notes and one or more other positions, and persons who are former citizens or residents of the United States. This discussion does not address the Medicare tax on net investment income or alternative minimum tax
provisions and, except where specifically indicated, this discussion does not discuss the effect of any other federal tax laws (e.g., estate and gift tax), or any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, this discussion applies to you only if you purchase your Notes for cash pursuant to this offering at the public offering price
that appears on the front of this prospectus supplement. This discussion does not apply to bond houses, brokers or similar persons or organizations acting in the capacity of underwriters, placement agents, or wholesalers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership (including any entity treated as a partnership or other pass-through entity for U.S. federal income tax purposes) holds the
Notes, the tax treatment of a partner of such partnership or member of such other pass-through entity will generally depend upon the status of the partner or member and the activities of the partnership or other pass-through entity. Partnerships and
other pass-through entities holding the Notes, and any person who is a partner or member of any such entity, should consult their own tax advisors regarding the particular U.S. federal income tax considerations applicable to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary of U.S. income tax considerations is for general information purposes only and is not tax advice. Each potential holder of the
Notes is urged to consult his, her or its own tax advisor regarding the applicable U.S. federal, state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> income and other tax consequences of the ownership and disposition of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is anticipated, and this discussion assumes, that the Notes will not be issued with more than a <I>de minimis </I>amount of original issue
discount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section applies to you only if you are a U.S. Holder. For purposes of this discussion, you are a &#147;U.S. Holder&#148; if you are a
beneficial owner of a Note and you are, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or other entity taxable as a corporation) created or organized in the U.S. or under the laws of
the U.S., any state thereof, or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust that (i)&nbsp;is subject to the primary supervision of a court within the United States and under the
control of one or more &#147;United States persons&#148; (as defined for U.S. federal income tax purposes) or (ii)&nbsp;has a valid election in effect under applicable U.S. Treasury regulations to be treated as a &#147;United States person.&#148;
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on the Notes will generally be taxable to you as ordinary interest income at the time it is paid or accrued in accordance with your
regular method of accounting for U.S. federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A U.S. Holder that uses the cash method of tax accounting will be
required to include in income the U.S. dollar value of each interest payment received based on the spot rate of exchange on the date of receipt. No foreign currency exchange gain or loss will be recognized with respect to the receipt of such payment
(other than foreign currency exchange gain or loss realized on the disposition of the euros so received, see &#147; &#151; <I>Transactions in Euros</I>,&#148; below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A U.S. Holder that uses the accrual method of tax accounting will accrue interest income on such Note in euros and translate the amount
accrued into U.S. dollars based on: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average exchange rate in effect during the interest accrual period, or portion thereof, within such U.S.
Holder&#146;s taxable year; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at your election, at the spot rate of exchange on (1)&nbsp;the last day of the accrual period, or (2)&nbsp;the
date of receipt, if such date is within five business days of the last day of the accrual period or the last day of the taxable year within such accrual period if the accrual period spans more than one taxable year. Such election must be applied
consistently by you to all debt instruments from year to year and can be changed only with the consent of the IRS. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
U.S. Holder that uses the accrual method of tax accounting will recognize foreign currency exchange gain or loss on the receipt of an interest payment equal to the difference between (i)&nbsp;the value of the euros received as interest, as
translated into U.S. dollars using the spot rate of exchange on the date of receipt and (ii)&nbsp;the U.S. dollar amount of such accrued interest as previously included in your income. Such foreign currency exchange gain or loss will be treated as
ordinary income or loss but will generally not be treated as an adjustment to interest income received on the Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale or Other Taxable
Disposition of the Notes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the sale, exchange, retirement at maturity, redemption or other taxable disposition of a Note
(collectively, a &#147;Disposition&#148;), except as noted below with respect to foreign currency exchange gain or loss, you will generally recognize capital gain or loss equal to the difference between the amount realized by you (except to the
extent such amount is attributable to accrued but unpaid interest, which will be treated as ordinary interest income if such interest has not been previously included in income) and your adjusted tax basis in the Note. Subject to the discussion
below, the adjusted tax basis of a Note to you will generally be the U.S. dollar value of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the euro purchase price calculated at the spot rate of exchange on the date of purchase and the amount realized by you upon the Disposition of a Note will generally be the U.S. dollar value of
the euros received calculated at the spot rate of exchange on the date of Disposition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Notes are traded on an established
securities market, a U.S. Holder that uses the cash method of tax accounting, and if it so elects, a U.S. Holder that uses the accrual method of tax accounting, will determine the U.S. dollar values of its adjusted tax basis in a Note and the amount
realized on the Disposition of a Note by translating the relevant euro amounts at the spot rate of exchange on the settlement date of the purchase or the Disposition, respectively. The election available to accrual basis U.S. Holders discussed above
must be applied consistently by you to all debt instruments from year to year and can be changed only with the consent of the IRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain
or loss recognized by you on a Disposition of a Note will generally be treated as ordinary income or loss to the extent that the gain or loss is attributable to changes in the euro to U.S. dollar exchange rate during the period in which you held
such Note. Such foreign currency exchange gain or loss will equal the difference between (x)&nbsp;the U.S. dollar value of the euro purchase price of the Notes, as determined on the date of Disposition (or on the settlement date in respect of such
Disposition, if the Notes are traded on an established securities market and you are either a cash basis U.S. Holder or an electing accrual basis U.S. Holder), and (y)&nbsp;the U.S. dollar value of such euro purchase price, as determined using the
spot rate of exchange on the date when you acquired the Note (or on the settlement date in respect of such acquisition, if the Notes are traded on an established securities market and you are either a cash basis U.S. Holder or an electing accrual
basis U.S. Holder). The recognition of such foreign currency exchange gain or loss on the Disposition of a Note will be limited to the amount of overall gain or loss realized on the Disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as described above, any gain or loss on the Disposition of a Note will be long-term capital gain or loss if your holding period for the
Note exceeds one year on the date of Disposition. Long-term capital gains recognized by individuals and certain other <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders are eligible for reduced rates of taxation. The deductibility of
capital losses is subject to limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transactions in Euros </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Euros received as interest on, or on a Disposition of, a Note will have a tax basis equal to their U.S. dollar value at the time such interest
is received or at the time such proceeds from Disposition are received. The amount of gain or loss on a sale or other Disposition of such euros will be equal to the difference between (1)&nbsp;the amount of U.S. dollars, or the fair market value in
U.S. dollars of the other property received in such sale or other Disposition, and (2)&nbsp;the U.S. Holder&#146;s adjusted tax basis in such euros. A U.S. Holder that purchases a Note with previously owned euros will generally recognize gain or
loss in an amount equal to the difference, if any, between such U.S. Holder&#146;s adjusted tax basis in such euros and the U.S. dollar fair market value of such Note on the date of purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such gain or loss will generally be ordinary income or loss and will not be treated as interest income or expense. The conversion of U.S.
dollars to euros and the immediate use of such euros to purchase a Note will generally not result in any exchange gain or loss for a U.S. Holder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reportable Transaction Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under applicable Treasury Regulations, a U.S. Holder who participates in &#147;reportable transactions&#148; (as defined in the Treasury
Regulations) must attach to its United States federal income tax return a disclosure statement on IRS Form 8886. Under the relevant rules, you may be required to treat a foreign currency exchange loss from the Notes as a reportable transaction if
this loss exceeds the relevant threshold in the Treasury Regulations. You should consult with your tax advisor to determine the tax reporting obligations, if any, including any requirement to file IRS Form 8886, with respect to the ownership or
Disposition of the Notes or any related transaction such as the Disposition of any euros received in respect of the Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Information Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information reporting generally will apply to payments of interest on the Notes and to the proceeds of a sale or other taxable disposition of a
Note paid to a U.S. Holder unless the U.S. Holder is an exempt recipient. U.S. federal backup withholding generally will apply to such payments if the U.S. Holder fails to provide the applicable withholding agent with a properly completed and
executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> providing such U.S. Holder&#146;s correct taxpayer identification number and certifying that such U.S. holder is not subject to backup withholding, or to otherwise establish an exemption.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules will be allowed as a refund or a
credit against a U.S. Holder&#146;s U.S. federal income tax liability, if any, provided that the required information is furnished timely to the IRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section applies to you only if you are a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder. For purposes of this discussion, you are a <FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> Holder&#148; if you are a beneficial owner of the Notes that, for U.S. federal income tax
purposes, is neither a U.S. Holder nor an entity or arrangement classified as a partnership under the Code. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of interest on the Notes by us or any paying agent to you will be exempt from U.S. federal withholding tax, if you: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">do not own, actually or constructively, 10% or more of the combined voting power of all classes of our stock
entitled to vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">are not a &#147;controlled foreign corporation&#148; related directly or indirectly to us through stock
ownership; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certify to the U.S. payor on IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or IRS Form <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable (or an appropriate substitute form), under penalties of perjury, that you are not a United States person for U.S. federal income tax purposes and are
not subject to withholding required pursuant to FATCA (discussed below). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold the Notes through a financial
institution or other agent acting on your behalf, you will be required to provide appropriate documentation to the agent who will then be required to provide certification to the U.S. payor, either directly or through other intermediaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you do not qualify for this exemption from U.S. federal withholding tax you may also be entitled to an exemption from, or reduction of,
U.S. federal withholding tax if you are entitled to the benefits of an income tax treaty under which interest is exempt from, or eligible for a reduced rate of, U.S. federal withholding tax, and you (or your agent) provide to the applicable
withholding agent a properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable (or an appropriate substitute form),
claiming eligibility for the benefits of the income tax treaty with respect to interest payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Otherwise, payments of interest are
generally subject to U.S. federal withholding tax at a rate of 30%. No U.S. federal withholding tax applies, however, if interest on your Note is effectively connected with the conduct by you of a trade or business in the United States (and, if
required by an applicable income tax treaty, the interest is attributable to a permanent establishment or fixed base maintained in the United States), provided that you (or your agent) have provided a properly executed IRS Form <FONT
STYLE="white-space:nowrap">W-8ECI.</FONT> To the extent payments of interest are effectively connected with your conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, the interest is attributable
to a permanent establishment or fixed base maintained in the United States), you will be subject to U.S. federal income tax on a net basis. Furthermore, if you are a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder, you may, under certain circumstances, be subject to an additional branch profits tax at a 30% rate (or such lower rate under an
applicable income tax treaty) with respect to your &#147;effectively connected&#148; interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale or Other Taxable Disposition of the Notes
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except with respect to accrued and unpaid interest (which would be subject to the rules discussed above under
&#147;&#151;<I>Interest Payments</I>&#148;)<I>,</I> you will generally not be subject to U.S. federal income tax on gain recognized on a Disposition of the Notes, unless the gain is effectively connected with the conduct of a trade or business in
the United States (and, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment or fixed base maintained in the United States) or, if you are an individual
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder, unless you are present in the United States for 183 days or more in the taxable year of the Disposition and certain other conditions are met. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are engaged in a trade or business in the United States and you recognize gain on a Disposition of the Notes that is effectively
connected with that trade or business (and, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment or fixed base maintained in the United States), you will generally be taxed on a net income basis with
respect to such gain as if you were a U.S. Holder. If you are a corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder, you may, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; at a 30% rate (or at
a lower rate under an applicable income tax treaty) on your &#147;effectively connected&#148; gains. If you are an individual <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is present for 183 days or more during the taxable year in
which gain is realized (and certain other conditions are met), you will generally be subject to U.S. federal income tax at a rate of 30% (or at a reduced rate under an applicable income tax treaty) on the amount by which your capital gains allocable
to U.S. sources (including gains from the Disposition of the Notes) exceed your capital losses allocable to U.S. sources. You should consult your tax advisor with respect to the tax consequences of the ownership and Disposition of the Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Information Reporting and Backup Withholding </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of interest made to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder, and any amounts withheld from such payments, generally
will be required to be reported to the IRS. The IRS may make this information available under the provisions of an applicable tax treaty to the tax authorities in the country in which the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is
resident. Backup withholding generally will not apply to payments of interest and principal on a note to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder if you duly provide a certification of foreign status such as a properly executed IRS
Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other appropriate IRS Form <FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable (or
appropriate substitute or successor form) or if you otherwise establish an exemption from backup withholding, provided that we do not have actual knowledge or reason to know that you are a U.S. person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of the proceeds of a sale or other disposition of a note effected by the U.S. office of a U.S. or foreign broker will be subject to
information reporting requirements and backup withholding unless you properly certify under penalties of perjury as to your foreign status and certain other conditions are met or you otherwise establish an exemption. Information reporting
requirements, but not backup withholding, generally will apply to any payment of the proceeds of the sale of a note effected outside the United States by a foreign office of a broker that has certain connections to the U.S. unless such a broker has
documentary evidence in its records that you are a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder and certain other conditions are met or you otherwise establish an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amount withheld under the backup withholding rules may be credited against your U.S. federal
income tax liability and any excess may be refunded if the proper information is provided to the IRS on a timely basis.<B><I>&nbsp;</I></B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FATCA
Withholding </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Code and applicable Treasury Regulations thereunder (commonly referred to as
&#147;FATCA&#148;) generally impose a 30% withholding tax in certain circumstances on interest payable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(including any original issue discount) on certain debt obligations of U.S. issuers held by or through certain financial institutions (including investment funds), unless such institution
(i)&nbsp;enters into, and complies with, an agreement with the IRS to report, on an annual basis, information with respect to interests in, and accounts maintained by, the institution that are owned by certain U.S. persons or by certain <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> entities that are wholly or partially owned by U.S. persons and to withhold on certain payments, (ii)&nbsp;if required under an intergovernmental agreement between the United States and an applicable
foreign country, reports such information to its local tax authority, which will exchange such information with the U.S. authorities, or (iii)&nbsp;otherwise qualifies for an exemption from these requirements. An intergovernmental agreement between
the United States and an applicable foreign country may modify these requirements. Accordingly, the entity through which Notes are held will affect the determination of whether such withholding is required. Similarly, interest payable on Notes held
by an investor that is a <FONT STYLE="white-space:nowrap">non-financial</FONT> <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entity that does not qualify under certain exemptions will generally be subject to withholding at a rate of 30%, unless
such entity either (i)&nbsp;certifies that such entity does not have any &#147;substantial United States owners,&#148; (ii)&nbsp;provides certain information regarding the entity&#146;s &#147;substantial United States owners,&#148; which the payor
will generally be required to provide to the IRS or (iii) otherwise qualifies for an exemption from these requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prospective
investors should consult with their own tax advisors regarding the possible implications of FATCA with respect to an investment in the Notes. In addition, prospective investors whose Notes will be held through a bank or broker should consult their
bank or broker about the likelihood that payments to the bank or broker (for credit to such investors) will become subject to withholding in the payment chain. Investors in the Notes could be affected by FATCA withholding if a financial institution
or other intermediary in the payment chain, such as a bank or broker, through which they hold the Notes is subject to withholding because it fails to comply with the reporting requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_9"></A>UNDERWRITING (CONFLICTS OF INTEREST) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC, Cr&eacute;dit Agricole Corporate&nbsp;&amp; Investment Bank, Deutsche Bank AG, London Branch, J.P. Morgan Securities plc,
and Standard Chartered Bank are acting as representatives of each of the underwriters named below. Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters,
and each of the underwriters has agreed, severally and not jointly, to purchase from us, the principal amount of Notes set forth opposite its name below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of&nbsp;Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cr&eacute;dit Agricole Corporate&nbsp;&amp; Investment Bank</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deutsche Bank AG, London Branch</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Standard Chartered Bank</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed,
severally and not jointly, to purchase all of the Notes sold under the underwriting agreement if any of these Notes are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may be increased or the underwriting agreement may be terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
agreed to indemnify the underwriters and their controlling persons against certain liabilities in connection with this offering, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in
respect of those liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters are offering the Notes, subject to prior sale, when, as and if issued to and accepted by
them, subject to approval of legal matters by their counsel, including the validity of the Notes, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officer&#146;s certificates and legal
opinions. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions
and Discounts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the underwriting discounts that we will pay to the underwriters in connection with this
offering of the Notes. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discount paid by us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.400</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representatives have advised us that the underwriters propose initially to offer the Notes to the public
at the public offering prices set forth on the cover page of this prospectus supplement and to certain dealers at such price less a concession not in excess of 0.250% of the principal amount of the Notes. In addition, the underwriters may allow, and
those selected dealers may reallow, a selling concession of up to 0.150% of the principal amount of the Notes on sales to other dealers. After the initial offering, the public offering prices, concessions or other selling terms of the offering may
be changed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expenses of the offering, not including the underwriting discounts, are estimated at &#128;1.1&nbsp;million and are
payable by us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Issue of Notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are a new issue of securities with no established trading market. We intend to apply for listing of the Notes on the NYSE and we
expect trading in the Notes on the NYSE to begin within 30 days after the initial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issuance of the Notes. We will have no obligation to maintain the listing of the Notes, and we may delist the Notes at any time. If the Notes are traded after their initial issuance, they may
trade at discounts from their initial offering price depending on prevailing interest rates, the markets for similar securities, general economic conditions, fluctuations in exchange rates with the euro, our financial condition, performance and
prospects and other factors. We have been advised by the underwriters that they presently intend to make a market in the Notes after completion of the offering. However, they are under no obligation to do so and may discontinue any market-making
activities at any time without any notice. We cannot assure the liquidity of the trading market for the Notes or that an active public market for the Notes will develop, that you will be able to sell your Notes or that the prices you receive when
you sell will be favorable. If an active public trading market for the Notes does not develop, the market prices and liquidity of the Notes may be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Settlement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that delivery of
the Notes will be made to investors on or about the date specified on the cover page of this prospectus supplement, which will be the fourth business day following the date of this prospectus supplement (such settlement being referred to as
&#147;T+4&#148;). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Exchange Act, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise.
Accordingly, purchasers who wish to trade the Notes more than one business day prior to the delivery of the Notes hereunder will be required, by virtue of the fact that the Notes initially settle in T+4, to specify an alternate settlement
arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to their date of delivery hereunder should consult their advisors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
agreed that we will not, during the period commencing on the date of this prospectus supplement and ending on the date that the Notes are delivered by the underwriters to purchasers, without first obtaining the prior written consent of the
representatives, directly or indirectly, issue, sell, offer to contract or grant any option to sell, pledge, transfer or otherwise dispose of, any debt securities or securities exchangeable for or convertible into debt securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Short Positions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the
offering, the underwriters may purchase and sell the Notes in the open market. These transactions may include short sales and purchases on the open market to cover positions created by short sales. Short sales involve the sale by the underwriters of
a greater principal amount of Notes than they are required to purchase in the offering. The underwriters must close out any short position by purchasing Notes in the open market. A short position is more likely to be created if the underwriters are
concerned that there may be downward pressure on the price of the Notes in the open market after pricing that could adversely affect investors who purchase in the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to other purchase transactions, the underwriters&#146; purchases to cover the syndicate short sales may have the effect of raising or
maintaining the market price of the Notes or preventing or retarding a decline in the market price of the Notes. As a result, the price of the Notes may be higher than the price that might otherwise exist in the open market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the
transactions described above may have on the prices of the Notes. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once commenced, will
not be discontinued without notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial
dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of
investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities
may involve securities and/or instruments of ours or our affiliates. Certain of the underwriters or their affiliates that have a lending relationship with us routinely hedge, and certain other of those underwriters or their affiliates may hedge,
their credit exposure to us consistent with their customary risk management policies. Typically, such underwriters and their affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit default
swaps or the creation of short positions in our securities, including potentially the Notes offered hereby. Any such credit default swaps or short positions could adversely affect future trading prices of the Notes offered hereby. The underwriters
and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short
positions in such securities and instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conflicts of Interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described under &#147;<I>Use of Proceeds</I>,&#148; we intend to use a portion of the net proceeds from the sale of the Notes to repay
outstanding commercial paper obligations. Certain of the underwriters and/or their respective affiliates may hold our commercial paper and, accordingly, may receive a portion of the net proceeds of this offering. In the event that any of the
underwriters, together with their respective affiliates, receives at least 5% of the net proceeds of this offering, not including underwriting compensation, such underwriters will be deemed to have a &#147;conflict of interest&#148; within the
meaning of FINRA Rule 5121. Accordingly, this offering is being made in compliance with the requirements of FINRA Rule 5121. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than in the United States, to the best of our knowledge, no action has been taken by us or the underwriters that would permit a
public offering of the Notes in any jurisdiction where action for that purpose is required. The Notes may not be offered or sold, directly or indirectly, nor may this prospectus supplement or any other offering material or advertisements in
connection with the offer and sale of any such Notes be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose
possession this prospectus supplement comes are advised to inform themselves about and to observe any restrictions relating to the offering of the Notes and the distribution of this prospectus supplement. This prospectus supplement does not
constitute an offer to sell or a solicitation of an offer to buy any Notes offered by this prospectus supplement in any jurisdiction in which such an offer or a solicitation is unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of the Notes in the United States by any underwriter that is not a broker-dealer registered with the SEC will be made only through one
or more U.S.-registered broker-dealers in compliance with applicable securities laws and the rules of FINRA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prohibition of Sales to EEA Retail
Investors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has represented and agreed that it has not offered, sold or otherwise made available and will not offer,
sell or otherwise make available any Notes to any retail investor in the EEA. For the purposes of this provision: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;retail investor&#148; means a person who is one (or more) of the following:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a retail client as defined in point (11)&nbsp;of Article 4(1) of MiFID II; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a customer within the meaning of the Insurance Distribution Directive, where that customer would not qualify as
a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not a qualified investor as defined in the Prospectus Regulation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;offer&#148; includes the communication in any form and by any means of sufficient
information on the terms of the offer and the Notes to be offered so as to enable an investor to decide to purchase or subscribe the Notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consequently no key information document required by the PRIIPs Regulation for offering or selling the Notes or otherwise making them
available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in the United Kingdom </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has represented and agreed that it has not offered, sold or otherwise made available and will not offer, sell or otherwise
make available any Notes to any retail investor in the U.K. For the purposes of this provision: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;retail investor&#148; means a person who is one (or more) of the following:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a retail client as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No.&nbsp;2017/565 as it forms part
of domestic law by virtue of the EUWA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to
implement the Insurance Distribution Directive, where that customer would not qualify as a professional client as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No.&nbsp;600/2014 as it forms part of domestic law by virtue of the EUWA;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not a qualified investor as defined in the U.K. Prospectus Regulation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;offer&#148; includes the communication in any form and by any means of sufficient
information on the terms of the offer and the Notes to be offered so as to enable an investor to decide to purchase or subscribe the Notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consequently no key information document required by the U.K. PRIIPs Regulation for offering or selling the Notes or otherwise making them
available to retail investors in the U.K. has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the U.K. may be unlawful under the U.K. PRIIPs Regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has represented and agreed that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has only communicated or caused to be communicated and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the FSMA) received by it in connection with the issue or sale of the Notes in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to
Air Products; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has complied with, and will comply with, all applicable provisions of the FSMA with respect to anything done
by it in relation to the Notes in, from or otherwise involving the U.K. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement is only for
distribution to and directed at: (i)&nbsp;in the U.K., persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as
amended) (the &#147;Order&#148;) and high net worth entities falling within Article 49(2)(a) to (d)&nbsp;of the Order; (ii)&nbsp;persons who are outside the U.K.; and (iii)&nbsp;any other person to whom it can otherwise be lawfully distributed (all
such persons together being referred to as &#147;Relevant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Persons&#148;). Any investment or investment activity to which this prospectus supplement relates is available only to and will be engaged in only with Relevant Persons, and any person who is not
a Relevant Person should not rely on it. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Switzerland </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are not intended to constitute an offer or solicitation to purchase or invest in the
Notes. The Notes may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act (&#147;FinSA&#148;), and no application has or will be made to admit the Notes to trading on any trading
venue (exchange or multilateral trading facility) in Switzerland. Neither this prospectus supplement or accompanying prospectus nor any other offering or marketing material relating to the Notes constitutes a prospectus pursuant to the FinSA, and
neither this prospectus supplement or accompanying prospectus nor any other offering or marketing material relating to the Notes may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Canada </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the Notes must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser
with remedies for rescission or damages if this prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit
prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these
rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT>
Underwriting Conflicts (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest
in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Hong Kong </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document other than (i)&nbsp;to
&#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap.571 of the Laws of Hong Kong) (the &#147;SFO&#148;) and any rules made under the SFO, or (ii)&nbsp;in other circumstances which do not result in the document
being a &#147;prospectus&#148; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.32 of the Laws of Hong Kong) (the &#147;C(WUMP)O&#148;) or which do not constitute an offer to the public within the meaning of the
C(WUMP)O. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No advertisement, invitation or document relating to the Notes has been or will be issued, or has been or will be in the
possession of any person for the purposes of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the
securities laws of Hong Kong) other than with respect to notes which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the SFO and any rules made under the SFO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Japan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes offered by this prospectus supplement and the accompanying prospectus have not been and will not be registered under the Financial
Instruments and Exchange Act of Japan (Act No.&nbsp;25 of 1948, as amended (the &#147;FIEA&#148;)). The Notes offered by this prospectus supplement and the accompanying prospectus have not been directly or indirectly offered or sold, and will not be
directly or indirectly offered or sold in Japan or to, or for the benefit of, any resident of Japan (as defined under Item 5, Paragraph 1, Article 6 of the Foreign Exchange and Foreign Trade Act (Act No.&nbsp;228 of 1949, as amended)), or to others
for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to, or for the benefit of, a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance
with, the FIEA and any other applicable laws, regulations and ministerial guidelines of Japan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Korea </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes may not be offered, sold and delivered directly or indirectly, or offered or sold to any person for reoffering or resale, directly or
indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea, including the Korea Securities and Exchange Act and the Foreign Exchange Transaction Law and the decrees and regulations thereunder.
The Notes have not been and will not be registered with the Financial Services Commission of Korea for public offering in Korea. Furthermore, the Notes may not be resold to Korean residents unless the purchaser of the Notes complies with all
applicable regulatory requirements (including but not limited to government approval requirements under the Foreign Exchange Transaction Law and its subordinate decrees and regulations) in connection with the purchase of the Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Singapore </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus have not been and will not be registered as a prospectus with the Monetary Authority
of Singapore. Accordingly, this prospectus supplement, the accompanying prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the Notes, may not be circulated or
distributed, nor may the Notes be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor (as defined in
Section&nbsp;4A of the Securities and Futures Act 2001 of Singapore, as modified or amended from time to time (the &#147;SFA&#148;)) pursuant to Section&nbsp;274 of the SFA or (ii)&nbsp;to an accredited investor (as defined in Section&nbsp;4A of the
SFA) pursuant to and in accordance with the conditions specified in Section&nbsp;275 of the SFA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Taiwan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes have not been and will not be registered or filed with, or approved by, the Financial Supervisory Commission of Taiwan and/or any
other regulatory authority of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which could constitute an offer within the meaning of the
Securities and Exchange Act of Taiwan or relevant laws and regulations that require a registration, filing or approval of the Financial Supervisory Commission of Taiwan and/or other regulatory authority of Taiwan. No person or entity in Taiwan has
been authorized to offer or sell the Notes in Taiwan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_10"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the Notes offered hereby will be passed upon for us by Covington&nbsp;&amp; Burling LLP, Washington, D.C. Davis
Polk&nbsp;&amp; Wardwell LLP, New York, New York, will pass on certain legal matters for the underwriters. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_11"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements for the fiscal year ended September&nbsp;30, 2024 incorporated in this prospectus supplement by
reference from our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September&nbsp;30, 2024, and the effectiveness of our internal control over financial reporting as of September&nbsp;30, 2024, have been
audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report, which is incorporated herein by reference. Such consolidated financial statements have been so incorporated in reliance upon the
reports of such firm given upon their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx942740_12"></A>WHERE YOU CAN FIND
MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information we file with the SEC under the Exchange
Act, which means that we can disclose important information to you by referring you to those documents. Information incorporated by reference is considered to be a part of this prospectus supplement, and information that we file later with the SEC
will automatically update, modify and, where applicable, supersede this information. The following documents that we have previously filed with the SEC (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-04534)</FONT> are incorporated by reference
herein: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000000296924000056/apd-20240930.htm">Annual
 Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September<U></U>&nbsp;30, 2024</A>, filed with the SEC on November&nbsp;21, 2024; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000000296925000013/apd-20241231.htm">December
<U></U>&nbsp;31, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000000296925000027/apd-20250331.htm">March<U></U>&nbsp;
31, 2025</A>, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000000296925000013/apd-20241231.htm">February&nbsp;
6, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000000296925000027/apd-20250331.htm">May&nbsp;1, 2025</A>, respectively; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312524260402/d719958d8k.htm">November
<U></U>&nbsp;18, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312524271060/d843347d8k.htm">December<U></U>&nbsp;
5, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312525013460/d849404d8k.htm">January<U></U>&nbsp;
27, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312525020026/d812080d8k.htm">February<U></U>&nbsp;
4, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312525020828/d926234d8k.htm">February<U></U>&nbsp;
5, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312525026169/d812755d8k.htm">February<U></U>&nbsp;
13, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000002969/000119312525033509/d830166d8k.htm">February<U></U>&nbsp;24, 2025</A> (Item 2.06 only). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all reports and other documents that we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act
prior to the termination of this offering, but excluding any information furnished to, rather than filed with, the SEC, will be deemed to be incorporated by reference into this prospectus supplement and the accompanying prospectus and deemed to be
part of this prospectus supplement and the accompanying prospectus from the time of the filing of such reports and documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
encourage you to read the SEC filings incorporated by reference into this prospectus supplement before investing in any of our securities. Our SEC filings are available to the public over the internet on the SEC&#146;s website at www.sec.gov. We
also make available free of charge our SEC filings through our website, www.airproducts.com, as soon as reasonably practical after they are filed with the SEC. The information contained in, or that can be accessed through, our website is not a part
of, or incorporated by reference in, this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide to each person, including any beneficial owner, to whom
this prospectus is delivered, upon written or oral request and without charge, a copy of the documents referred to above that we have incorporated by reference into this prospectus supplement and a copy of the registration statement of which this
prospectus is a part. We will not provide exhibits to such documents unless such exhibits are specifically incorporated by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reference into this prospectus supplement or accompanying prospectus. You can request copies of such documents if you call or write us at the following address or telephone number: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Corporate Secretary&#146;s Office </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Air Products and Chemicals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1940 Air Products Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Allentown, Pennsylvania 18106-5500 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: (610) <FONT STYLE="white-space:nowrap">481-4911</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g942740g59d47.jpg" ALT="LOGO" STYLE="width:3.01638in;height:0.639601in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>AIR PRODUCTS AND CHEMICALS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Depositary
Shares </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer and sell shares of our common stock, shares of our preferred stock, unsecured debt securities (referred to herein as debt
securities), warrants, depositary shares or units, which we refer to collectively in this prospectus as the &#147;securities.&#148; We may offer and sell the securities, together or separately, from time to time, in one or more offerings, in
amounts, at prices and on terms that will be determined at the time of any such offering. The preferred stock, debt securities, warrants and units may be convertible or exercisable or exchangeable for common stock, preferred stock, debt securities
or other securities or property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus describes some of the general terms that may apply to the offered securities. The
specific prices and terms of any securities to be offered will be described in supplements to this prospectus, which may also add, update or change information contained in this prospectus. You should read this prospectus and the applicable
prospectus supplement, together with the documents we incorporate by reference herein and therein, carefully before you decide to invest in any of these securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer and sell these securities to or through one or more underwriters, dealers or agents, directly to purchasers, or through a
combination of these methods on an immediate, continuous or delayed basis. You can find additional information about our plan of distribution for the securities under the heading &#147;<I>Plan of Distribution</I>&#148; beginning on page 24 of this
prospectus. We will identify any underwriters, dealers or agents and describe plan of distribution of any particular offering of these securities in the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York Stock Exchange under the symbol &#147;APD.&#148; If we decide to seek a listing of any other
securities offered by this prospectus, the applicable prospectus supplement will disclose the exchange or market on which such securities will be listed or where we have made an application for listing, as the case may be. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:11.5pt; font-family:Times New Roman"><B>Investing in these securities involves risks. You should carefully consider the risk factors incorporated herein by reference and
described under the heading &#147;<A HREF="#tx942740_4">Risk&nbsp;Factors</A>&#148; beginning on page 3. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities
and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is November&nbsp;20, 2023 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc1"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_3">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_6">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_7">DESCRIPTION OF PREFERRED STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_8">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_9">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_10">DESCRIPTION OF DEPOSITARY SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_10a">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_11">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx942740_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, the applicable prospectus supplement and the information incorporated by reference herein and therein include
&#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933 (the &#147;Securities Act&#148;) and Section&nbsp;21E of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;), and are subject
to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can generally be identified by words such
as &#147;anticipate,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;forecast,&#148; &#147;future,&#148; &#147;goal,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;outlook,&#148; &#147;plan,&#148;
&#147;positioned,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would,&#148; and similar expressions or variations thereof, or the negative thereof, but these
terms are not the exclusive means of identifying such statements. Forward-looking statements are based on management&#146;s expectations and assumptions as of the date they are made and are not guarantees of future performance. You are cautioned not
to place undue reliance on our forward-looking statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements may relate to a number of matters, including
expectations regarding revenue, margins, expenses, earnings, tax provisions, cash flows, pension obligations, share repurchases or other statements regarding economic conditions or our business outlook; statements regarding capital expenditures and
plans, projects, strategies and objectives for our future operations, including our ability to win new projects and execute the projects in our backlog; and statements regarding our expectations with respect to pending legal claims or disputes.
While forward-looking statements are made in good faith and based on assumptions, expectations and projections that management believes are reasonable based on currently available information, actual performance and financial results may differ
materially from projections and estimates expressed in the forward-looking statements because of many factors, including, without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in global or regional economic conditions, inflation, and supply and demand dynamics in the market
segments we serve, including demand for technologies and projects to limit the impact of global climate change; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the financial markets that may affect the availability and terms on which we may obtain financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to implement price increases to offset cost increases; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruptions to our supply chain and related distribution delays and cost increases; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with having extensive international operations, including political risks, risks associated with
unanticipated government actions and risks of investing in developing markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">project delays, scope changes, cost escalations, contract terminations, customer cancellations, or postponement
of projects and sales; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to safely develop, operate, and manage costs of large-scale and technically complex projects;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the future financial and operating performance of major customers, joint ventures, and equity affiliates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop, implement, and operate new technologies and to market products produced utilizing new
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to execute the projects in our backlog and refresh our pipeline of new projects;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">tariffs, economic sanctions and regulatory activities in jurisdictions in which we and our affiliates and joint
ventures operate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of environmental, tax, safety, or other legislation, as well as regulations and other public policy
initiatives affecting our business and the business of our affiliates and related compliance requirements, including legislation, regulations, or policies intended to address global climate change; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in tax rates and other changes in tax law; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safety incidents relating to our operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing, impact, and other uncertainties relating to acquisitions and divestitures, including our ability to
integrate acquisitions and separate divested businesses, respectively; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks relating to cybersecurity incidents, including risks from the interruption, failure or compromise of our
information systems or those of our business partners or service providers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">catastrophic events, such as natural disasters and extreme weather events, pandemics and other public health
crises, acts of war, including Russia&#146;s invasion of Ukraine and new and ongoing conflicts in the Middle East, or terrorism; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on our business and customers of price fluctuations in oil and natural gas and disruptions in markets
and the economy due to oil and natural gas price volatility; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs and outcomes of legal or regulatory proceedings and investigations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">asset impairments due to economic conditions or specific events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant fluctuations in inflation, interest rates and foreign currency exchange rates from those currently
anticipated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">damage to facilities, pipelines or delivery systems, including those we are constructing or that we own or
operate for third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability and cost of electric power, natural gas, and other raw materials; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of productivity and operational improvement programs. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should carefully read the factors described in Risk Factors, Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations, Quantitative and Qualitative Disclosures About Market Risk and other cautionary statements in this prospectus, the applicable prospectus and the information in our filings with the SEC that are incorporated by reference herein and
therein for a description of certain risks that could, among other things, cause our actual results to differ from these forward-looking statements. Any of these factors, as well as those not currently anticipated by management, could cause our
results of operations, financial condition or liquidity to differ materially from what is expressed or implied by any forward-looking statement. Except as required by law, we disclaim any obligation or undertaking to update or revise any
forward-looking statements contained herein to reflect any change in assumptions, beliefs, or expectations or any change in events, conditions, or circumstances upon which any such forward-looking statements are based. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an automatic shelf registration statement that we have filed with the SEC as a &#147;well-known seasoned
issuer&#148; as defined in Rule 405 under the Securities Act. Under this shelf registration process, we may, from time to time, offer and sell any combination of the securities described in this prospectus in one or more offerings in amounts, at
prices and on terms that we determine at the time of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus provides you with a general description of the
securities that we may offer. Each time we offer securities, we will provide a prospectus supplement that contains specific information about the terms of that offering and the securities offered, including the specific amounts, prices and terms of
the securities offered. The prospectus supplement may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and any prospectus supplement, you should rely on the
information in the prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before making an investment decision, you should carefully read both this prospectus, the
applicable prospectus supplement and any free writing prospectus prepared by us or on our behalf, together with the documents incorporated by reference herein and therein as described below under the heading &#147;<I>Where You Can Find More
Information</I>.&#148; In addition, this prospectus does not contain all of the information included in the registration statement of which this prospectus forms a part. For a more complete understanding of the offering of securities offered hereby,
you should refer to the registration statement, including the exhibits thereto. Those exhibits may be filed with the registration statement or may be incorporated by reference to earlier SEC filings listed in the registration statement or in
subsequent filings that we may make under the Exchange Act that are incorporated by reference herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>We have not authorized anyone to
provide any information different from or in addition to that contained or incorporated by reference in this supplement, the applicable prospectus supplement and in any free writing prospectus prepared by us or on our behalf to which we have
referred you. We have not authorized any other person to provide you with different or additional information and we take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.
We are not making an offer to sell the securities in any jurisdiction where the offer or sale is not permitted. Further, you should assume that the information appearing in this prospectus, the applicable prospectus supplement, and the documents
incorporated by reference herein and therein, and any free writing prospectus, is accurate only as of the respective dates of those documents in which the information is contained. Our business, financial condition, results of operations and
prospects may have changed since those dates. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise expressly stated herein or the context otherwise requires, all
references in this prospectus to &#147;<I>Air Products</I>,&#148; the &#147;<I>Company</I>,&#148; &#147;<I>we</I>,&#148; &#147;<I>us</I>&#148; and &#147;<I>our</I>&#148; refer to Air Products and Chemicals, Inc. and its consolidated subsidiaries.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our filings with the SEC are available on
the SEC&#146;s website at www.sec.gov and on our website at www.airproducts.com as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. However, the information on our website is not incorporated
by reference herein, and is not a part of this prospectus, any prospectus supplement or our other filings with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us
to &#147;incorporate by reference&#148; the information we file with the SEC under the Exchange Act, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an
important part of this prospectus, and information that we subsequently file with the SEC will automatically update and supersede this information. The following documents that we previously filed with the SEC (File
<FONT STYLE="white-space:nowrap">No.&nbsp;001-04534)</FONT> are incorporated by reference herein: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000000296923000047/apd-20230930.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended September&nbsp;30, 2023, which was filed with the SEC on November&nbsp;16, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000000296922000054/apd-20220930.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended September&nbsp;30, 2022, which was filed with the SEC on November<U></U>&nbsp;22, 2022, from our Definitive Proxy Statement on Schedule 14A for our 2023 Annual Meeting of
Shareholders, which was filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/2969/000130817922000394/apd4098671-def14a.htm">December<U></U>&nbsp;9, 2022</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000119312523253487/d562366d8k.htm">October
<U></U>&nbsp;10, 2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/2969/000119312523278640/d81941d8k.htm">November 16, 2023</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/2969/000000296923000047/apd-exhibit43x30sep23.htm">Exhibit
 4.3</A> to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September&nbsp;30, 2023, filed with the SEC on November&nbsp;16, 2023, and any amendment or report filed for the purpose of updating such
description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all reports and other documents that we subsequently file pursuant to Section&nbsp;13(a),
13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and prior to the termination of this offering, but excluding any information furnished to, rather than filed with, the SEC, will be deemed to be incorporated by reference into
this prospectus from the time of the filing of such reports and documents. Any statement made in this prospectus or in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement contained in this prospectus or in any other subsequently filed document that is also incorporated or deemed to be incorporated by reference herein modifies or supersedes that statement.
Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide without charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral
request, a copy of any or all of the foregoing documents, and any other documents that are incorporated herein by reference (other than exhibits unless we specifically have incorporated those exhibits by reference in this prospectus or an applicable
prospectus supplement). Requests for such documents should be directed to our principal executive office, located at: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Corporate
Secretary&#146;s Office </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Air Products and Chemicals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1940 Air Products Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Allentown, Pennsylvania 18106-5500 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: (610) <FONT STYLE="white-space:nowrap">481-4911</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_3"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Air Products and Chemicals, Inc., a Delaware corporation originally founded in 1940, is a world-leading industrial gases company that has
built a reputation for its innovative culture, operational excellence, and commitment to safety and the environment. Focused on serving energy, environmental, and emerging markets, we offer a portfolio of products and services that enables customers
to improve their environmental performance, product quality, and productivity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Air Products has a sustainability-driven <FONT
STYLE="white-space:nowrap">two-pillar</FONT> growth strategy consisting of the expansion and efficient operation of our core industrial gases business and the execution of projects that provide world-scale clean hydrogen. Our industrial gases
business provides essential gases, related equipment, and applications expertise to customers in dozens of industries, including refining, chemicals, metals, electronics, manufacturing, medical, and food. We also develop, engineer, build, own, and
operate some of the world&#146;s largest clean hydrogen projects that will support the transition to <FONT STYLE="white-space:nowrap">low-</FONT> and <FONT STYLE="white-space:nowrap">zero-carbon</FONT> energy in the heavy-duty transportation and
industrial sectors. Additionally, we are the world leader in the supply of liquefied natural gas process technology and equipment, and provide turbomachinery, membrane systems, and cryogenic containers globally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate offices are located at 1940 Air Products Boulevard, Allentown, Pennsylvania 18106-5500. Our telephone number is (610) <FONT
STYLE="white-space:nowrap">481-4911,</FONT> and our website is www.airproducts.com. The information contained in, or that can be accessed through, our website is not a part of, or incorporated by reference in, this prospectus. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our securities involves risk. Before deciding whether to invest in any of our securities, in addition to the other information
included or incorporated by reference into this prospectus and the applicable prospectus supplement, you should carefully consider the risk factors described in the applicable prospectus supplement and those described in our filings with the SEC
that are incorporated by reference in this prospectus and the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The occurrence of any of these risks
might cause you to lose all or a part of your investment in the offered securities. In addition, new risks may emerge at any time and we cannot predict such risks or estimate the extent to which they may affect our business, financial condition,
liquidity or results of operations. See &#147;<I>Caution Regarding Forward-Looking Statements</I>&#148; and &#147;<I>Where You Can Find More Information</I>.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the net proceeds we receive from the sale of the securities offered by
this prospectus and the applicable prospectus supplement will be used for general corporate purposes, which may include financing our operations, the repayment or refinancing of debt, including repayment of commercial paper, investments in or
extensions of credit to our subsidiaries, repurchases of common stock or preferred stock and the financing of possible acquisitions or business expansion. Pending any specific application, we may initially invest funds in short-term marketable
securities or apply them to the reduction of short-term indebtedness. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_6"></A>DESCRIPTION OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of the general terms of the shares of our common stock that we may issue under this prospectus. This
description and that appearing in any prospectus supplement does not include all of the terms of our common stock, and should be read together with our Restated Certificate of Incorporation (our &#147;Certificate of Incorporation&#148;), our Amended
and Restated Bylaws (our &#147;Bylaws&#148;) and applicable provisions of the General Corporation Law of the State of Delaware (the &#147;DGCL&#148;). Our Certificate of Incorporation and Bylaws are incorporated by reference to the registration
statement of which this prospectus forms a part. For more information on how you can obtain copies of our Certificate of Incorporation and Bylaws, see &#147;<I>Where You Can Find More Information</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this
prospectus, we are authorized to issue up to 300,000,000 shares of common stock, par value $1.00 per share. As of October&nbsp;31, 2023, 222,207,726 shares of common stock were outstanding. Our common stock is listed on the New York Stock Exchange
under the symbol &#147;APD.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of common stock is entitled to one vote per share on all matters requiring a vote of the stockholders.<B> </B>A majority of the
votes cast is required for stockholders to elect directors in uncontested elections, while in contested elections directors are elected by a plurality of the votes cast. All other matters put to a stockholder vote generally require the approval of a
majority of the shares entitled to vote on the matter and present in person or represented by proxy. Stockholders do not have cumulative voting rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of common stock are
entitled to receive dividends, in cash, securities, or property, as may from time to time be declared by our board of directors, subject to the rights of the holders of any outstanding preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rights Upon Liquidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of
our voluntary or involuntary liquidation, dissolution, or winding up, the holders of common stock will be entitled to share equally in our assets available for distribution after payment in full of all debts and after the holders of any outstanding
preferred stock have received their liquidation preferences (including accrued and unpaid dividends) in full. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Statutory Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 of the DGCL prohibits a defined set of transactions between a Delaware corporation and an interested stockholder. An
interested stockholder is generally defined as a person who, together with any affiliates or associates of such person, beneficially owns, directly or indirectly, 15% or more of the outstanding voting shares of a corporation. This provision may
prohibit business combinations between an interested stockholder and a corporation for a period of three years after the date the interested stockholder becomes an interested stockholder. The term business combination is broadly defined to include
mergers, consolidations, sales or other dispositions of assets of the corporation or of any direct or indirect majority-owned subsidiary which assets have an aggregate market value equal to 10% or more of either the aggregate market value of all the
assets of the corporation determined on a consolidated basis or the aggregate market value of all the outstanding stock of the corporation, and some other transactions that would increase the interested stockholder&#146;s proportionate share
ownership in the corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prohibition is effective unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the business combination or the transaction which resulted in the stockholder becoming an interested stockholder
is approved by the corporation&#146;s board of directors prior to the time the interested stockholder becomes an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interested stockholder acquired at least 85% of the voting stock of the corporation, other than stock held by
directors who are also officers or by qualified employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer, in the
transaction in which it becomes an interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the business combination is approved by a majority of the board of directors and authorized at an annual or
special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certificate of Incorporation and Bylaw Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Vacancies and newly-created directorships resulting from any increase in the size of our board may be filled by a majority vote of all
remaining directors, even if the directors then on the board do not constitute a quorum or only one director is left in office. In addition, the board of directors is authorized to issue preferred stock without stockholder approval. These
provisions, together with the provisions of Section&nbsp;203 of the DGCL (as discussed above), could have the effect of delaying, deferring or preventing a change in control or the removal of existing management, of deterring potential acquirers
from making an offer to our stockholders and of limiting any opportunity to realize premiums over prevailing market prices for our common stock in connection therewith. This could be the case even if a majority of our stockholders could benefit from
such a change in control or offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our Bylaws contain a forum selection provision for the adjudication of certain disputes.
Unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (a)&nbsp;any derivative action or proceeding brought on our behalf; (b)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by
any of our directors, officers or other employees to us or our stockholders; (c)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL, our Certificate of Incorporation or Bylaws; or (d)&nbsp;any action asserting a claim
governed by the internal affairs doctrine will be the Court of Chancery of the State of Delaware, or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the Superior Court of the State of Delaware, or, if the Superior
Court of the State of Delaware does not have jurisdiction, the United States District Court for the District of Delaware, in each case, subject to said court having personal jurisdiction over the indispensable parties named as defendants. If any
action the subject matter of which is within the scope of the forgoing is filed in a court other than a court located within the State of Delaware in the name of any stockholder, such stockholder shall be deemed to have consented to (i)&nbsp;the
personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce our forum selection clause and (ii)&nbsp;having service of process made upon such
stockholder in any such enforcement action by service upon such stockholder&#146;s counsel in such action as agent for such stockholder. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be
deemed to have notice of and consented to the forum selection provision of our Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed above, our Certificate of
Incorporation authorizes the issuance of undesignated preferred stock, in one or more classes or series. Undesignated preferred stock may enable our board of directors to render it more difficult or to discourage an attempt to obtain control of us
by means of a tender offer, proxy contest, merger or otherwise, and to thereby protect the continuity of our management. The issuance of shares of preferred stock may adversely affect the rights of the holders of our common stock. For example, any
preferred stock issued may rank prior to our common stock as to dividend rights, liquidation preference or both, may have full or limited voting rights and may be convertible into shares of common stock. As a result, the issuance of shares of
preferred stock may discourage bids for our common stock or may otherwise adversely affect the market price of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock or any existing preferred stock. In some instances the preferred stock could be issued and have the effect of preventing a merger, tender offer or other takeover attempt that our
board of directors opposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Miscellaneous </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of our common stock are <FONT STYLE="white-space:nowrap">non-assessable</FONT> and not redeemable and have no sinking fund provisions or
subscription, conversion or preemptive rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights, preferences and privileges of holders of our common stock are subject to the
rights of the holders of shares of any series of preferred stock which we may issue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent for our common stock is Broadridge Corporate Issuer Solutions, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_7"></A>DESCRIPTION OF PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of general terms and provisions of the preferred stock that we may issue under this prospectus. The particular
terms of any offering of a series of preferred stock will be described in the applicable prospectus supplement and will be specified in a certificate of designations under our Certificate of Incorporation in accordance with the DGCL. Such
certificate of designations will be filed with the SEC at or prior to the time of issuance of the applicable series of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are authorized to issue up to 25,000,000 shares of preferred stock, par value $1.00 per share. As of October&nbsp;31, 2023, no
shares of preferred stock were outstanding. Subject to limitations prescribed by law, the board of directors is authorized at any time to issue one or more series of preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors is authorized to determine, for each series of preferred stock, and the prospectus supplement relating to the issuance
of a series of preferred stock will set forth, with respect to such series the following information: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation for any series by number, letter or title that shall distinguish the series from any other series
of preferred stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares in any series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether dividends on that series of preferred stock will be cumulative and, if so, from what date or dates, and
the relative rights of priority, if any, of payment of dividends on shares of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dividend rate (or method for determining the rate); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any voting rights of that series of preferred stock and the terms of such voting rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any conversion provisions applicable to that series of preferred stock, including provision for adjustment of the
conversion rate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any redemption or sinking fund provisions applicable to that series of preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any liquidation preference per share of that series of preferred stock and any relative rights of priority, if
any, in the event of liquidation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of any other rights, preferences or limitations applicable to that series of preferred stock.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preferred stock, when issued, will be fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The DGCL provides that the
holders of shares of preferred stock will have the right to vote separately as a class on any proposal involving fundamental changes in the rights of holders of that preferred stock. This right is in addition to any voting rights that may be
provided for in the applicable certificate of designations. Otherwise, the holders of a series of preferred stock will, as a general matter, not be entitled to vote except as set forth in the applicable prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of preferred stock
will be entitled to receive, when, as and if declared by the board of directors, dividends at the rates and on the dates set forth in the prospectus supplement. Generally, dividends on outstanding shares of preferred stock shall be declared and
paid, or set apart for payment, before any dividends shall be declared or paid, or set apart for payment, on the outstanding shares of common stock with respect to the same dividend period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of dividends on any series of preferred stock may be restricted by loan agreements,
indentures and other transactions we may enter into. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we voluntarily or involuntarily liquidate, dissolve or wind up our affairs, the holders of each series of preferred stock will be entitled
to receive the liquidation preference per share specified in the certificate of designations and described in the applicable prospectus supplement plus any accrued and unpaid dividends and any other relative rights of priority in the event of
liquidation. Holders of preferred stock will be entitled to receive these amounts before any distribution is made to the holders of our common stock. If the amounts payable with respect to preferred stock are not paid in full, the holders of
preferred stock will share ratably in any distribution of assets based upon the aggregate liquidation preference for all outstanding shares for each series. After the holders of shares of preferred stock are paid in full, they will have no right or
claim to any of our remaining assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the par value nor the liquidation preference is indicative of the price at which the
preferred stock will actually trade on or after the date of issuance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Other Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of a series of preferred stock will not have any preemptive rights, preferences, voting powers or participating, optional or other
special rights except as specified in the certificate of designations and described in the applicable prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and
Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent for each series of preferred stock will be designated in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_8"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer unsecured debt securities in one or more series, which will be our debt securities and which may be convertible into another
security. Any debt securities offered hereby will be issued under an Indenture, dated as of April&nbsp;30, 2020 (the &#147;Indenture&#148;), between us and The Bank of New York Mellon Trust Company, N.A., as trustee. The Indenture is incorporated by
reference as an exhibit to the registration statement of which this prospectus is a part. Please see &#147;<I>Where You Can Find More Information</I>&#148; for information on how to obtain a copy of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description of the terms of the debt securities sets forth general terms that may apply to the debt securities. The prospectus
supplement relating to any particular debt securities offered will describe the specific terms of the debt securities, which may be in addition to or different from the general terms summarized in this section. This summary does not purport to be
complete and is subject to, and is qualified in its entirety by reference to, the terms of the Indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt securities issued under the Indenture will be issued in one or more series established pursuant to a resolution of our board of directors,
an officer&#146;s certificate or in one or more supplemental indentures. The Indenture does not limit the aggregate principal amount of debt securities that may be issued thereunder, or the amount of series that may be issued. The debt securities
will be unsecured and will have the same rank as all of our other unsecured and unsubordinated debt, unless otherwise set forth in the specific terms of a series of debt securities issued under the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities may be issued in one or more separate series. The prospectus supplement relating to the particular series of debt
securities being offered will specify the particular amounts, prices and terms of those debt securities. These terms may include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit upon the aggregate principal amount issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the maturity date or dates, or the method of determining or extending the maturity dates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities are to be issued as original issue discount securities and, if so, the amount of
discount with which such debt securities may be issued; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interest rate or rates, the method of determining those rates, including the date or dates from which such
interest shall accrue, and the form of interest payments, including cash or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">payment-in-kind;</FONT></FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interest payment dates and the regular record dates and the right, if any, to extend or defer interest
payments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the places where payments may be made and where securities may be presented for transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any mandatory or optional redemption provisions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sinking fund or analogous provisions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion of principal amount of the debt security payable upon acceleration of maturity if other than the full
principal amount; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any deletions of, or changes or additions to, the events of default, covenants, satisfaction and discharge or
amendment provisions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the form of the debt securities, including denomination (if other than denominations of $2,000 and any integral
multiple of $1,000) and any required legends, and any transfer restrictions thereon; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than U.S. dollars, the currency or currencies in which payments on the debt securities will be payable
and any applicable exchange rates or method of calculating such exchange rates and whether we or a holder may elect payment to be made in a different currency; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the method of determining the amount of any payments on the debt securities which are linked to an index;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will be issued in the form of one or more global securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any conversion or exchange provisions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any guarantees or subordination provisions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions, if any, granting special rights to holders upon the occurrence of specified events;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustee, paying agent and other agents for the securities and rights and obligations thereof; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other specific terms of the debt securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration, Transfer and Exchange </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
principal of, premium, if any, and interest on any series of debt securities will be payable at the corporate trust office of the trustee. Unless the applicable prospectus supplement provides otherwise, the trustee will serve as the initial paying
agent for debt securities issued under the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will make payments of principal, premium, if any, and interest on the debt
securities represented by any global security registered in the name of and held by The Depository Trust Company (&#147;DTC&#148;) or its nominee to DTC or its nominee, as the case may be, as the registered owner and holder of such global security.
Neither we, the trustee nor any of its or our respective agents will have any responsibility or liability for any aspect of records relating to, or payments made on account of, beneficial interests in any global security or for maintaining,
supervising or reviewing any records of DTC, its nominee or any participant relating to such beneficial interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No service charge will
be made for any registration of transfer or exchange, but we may require payment of a sum sufficient to cover any tax, assessment or other governmental charge payable in connection with certain transfers and exchanges. We may act as registrar and
may change any registrar without notice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Covenants of the Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitation on Liens </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the
exceptions set forth below under &#147;<I>Exempted Indebtedness</I>,&#148; we covenant that we will not create or assume, nor will we permit any Restricted Subsidiary (as hereinafter defined) to create or assume, any mortgage, security interest,
pledge or lien (collectively, &#147;liens&#148;) of or upon any Principal Property (as defined below) or shares of capital stock or indebtedness of any Restricted Subsidiary, whether owned as of the date of the Indenture or thereafter acquired, in
each case securing any new debt incurred or guaranteed by us or any Restricted Subsidiary, without equally and ratably securing the outstanding debt securities for so long as such other debt is secured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This restriction will not apply to certain permitted liens, which include the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens on any Principal Property (including any underlying real estate) acquired, repaired, constructed or
improved by us or any Restricted Subsidiary which are created or assumed prior to, contemporaneously with, or within 180 days after (or in the case of any such Principal Property which is being financed on the basis of long-term contracts or similar
financing arrangements for which a firm commitment is made by one or more banks, insurance companies or other lenders or investors (not including us or any Restricted Subsidiary), then within 360 days after), the completion of such acquisition,
repair, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
construction or improvement of such Principal Property to secure or provide for the payment of any part of the purchase price and other acquisition costs of such property or the cost of such
repair, construction or improvement, or liens on any Principal Property at the time of acquisition thereof (including by means of a merger or consolidation); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens on property or shares of capital stock or indebtedness of a person existing at the time such person is
merged into or consolidated with us or a Restricted Subsidiary or at the time of a sale, lease or other disposition of the properties of a person as an entirety or substantially as an entirety to us or a Restricted Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens existing on the date of this Indenture or liens on property or shares of capital stock or indebtedness of a
person existing at the time such person becomes a Restricted Subsidiary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens in favor of us or any Restricted Subsidiary or liens to secure debt of a Restricted Subsidiary to us or to
another Restricted Subsidiary, but only so long as such indebtedness is held by us or a Restricted Subsidiary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens in favor of the United States of America or any State or territory thereof (including the District of
Columbia) or any foreign jurisdiction, or any department, agency or political subdivision of the United States of America or any State or territory thereof (including the District of Columbia) or any foreign jurisdiction, to secure partial,
progress, advance or other payments pursuant to any contract, statute or regulation, including, without limitation, liens to secure indebtedness of the pollution control or industrial revenue bond type, or to secure any indebtedness incurred for the
purpose of financing all or any part of the purchase price and other acquisition costs or the cost of constructing or improving the property subject to such liens; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens in favor of any customer arising in respect of partial, progress, advance or other payments made by or on
behalf of such customer for goods produced for or services rendered to such customer in the ordinary course of business not exceeding the amount of such payments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens for the sole purpose of extending, renewing or replacing (including successive extensions, renewals or
replacements), in whole or in part, any lien referred to above, or in this paragraph, including any lien created prior to and existing on the date of the Indenture, provided that the principal amount of debt secured thereby shall not exceed the
principal amount of debt so secured at the time of such extension, renewal or replacement (plus an amount in respect of fees, costs and expenses, including premiums and accrued and unpaid interest in relation to any refinancing, refunding,
extension, renewal or replacement of such debt), and that such extension, renewal or replacement shall be limited to all or a part of the property subject to the lien so extended, renewed or replaced (plus improvements on such property);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mechanics&#146;, workmen&#146;s, repairmen&#146;s, materialmen&#146;s, carriers&#146; or other similar liens
arising in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens created by or resulting from any litigation or proceedings or arising out of judgments or awards which are
being contested in good faith or liens incurred by us or any Restricted Subsidiary for the purpose of obtaining a stay or discharge in the course of any legal proceeding; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain statutory liens, liens for taxes and certain other liens; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liens in respect of a sale and lease-back transaction permitted pursuant to &#147;<I>Limitations on Sale and
Lease-Back Transactions</I>&#148; set forth below. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any lien created for the benefit of the holders of the debt
securities of any series pursuant to the limitation on liens covenant in the Indenture will be deemed automatically and unconditionally released and discharged upon the release and discharge of the applicable lien described in the first paragraph of
this limitation on liens covenant in the Indenture without any further action on the part of the holders or us or any Restricted Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitations on Sale and Lease-Back Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the exceptions set forth below under &#147;<I>Exempted Indebtedness</I>,&#148; sale and lease-back transactions by us or any
Restricted Subsidiary of any Principal Property which has been owned and operated by us or a Restricted Subsidiary for more than 120 days are prohibited unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or such Restricted Subsidiary would be entitled to incur debt secured by a lien on the property involved in a
principal amount at least equal to the Attributable Debt (as hereinafter defined) of any such sale and lease-back transaction without equally and ratably securing the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or such Restricted Subsidiary apply an amount equal to the Attributable Debt (as hereinafter defined) of any
such sale and lease-back transaction to (i)&nbsp;the acquisition of additional Principal Property of equal or greater fair market value (as determined in good faith by us or such Restricted Subsidiary) or (ii)&nbsp;the retirement of indebtedness for
borrowed money (excluding indebtedness under a revolving loan facility, unless the commitment is reduced by the amount of such payment), including the debt securities, incurred or assumed by us or any Restricted Subsidiary (other than indebtedness
for borrowed money (excluding indebtedness under a revolving loan facility, unless the commitment is reduced by the receipt of such payment), owed to us or any Restricted Subsidiary) which by its terms matures on, or is extendable or renewable at
the option of the obligor to, a date more than 12 months after the date of the creation of such indebtedness; provided, however, that the amount to be applied to the retirement of indebtedness as described in this paragraph shall be reduced by
(A)&nbsp;the aggregate principal amount of any debt securities delivered to the trustee for retirement within 180 days of the effective date of such sale and lease-back transaction and (B)&nbsp;the aggregate principal amount of such indebtedness
(other than the debt securities) retired by us or a Restricted Subsidiary within 180 days of the effective date of such sale and lease-back transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lease involved is for a term (including renewals) of not more than three years (or which may be terminated by
us or the applicable Restricted Subsidiary within a period of not more than three years); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lease involved is between us and a Restricted Subsidiary or between Restricted Subsidiaries; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such sale and lease-back transaction was entered into prior to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exempted Indebtedness </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Either we or a
Restricted Subsidiary may create or assume liens and enter into sale and lease-back transactions, which would otherwise require securing of the debt securities, the acquisition of another Principal Property or the retirement of indebtedness for
borrowed money under said provisions, notwithstanding the limitations outlined above, provided that at the time thereof and after giving effect thereto the aggregate amount of debt secured by all such liens (other than such liens described in
&#147;<I>Limitation on Liens</I>&#148; above) and Attributable Debt of all such sale and lease-back transactions outstanding or to be entered into (other than any sale and lease-back transactions permitted by &#147;<I>Limitations on Sale and
Lease-Back Transactions</I>&#148; described above) shall not exceed 15% of our Consolidated Net Tangible Assets (as hereinafter defined), as determined in accordance with our most recently available consolidated balance sheet. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain Definitions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term
&#147;Attributable Debt&#148; in respect of a sale and lease-back transaction means, as to any particular lease under which any person is at the time liable, at any date as of which the amount thereof is to be determined, the total net amount of
rent required to be paid by such person under such lease during the remaining term thereof, excluding renewals, discounted at the rate of interest implicit in the terms of such lease (as determined in good faith by us). If and to the extent the
amount of any lease payment during any future period is not definitely determinable under the lease in question, the amount of such lease-payment will be estimated in such reasonable manner as we may in good faith determine. The net amount of rent
required to be paid under any such lease for any such period shall be the amount of the rent payable by the lessee with respect to such period, after excluding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amounts required to be paid, whether or not designated as rent or additional rent, on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges and any
amounts required to be paid by such lessee contingent upon the amount of sales, maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease which is terminable by the lessee upon the payment of a
penalty, such net amount may, if we so elect, also include the amount of such penalty, in which case no rent shall be considered as required to be paid under such lease subsequent to the first date upon which it may be so terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#147;Consolidated Current Liabilities&#148; means, as of any date of determination, the aggregate of the current liabilities of us
and our consolidated Subsidiaries appearing on our most recently available consolidated balance sheet preceding the date of determination, prepared in accordance with generally accepted accounting principles in effect in the United States, excluding
the amount of those liabilities which are by their terms extendable or renewable at the option of the obligor to a date more than 12 months after the date as of which the amount is being determined. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#147;Consolidated Net Tangible Assets&#148; means, as of any date of determination, the total amount of all assets appearing on our
most recently available consolidated balance sheet preceding the date of determination prepared in accordance with generally accepted accounting principles in effect in the United States (after deducting related depreciation, depletion, amortization
and all other valuation reserves which, in accordance with generally accepted accounting principles in effect in the United States, are set aside in connection with the business conducted), <U>less</U> Consolidated Current Liabilities and goodwill,
trademarks, patents, unamortized debt discount and all other like segregated intangible assets properly classified as intangible assets under generally accepted accounting principles in effect in the United States, all as determined in accordance
with generally accepted accounting principles in effect in the United States; provided, that Consolidated Net Tangible Assets shall be calculated after giving pro forma effect to any investments, acquisitions or dispositions occurring outside the
ordinary course of business and subsequent to the date of such balance sheet, as well as any transaction giving rise to the need to calculate Consolidated Net Tangible Assets (including the application of the proceeds therefrom, as applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#147;Principal Property&#148; means any manufacturing plant, research facility or warehouse owned by us or any of our subsidiaries
which is located within the United States and has a net book value exceeding the greater of $50,000,000 and 3% of the total assets of our company and our consolidated subsidiaries, as shown on our most recent audited consolidated balance sheet,
excluding any property which the board of directors by resolution declares is not of material importance to our total business as consolidated with the business of our subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#147;Restricted Subsidiary&#148; means any of our subsidiaries (i)&nbsp;substantially all the property of which is located, or
substantially all the business of which is carried on, within the United States of America and (ii)&nbsp;which owns or leases a Principal Property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger, Consolidation or Sale of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the restrictions on liens and sale and lease-back transactions described above, the Indenture and debt securities do not prevent any
consolidation of the Company with any other entity or entities (whether or not our subsidiaries), or successive consolidations or mergers or shall prevent any sale, lease or conveyance of our property as an entirety or substantially as an entirety;
provided, however, that (i)&nbsp;we are the continuing entity or the successor entity is organized in the United Sates and (ii)&nbsp;we covenant that our obligations will be assumed by the surviving entity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default, Waiver and Notice </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
to any series of securities, an &#147;event of default&#148; is defined in the Indenture as being any of the following events: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default for 30 days in the payment of any interest on the securities of such series; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of all or any part of principal or premium, if any, due on the securities of any series
either at maturity, upon redemption (other than pursuant to a sinking fund), upon acceleration or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default for 30 days in the payment of any sinking fund installment on the securities of such series, when due;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our default for 90 days after receiving notice of such default in the performance of any other of the covenants
or agreements in the Indenture (other than those set forth exclusively in the terms of any other series of securities); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events of voluntary and involuntary bankruptcy, insolvency and reorganization of our company; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other events as may be established with respect to any applicable series of debt securities.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No event of default with respect to any particular series of securities necessarily constitutes an event of default
with respect to any other series of securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee must give notice of a default of which it has received written notice to the
holders of the series of debt securities on which the default exists within 90 days unless the default is cured or waived. However, except in the case of default in the payment of the principal of, premium, if any, or interest on any of the
securities of such series or in the making of any sinking fund payment with respect to such series, the trustee may withhold this notice if the trustee considers it in the interest of the holders of securities of such series to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default has occurred and is continuing (unless the principal of all of the securities of such series shall have already become
due and payable): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and the event of default does not relate to certain events of bankruptcy, insolvency or reorganization, either
the trustee or the holders of at least 25% in principal amount of the securities of such series then outstanding may declare the principal (or, in the case of original issue discount securities, the amount specified in the terms thereof) of all such
securities to be due and payable immediately; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and the event of default relates to certain events of bankruptcy, insolvency or reorganization, the principal
(or, in the case of original issue discount securities, the amount specified in the terms thereof) of all securities issued under the Indenture that are then outstanding shall automatically, and without any acceleration or any other action on the
part of the trustee or any holder, become immediately due and payable. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, upon certain conditions, past defaults
of the type described in the first through third and sixth bullets above may be waived by the holders of a majority in principal amount of the affected securities then outstanding (or in the case of past defaults on the type described in the fourth
or fifth bullet above, by the holders of a majority in principal amount of all securities then outstanding voting as one class), except for defaults in (i)&nbsp;the payment of principal of, or any premium or interest on, such securities; or
(ii)&nbsp;with respect to any covenant or provision which may not be amended without the approval of each holder affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of
a majority in principal amount of the securities of each series affected, voting as a separate class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee under the Indenture or exercising any
trust or power conferred on the trustee with respect to the securities of such series of the Indenture, subject to certain limitations specified in the Indenture, provided that the holders of securities shall have offered to the trustee reasonable
security or indemnity against costs, expenses and liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of our officers must certify to the trustee on a yearly basis whether
or not to the knowledge of such officer we are in default in the performance and observance of the terms, provisions, covenants and conditions of the Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification of the Indenture </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Together with the trustee, and subject to the consent of the holders of at least a majority of the outstanding principal amount of the
outstanding debt securities of all affected series (voting separately), we may modify the Indenture or any supplement to the Indenture. Without the consent of each affected holder, we may not: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">extend the final maturity of any security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal amount or rate of interest of any security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">extend the time of payment of interest of any security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount payable upon the redemption of any security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of the principal of an original issue discount security payable upon acceleration of the
maturity of the security or in the event of bankruptcy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right to institute suit to enforce payment or repayment; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the percentage of debt securities of any series that are required to approve a supplemental indenture.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the above, we may modify the Indenture or any supplement to the Indenture without the consent of any
holder to, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide for uncertificated debt securities in addition to certificated debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence the succession of another entity to us, or successive successions, in compliance with the terms of the
Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add covenants, restrictions, conditions or other provisions or additional events of default for the protection
of the holders or all or any series of debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cure any ambiguity or inconsistency or to correct or supplement any provision which may be defective or
inconsistent with any other provision and to conform the terms to the description of such terms in the applicable offering memorandum, prospectus supplement or other offering document for such debt securities at the time of initial sale thereof as
we may deem necessary or desirable and which shall not adversely affect the interests of the holders of the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish the form or terms of debt securities as permitted by the Indenture and to authorize the issuance of
additional debt securities of a series previously authorized or to add to the conditions, limitations or restrictions on the authorized amount, terms or purposes of issue, authentication or delivery of the debt securities of any series or other
conditions, limitations or restrictions to be observed, as well as the deletion or modification of any events of default with respect to such series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence and provide for the acceptance of appointment of a successor trustee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add to or change or eliminate any provision as shall be necessary or desirable in accordance with any amendment
to the Trust Indenture Act of 1939; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add guarantors or <FONT STYLE="white-space:nowrap">co-obligors</FONT> with respect to any series of debt
securities and to release guarantors from their guarantees of debt securities in accordance with their terms; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change in any series of debt securities that do not adversely affect in any material respect the rights
of the holders of such debt securities. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discharge and Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may discharge certain obligations to holders with respect to any series of debt securities that have not already been delivered to the
trustee for cancellation and that either have become due and payable or will become due and payable within one year (or are to be called for redemption within one year under arrangements satisfactory to the trustee for the giving of notice) by
irrevocably depositing with the trustee, in trust, funds </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sufficient to pay the entire indebtedness on those debt securities in respect of principal, premium, if any, and interest to the date of that deposit (if those securities have become due and
payable or to the maturity date, as the case may be). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, at any time, satisfy our obligations with respect to any payments of
principal, premium or interest of any security or securities of any series by irrevocably depositing in trust with the trustee: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">money (in the currency in which the securities are payable); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of securities denominated in U.S. dollars, U.S. Government Obligations (as defined in the Indenture),
or a combination of U.S. Government Obligations and money; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of securities denominated in a foreign currency, Foreign Government Securities (as defined in the
Indenture) or a combination of Foreign Government Securities and money. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the deposit is sufficient to make all
payments of interest, principal and premium when due, our obligations with respect to such securities will be discharged and terminated (except as to certain of our obligations to the trustee), and holders of the debt securities will be able to look
only to the trust fund for any payment of principal, premium and interest on securities of such series until maturity or redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any
deposit as described in the immediately preceding paragraph is likely to be treated, for United States federal income tax purposes, as a deemed taxable exchange of our securities for the property of the trust with the receipt of an interest in the
trust (or a debt instrument issued by the trust as discussed below). In such a case, at the time of the deemed exchange, you would be required to recognize taxable gain or loss in an amount equal to the difference between (1)&nbsp;the sum of
(a)&nbsp;the amount of money and (b)&nbsp;the fair market value of the property held in the trust that you are deemed to receive in the exchange and (2)&nbsp;your tax basis in our securities deemed exchanged. Even though United States federal income
tax may be imposed on the deemed exchange, you would not receive any cash until the maturity date or early redemption of the securities, except for any current interest payments. After such deposit, and subject to the discussion below, you will
likely be treated as if you hold an undivided interest in the cash (or investments made therewith) and the property held in trust (or investments made with interest received therefrom) and you may be required to include in taxable income your share
of the income, gain and loss of the trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the trust is considered a separate taxable entity, you will be treated as holding a debt
instrument issued by the trust. In such case, in addition to the taxable gain or loss recognized with respect to the deemed exchange, you may also be subject to a tax liability in respect of original issue discount and interest on such instrument.
You should consult your own advisors with respect to the more detailed tax consequences of such deposit and discharge, including possible liabilities with regard to tax laws other than United States federal income tax law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue the debt
securities of a series in whole or in part in the form of one or more global certificates that will be deposited with a depositary we will identify in a prospectus supplement. We will describe the specific terms of the depositary arrangement with
respect to a series of debt securities in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the issuance of a global security, the depositary
will credit, on its book-entry registration and transfer system, the respective principal amounts of that global security to the accounts of participants in the depositary. Ownership of beneficial interests in a global security will be limited to
participants or persons that hold interests through participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as the depositary for a global security, or its nominee, is the
registered owner of the global security, the depositary or its nominee, as the case may be, will be considered the sole owner or holder of the securities represented by that global security. Except as provided in the Indenture, owners of beneficial
interests in securities represented by a global security will not: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be entitled to have such securities registered in their names; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receive or be entitled to receive physical delivery of certificates representing such securities in definitive
form; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be considered the owners or holders thereof under the Indenture; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have any rights under the Indenture. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, in our sole discretion, at any time determine that any series of securities issued or issuable in the form of a global security shall
no longer be represented by such global security. In such event we will execute, and the trustee, upon receipt of an order for the authentication and delivery of individual debt securities of such series in exchange in whole or in part for such
global security will authenticate and deliver individual securities of such series of like tenor and terms in definitive form in an aggregate principal amount equal to the principal amount of such global security or securities representing such
series in exchange for such global security or securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concerning the Trustee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Bank of New York Mellon Trust Company, N.A. is the trustee under the Indenture. We may maintain deposit accounts and conduct other banking
transactions with the trustee or an affiliate of the trustee in the ordinary course of business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities and the Indenture will be governed by and construed in accordance with the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_9"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue warrants for the purchase of common stock, preferred stock or debt securities. Warrants may be issued independently or together
with any offered securities. Each series of warrants will be issued under a separate warrant agreement, the terms of which will be described in the applicable prospectus supplement. The following summary of the terms of the warrants does not purport
to be complete and is subject to, and is qualified in its entirety by reference to, the terms of the warrants and the warrant agreement to be described in the applicable prospectus supplement. For more information on how you can obtain copies of the
warrant agreement and related warrant certificate, see &#147;<I>Where You Can Find More Information</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to a particular issue of warrants will describe the terms of those warrants, including the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any offering price or prices for the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate number of the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number, designation and terms of the common stock, preferred stock or debt securities that may be purchased
upon exercise of the warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the designation and terms of the securities together with which the warrants are issued and the
number of warrants issued with each security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any date from and after which the warrants and any securities issued with them will be separately transferable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which the right to exercise the warrants will commence and expire; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any minimum or maximum amount of the warrants that may be exercised at any one time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currency units in which the offering price and the exercise price are payable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, a discussion of material United States federal income tax consequences applicable to the warrants,
or other income tax considerations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any anti-dilution provisions of the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any redemption or call provisions applicable to the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any additional terms of the warrants, including terms, procedures, and limitations relating to the exchange and
exercise of the warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the warrants represented by the warrant certificates or debt securities that may be issued upon exercise
of the warrants will be issued in registered or bearer form; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name of the warrant agent and any information with respect to book-entry procedures. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Rights as Stockholder or Noteholder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until a holder exercises warrants to purchase shares of our common stock, shares of our preferred stock or debt securities, the holder will not
have any rights as a holder of shares of our common stock, shares of our preferred stock or holder of our debt securities, respectively, by virtue of ownership of warrants. Holders of equity warrants will not have any right to vote, consent, receive
dividends or receive notice as a stockholder with respect to any meeting of stockholders for the election of directors or any other matter. Holders of debt warrants will not have any right to receive payment of principal or premium, if any, or
interest on the debt securities purchasable upon exercise of the warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exercise of Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of a warrant will be entitled to purchase, at the exercise price set forth in the warrants and described in the applicable
prospectus supplement (subject to adjustment as described in the applicable prospectus supplement), the number of shares of common stock, shares of preferred stock or principal amount of debt securities being offered. Holders may exercise warrants
at any time up to the date and time date set forth in the warrants and described in the applicable prospectus supplement. After such date and time, unexercised warrants will be void. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_10"></A>DESCRIPTION OF DEPOSITARY SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may elect to offer fractional shares of preferred stock, rather than full shares of preferred stock. The following is a summary of certain
general terms and provisions of depositary shares representing a fractional interest in a share of the applicable series of preferred stock. The following summary does not purport to be complete and is subject to, and is qualified in its entirety by
reference to, the terms of the depositary shares and our preferred stock, as well as the terms of the deposit agreement, depositary receipt, our Certificate of Incorporation and Bylaws, and the certificate of designations relating to the applicable
series of our preferred stock to be described in the applicable prospectus supplement. For more information on how you can obtain copies of the deposit agreement and related depositary receipt, see &#147;<I>Where You Can Find More
Information</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
we issue fractional shares of preferred stock, we will issue to the public receipts for depositary shares and each of these depositary shares will represent a fraction of a share of a particular series of preferred stock. Subject to the terms of the
depositary agreement, each owner of a depositary share will be entitled, in proportion to the applicable fractional interest in shares of preferred stock underlying that depositary share, to all rights and preferences of the preferred stock
underlying that depositary share (including, if applicable, dividend, voting, conversion, exchange, redemption, sinking fund, subscription and liquidation rights). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of preferred stock underlying the depositary shares will be deposited with a depositary under a deposit agreement between us, the
depositary and the holders of the depositary receipts evidencing the depositary shares and the depositary will issue, on our behalf, the related depositary receipts. Unless stated otherwise in the applicable prospectus supplement, the depositary
will be a bank or trust company selected by us and will act as the transfer agent, registrar and dividend disbursing agent for the depositary shares. Holders of depositary receipts agree to be bound by the deposit agreement, which requires holders
to take certain actions such as filing proof of residence and paying certain charges. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary will distribute cash dividends or other cash distributions received in respect of the series of preferred stock underlying the
depositary shares, if any, to the record holders of depositary receipts in proportion to the number of depositary shares owned by those holders on the relevant record date. The record date for the depositary shares will be the same date as the
record date for the preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a distribution other than in cash, the depositary will distribute property received
by it to the record holders of depositary receipts that are entitled to receive the distribution. However, if the depositary determines that it is not feasible to make the distribution, the depositary may, with our approval, adopt another method for
the distribution, including selling the property and distributing the net proceeds to the holders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidation Preference </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of our voluntary or involuntary liquidation, dissolution or winding up, the holders of each depositary share will be entitled to
receive the fraction of the liquidation preference accorded each share of the applicable series of preferred stock, as set forth in the applicable prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a series of preferred
stock underlying the depositary shares is subject to redemption, the depositary shares will be redeemed from the proceeds received by the depositary resulting from the redemption, in whole or in part, of preferred stock held by the depositary.
Whenever we redeem any preferred stock held by the depositary, the depositary will redeem, as of the same redemption date, the number of depositary shares representing the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preferred stock so redeemed. The depositary will mail the notice of redemption to the record holders of the depositary receipts promptly upon receiving the notice in accordance with the
procedures described in any accompany prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon receipt of notice of any meeting at which the holders of preferred stock are entitled to vote, the depositary will mail the information
contained in the notice of meeting to the record holders of the depositary receipts underlying the preferred stock. Each record holder of those depositary receipts on the record date will be entitled to instruct the depositary as to the exercise of
the voting rights pertaining to the amount of preferred stock underlying that holder&#146;s depositary shares. The record date for the depositary shares will be the same date as the record date for the preferred stock. The depositary will try, as
far as practicable, to vote the preferred stock underlying the depositary shares in accordance with the instructions of the holders of the depositary receipts. We will agree to take all action which may be deemed necessary by the depositary in order
to enable the depositary to do so. The depositary will not vote the preferred stock to the extent that it does not receive specific instructions from the holders of depositary receipts. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withdrawal of Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Owners of
depositary shares are entitled, upon surrender of depositary receipts at the principal office of the depositary and payment of any unpaid amount due the depositary, to receive the number of whole shares of preferred stock underlying the depositary
shares. Partial shares of preferred stock will not be issued. Holders of preferred stock will not be entitled to deposit the shares under the deposit agreement or to receive depositary receipts evidencing depositary shares for the preferred stock.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment and Termination of Deposit Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form of depositary receipt evidencing the depositary shares and any provision of the deposit agreement may be amended at any time and from
time to time by agreement between us and the depositary. However, any amendment which materially and adversely alters the rights of the holders of depositary shares, other than any change in fees, will not be effective unless the amendment has been
approved by at least a majority of the depositary shares then outstanding. The deposit agreement may be terminated by us or the depositary only if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all outstanding depositary shares have been redeemed; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there has been a final distribution in respect of the preferred stock in connection with our dissolution and such
distribution has been made to all the holders of depositary shares. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Charges of Depositary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangements. We will
also pay charges of the depositary in connection with the initial deposit of the preferred stock and the initial issuance of the depositary shares, any redemption of the preferred stock and all withdrawals of preferred stock by owners of depositary
shares. Holders of depositary receipts will pay transfer, income and other taxes and governmental charges and certain other charges as provided in the deposit agreement to be for their accounts. In certain circumstances, the depositary may refuse to
transfer depositary shares, may withhold dividends and distributions and sell the depositary shares evidenced by the depositary receipt if the charges are not paid. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reports to Holders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary will
forward to the holders of depositary receipts all reports and communications we deliver to the depositary that we are required to furnish to the holders of the preferred stock. In addition, the depositary
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will make available for inspection by holders of depositary receipts at the principal office of the depositary, and at other places as it may from time to time deem advisable, any reports and
communications we deliver to the depositary as the holder of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liability and Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the depositary will be liable if either of us are prevented or delayed by law or any circumstance beyond our control in
performing our respective obligations under the deposit agreement. Our obligations and those of the depositary will be limited to performance in good faith of our respective duties under the deposit agreement. Neither we nor the depositary will be
obligated to prosecute or defend any legal proceeding in respect of any depositary shares or preferred stock unless satisfactory indemnity is furnished. We and the depositary may rely on written advice of counsel or accountants, on information
provided by holders of depositary receipts or other persons believed in good faith to be competent to give such information and on documents believed to be genuine and to have been signed or presented by the proper party or parties. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Resignation and Removal of Depositary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary may resign at any time by delivering a notice to us of its election to do so. We may remove the depositary at any time. Any such
resignation or removal will take effect upon the appointment of a successor depositary and its acceptance of such appointment. The successor depositary must be appointed within 60 days after delivery of the notice for resignation or removal. In
addition, unless otherwise stated in the applicable prospectus supplement, the successor depositary must be a bank or trust company having its principal office in the United States of America and having a combined capital and surplus of at least
$150,000,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_10a"></A>DESCRIPTION OF UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue units comprised of one or more of the securities described in this prospectus or any prospectus supplement in any combination.
Each unit will be issued so that the holder of the unit is also the holder, with the rights and obligations of a holder, of each security included in the unit. The units may be issued under unit agreements to be entered into between us and a unit
agent, which may provide that the securities included in the unit may not be held or transferred separately, at any time or times before a specified date or upon the occurrence of a specified event or occurrence. For more information on how you can
obtain copies of the unit agreement and related unit certificate, see &#147;<I>Where You Can Find More Information</I>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
prospectus supplement relating to an offering of units will describe the specific terms of the units, including, to the extent applicable, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of the units and of the securities comprising the units, including whether and under
what circumstances the securities comprising the units may be held or transferred separately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of the terms of any unit agreement governing the units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of the provisions for the payment, settlement, transfer or exchange of the units;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a discussion of material federal income tax considerations, if applicable; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the units, if issued as a separate security, will be issued in fully registered or global form.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_11"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the securities covered by this prospectus from time to time in one or more of the following ways: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters, dealers or agents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to agents or other purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in an &#147;at the market offering,&#148; within the meaning of Rule 415(a)(4) under the Securities Act, to or
through a market maker or into an existing trading market, on an exchange or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in forward contracts or similar arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through a combination of any of the foregoing methods; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through any other method described in the applicable prospectus supplement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, directly or through underwriters dealers or agents, may offer and sell the securities covered by this prospectus in one or more
transactions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price or fixed prices, which may be changed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale, including through transactions on the New York Stock Exchange or
any other organized market where our securities may be sold; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to the prevailing market price; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may solicit offers to purchase securities directly or by the means of designated agents from time to time. Any such agent, who may be
deemed to be an underwriter as that term is defined in the Securities Act involved in the offer or sale of the securities in respect of which this prospectus is delivered will be named, and any commissions payable by us to such agent will be set
forth, in the prospectus supplement. Unless otherwise indicated in the prospectus supplement, any such agent will be acting on a best efforts basis for the period of its appointment. Agents, underwriters and other third parties described above may
be entitled to indemnification by us against certain civil liabilities under the Securities Act, or to contribution with respect to payments which the agents or underwriters may be required to make in respect thereof. Agents, underwriters and such
other third parties may be customers of, engage in transactions with, or perform services for us in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
series of securities will be a new issue of securities and will have no established trading market, other than our common stock and certain series of our debt securities, which are listed on the New York Stock Exchange. Any common stock sold will be
listed on the New York Stock Exchange, upon official notice of issuance. The securities other than the common stock may or may not be listed on a national securities exchange and no assurance can be given that there will be a secondary market for
any such securities or liquidity in the secondary market if one develops. Any underwriters to whom securities are sold by us for public offering and sale may make a market in the securities, but such underwriters will not be obligated to do so and
may discontinue any market making at any time without notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will identify the specific plan of distribution, including any
underwriters, dealers, agents or direct purchasers and their compensation in a prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales Through Underwriters or Dealers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If underwriters are used in a sale, securities will be acquired by the underwriters for their own account and may be resold from time to time
in one or more transactions, including negotiated transactions, at a fixed public </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
offering price or at varying prices determined at the time of sale, or under delayed delivery contracts or other contractual commitments. Securities may be offered to the public either through
underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters. If an underwriter or underwriters are used in the sale of securities, an underwriting agreement will be executed with
the underwriter or underwriters at the time an agreement for the sale is reached. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a dealer is used in the sale of the securities, we
or an underwriter will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. To the extent required, we will set forth in the
prospectus supplement the name of the dealer and the terms of the transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales Through Agents and Direct Sales </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Agents may from time to time solicit offers to purchase the securities. If required, we will name in the applicable prospectus supplement any
agent involved in the offer or sale of the securities. Unless otherwise indicated in the prospectus supplement, any agent will be acting on a best efforts basis for the period of its appointment. Any agent selling the securities covered by this
prospectus may be deemed to be an underwriter, as that term is defined in the Securities Act, of the securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may directly solicit
offers to purchase the securities and we may make sales of securities directly to institutional investors or others. These persons may be deemed to be underwriters within the meaning of the Securities Act with respect to any resale of the
securities. To the extent required, the prospectus supplement will describe the terms of any such sales, including the terms of any bidding or auction process, if used. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delayed Delivery Contracts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
prospectus supplement indicates, we may authorize underwriters, dealers or agents to solicit offers from certain institutions to purchase securities at the public offering price under delayed delivery contracts. These contracts would provide for
payment and delivery of securities on a specified date in the future. The contracts would be subject only to those conditions described in the prospectus supplement. The applicable prospectus supplement will describe the commission payable for
solicitation of those contracts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Making, Stabilization and Other Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain persons participating in an offering may engage in option transactions, stabilizing transactions, short-covering transactions and
penalty bids in accordance with Regulation M under the Exchange Act that stabilize, maintain or otherwise affect the price of the offered securities. These transactions may have the effect of raising or maintaining the market price of our securities
or preventing or retarding a decline in the market price of our securities. As a result, the price of the securities in the open market may be higher than it would otherwise be in the absence of these transactions. If any such activities will occur,
they will be described in the applicable prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Derivative Transactions and Hedging </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the underwriters, dealers or agents may engage in derivative transactions involving the securities. These derivatives may consist of
short sale transactions and other hedging activities. The underwriters, dealers or agents may acquire a long or short position in the securities, hold or resell securities acquired and purchase options or futures on the securities and other
derivative instruments with returns linked to or related to changes in the price of the securities. In order to facilitate these derivative transactions, we may enter into security lending or repurchase agreements with the underwriters, dealers or
agents, and they may effect the derivative transactions through sales of the securities to the public, including short sales, or by lending the securities in order to facilitate short sale transactions by others. The underwriters or agents may also
use the securities purchased or borrowed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
from us or others (or, in the case of derivatives, securities received from us in settlement of those derivatives) to directly or indirectly settle sales of the securities or close out any
related open borrowings of the securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents may be entitled under agreements which may be entered into with us to indemnification by us against specified
liabilities, including liabilities incurred under the Securities Act, or to contribution by us to payments they may be required to make in respect of such liabilities. If required, the prospectus supplement will describe the terms and conditions of
such indemnification or contribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the securities laws of some states, the securities offered by this prospectus may be sold in
those states only through registered or licensed brokers or dealers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents and their affiliates may engage in
transactions with us, or perform services for us, in the ordinary course of business for which they receive customary compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the legality of the securities covered by this prospectus will be passed
upon for us by Covington&nbsp;&amp; Burling LLP, Washington, DC. If legal matters in connection with offerings made pursuant to this prospectus are passed on by counsel for the underwriters, dealers or agents, if any, such counsel will be named the
in the applicable prospectus supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx942740_13"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s consolidated financial statements as of September 30, 2023 and 2022 and for each of the three years ended September 30,
2023 that are incorporated by reference in this prospectus from the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September 30, 2023, and the effectiveness of the Company&#146;s internal
control over financial reporting as of September 30, 2023, incorporated by reference herein, have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such consolidated financial
statements have been incorporated by reference in reliance upon the report of such firm, given their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>&#128;500,000,000 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g942740g37k37.jpg" ALT="LOGO" STYLE="width:4.69306in;height:1.04857in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>Air Products and Chemicals, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>3.250% Notes due 2032 </B></P>
<P STYLE="font-size:90pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:90pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint Book-Running Managers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>BARCLAYS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>CR&Eacute;DIT
AGRICOLE CIB </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>DEUTSCHE BANK </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>J.P. MORGAN </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>STANDARD
CHARTERED BANK </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>June 10, 2025 </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d942740dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
<title>EX-FILING FEES</title>
</head>
  <body> <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-206">S-3</ix:nonNumeric> <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-207">424B2</ix:nonNumeric> <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-208">EX-FILING FEES</ix:nonNumeric> <ix:nonNumeric name="ffd:RegnFileNb" contextRef="rc" id="ixv-209">333-275663</ix:nonNumeric> <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-210">0000002969</ix:nonNumeric> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-211">Air Products &amp; Chemicals, Inc.</ix:nonNumeric> <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="rc" format="ixt:booleanfalse" id="ixv-212">The prospectus is not a final prospectus for the related offering.</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="rc"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000002969</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-06-11</xbrli:startDate> <xbrli:endDate>2025-06-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_1"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000002969</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-06-11</xbrli:startDate> <xbrli:endDate>2025-06-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> </ix:resources> </ix:header> </div> <div>
<table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
<tr>
<td colspan="4" style="padding-bottom: .5em"> <p> <b>Calculation of Filing Fee Tables</b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-237">S-3</ix:nonNumeric> </b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-238">Air Products &amp; Chemicals, Inc.</ix:nonNumeric> </b> </p> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word"> <p style="margin: 0pt; text-align: center;"> <b>Table 1: Newly Registered and Carry Forward Securities</b> </p> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
<tr style="background-color:#9ADAF6">
<th style="width: 12%;">
 </th>
<th style="width: 2%;">
 </th>
<th style="width: 12%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Type</b> </p> </th>
<th style="width: 14%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Class Title </b> </p> </th>
<th style="width: 2%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Calculation or Carry Forward Rule</b> </p> </th>
<th style="width: 5%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount Registered</b> </p> </th>
<th style="width: 15%;"> <p style="margin: 0pt; text-align: center;"> <b>Proposed Maximum Offering Price Per Unit</b> </p> </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Maximum Aggregate Offering Price</b> </p> </th>
<th style="width: 5%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Rate</b> </p> </th>
<th style="width: 6%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount of Registration Fee</b> </p> </th>
<th style="width: 1%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward Form Type</b> </p> </th>
<th style="width: 7%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward File Number</b> </p> </th>
<th style="width: 6%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward Initial Effective Date</b> </p> </th>
<th style="width: 7%;"> <p style="margin: 0pt; text-align: center;"> <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b> </p> </th> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Newly Registered Securities</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-239">Fees to be Paid</ix:nonNumeric> </td>
<td style="text-align: center;"> 1 </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-240">Debt</ix:nonNumeric> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-241">3.250% Notes due 2032</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-242">457(r)</ix:nonNumeric> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-243">569,600,000</ix:nonFraction> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-244">567,669,056.00</ix:nonFraction> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-245">0.0001531</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-246">86,910.14</ix:nonFraction> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fees Previously Paid </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Carry Forward Securities</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p> </td>
<td>
 </td>
<td style="vertical-align: top; width: 16%;"> <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-247">567,669,056.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td style="vertical-align: top; border-bottom: 1px black; width: 16%;"> <p id="TotalFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-248">86,910.14</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fees Previously Paid: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-249">0.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fee Offsets: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-250">0.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Net Fee Due: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="NetFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-251">86,910.14</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr> </table> </div> <div>
<table style="width: 100%; text-indent: 0px;"> <tbody>
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td> <p style="margin:0pt;text-align:left; margin-bottom: 5px;"> <b>Offering Note</b> </p> </td>
<td/> </tr> </tbody> </table> </div> <div style="padding-bottom: 20px;">
<table style="width: 100%; text-indent: 0px;">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td style="width:10pt;"> <p style="margin:0pt;text-align:left;"> <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup> </p> </td>
<td colspan="7" style="white-space: pre-line;"> <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-252">The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering The filing fee is calculated and is being paid pursuant to Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, based on the maximum aggregate offering price of the 3.250% Notes due 2032 (the "2032 Notes"). The maximum aggregate offering price is calculated based on the public offering price of 99.661% of the principal amount of the 2032 Notes. The amount registered, maximum aggregate offering price and registration fee have been calculated by converting the amount registered from Euros to U.S. Dollars based upon the Euro to U.S. Dollar exchange rate at 9:00 a.m. (London time) on June 10, 2025 of Euro1.00 = $1.13920.</ix:nonNumeric> </td> </tr>
<tr>
<td style="width:10pt;"/>
<td colspan="7"> <hr style="width:100%;text-align:left;margin-left:0"/> </td> </tr> </table> </div> </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g942740g01k01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g942740g01k01.jpg
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M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "- FT# 2(
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M$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 ?,TC(8GRRO:R-C2YSG'
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MY!NX/2"Y4Q668*8[II'2RT>N!1G25V\I!AIQ3O)WOM8]''7G&.M4AYT-4_\
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M37"COS!- _>QXJ<.'.T^GP(Y%57"<'G!ATNGU-%BEMY>?-?^EJ(B+4>Z$1$
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*@FDHK""(B'3_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g942740g37k37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g942740g37k37.jpg
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M 0 " P$                #! $"!0;_Q  S$0 " @$"! 0%! ,  @,
M 0(#$002!1,Q410A05(588&1L2(R<?!"H<$CX3-BT?_:  P# 0 "$0,1 #\
MU2
M
M
M                                            #CXNOL.';#4W";)7
M,35B8OWWKZJ?^\"*4GNKXF_U:3\A.\TE8H^3*M^LKH>V74T(#/>ZOB;_ %:3
M\A.\;J^)O]6D_(3O-.?$@^)T_,T(#/>ZOB;_ %:3\A.\;J^)O]6D_(3O'/B/
MB=/S-" SWNKXF_U:3\A.\DVCS&.*,3X@CIGR4Z4<2>$J'MA1,F\2+QJN]U\1
ME71;PC>'$*K)*,4\LMX $I>
M
M
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M^%FB'^3.UPS3X7.E]  "P=<
M
M
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M!/IZ7?8H(LG"UE@P_8Z6W4^2I$WTWY>N]?6=TJ=4 OI8\CU,8J*45T  !D
M
M
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M^R/[J=.U>CB+ +E,-JRST7#]/RJ]SZL  E+X
M
M
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M=@I51/&I/M:AR<+UX.9-G1RDE4-S+NAT_.LR^B)(B9)DFP %T](
M
M
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M#V7FL6X7>NK';:B=\OQ.53QE*3RVSS5L]\Y2[L  P1@U#H_HO)^#+13JF3O
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MF>Y89!P[4<R&R75?@]X )CI
M
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MXWJOK%7/QB=\G0KE5#3.-:[R=A*[52+DYE.]&K_$J:J=JH98(KWT12XK/SC
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MX6IU\5:LU8],I*F1/2=R)^%.3KS)*"S"I1.SI]%71YKS?<  D+@
M                .??[K3V2SU5PJURB@9K9<+EX&IRJN2#H8;45EE=:;\3>
M+4;+%2/^VG1)*A47U6<#>E=_F3E*3/9>+C47:Z5-?6.UIYWJ]W)Q(G(B;W0>
M,HSEN>3RVIO=]CGZ>@ !H0    NS0?AGQ:BDOM6S[:H18Z=%3U6<+NE>Q.4K
M+ ^'Y,2XAIZ%N:0(OA)WI]V--O2NQ.533]/#'3P1PP,2.*-J,8UNQJ)O(A/1
M#+W,ZO#-/NES9=%T/V "T=P 'RJJB*EII:BH>D<,3%>]R[&M1,U4#H0G2]B;
MR'A]:2F?E75R+&W)=]C/O._9.?D,\G<QG?I<1X@J:^3-(U74A8OW(TV)^Z\J
MJ<,HV3W,\QK-1S[&UT70%G:$\3^(7-]EJWY4U6NM"JKO-EXOZD[43C*Q/U&]
MT4C9(W*U[51S7(N2HJ;%,1EM>2*BUTS4T:_!&M'N)&XEP[#4N5/&XOLJAJ<#
MTX>9=O\ \$E+R>5E'JH34XJ4>C  ,FP
M
M                                                          *C
MTWXHU(V8?HY/2?E)5*B[$VM9T[5Z.,L7%E\@P[8JFX5&2JQ,HV9^N]?5;_[P
M9F7;A63W"NGJZMZR3SO5[W+PJI!=/"VHYG$M1LCRX]7^#S@ JG!
M      )?HFK?$L=VU57)DRNA=RZS5R[<C21DFSU:T%VHJMNV"9DOPN1?V-:M
M5'-1S5S14S12UIWY-'<X5/,)1[,K[3C7>+8.;3HOI550QBI_"F;E[40H M?3
M_7:]RM5"B_Y43IG)_,N2?VKUE4$5SS(H<0GNO?R  (BD"RM ]#X?$]75N3-M
M-3JB+Q.<J(G8CBM2\M =#X*P7"M5,G5%0D:<J,;WN4DJ69%S00W7Q^19Y2>G
MZNU[K:Z%%WHH73*G*YV7_#M+L,V:5J[Q['5S5%S9"YL#>351$7MS)[GB)U>)
M3VTX[LB( *AYX   O_0=0^+8.=4*GI550]Z+QM3)J=J*6$<7!-#Y.PE::54R
M<RG8KD_B5-9>U5.T7X+$4CU>GALJC'Y&>-,MH\FXPEJ(VY0US4G3BUMCDZTS
MZ2"E_P"FZT>/X5;6QMSFH)$?GPZCMYW;JKT% %2V.V1P-=5R[GV?F  1E,&B
M-#E[\JX1CIY'9U% O@'9[5;M8O5O?TF=R=:&[WY*Q;'32NRIZ]/ .SV(_:Q>
MO>_J)*I;9%S07<JY9Z/R-#@ NGI0                           49ILQ
M-X_<V66D?G34BZTRHN\Z7B_I3M5>(M#'^(V8:P[/5HJ>-/\ LJ=J\+UX>9-O
M09CED?+*^25ROD>JN<Y5S557:JE>Z>%M1R>)ZC:N5'UZGY !6.(    "<Z),
M,^7L0)4U+-:@H521^:;SW_=;V9KR)RF8K<\(WJK=LU"/J6EHGPSY P\V:I9J
MU]:B22YIOL;]UO5OKRKR$V +\5M6$>JJK54%"/1  &20%3Z<,3> I8[#2/\
MM)D22I5%V,^ZWI7?YD3C+'Q#=H+'9JJXU:_9P,SRSWW.V(U.55R0RU=[A/=;
ME4UU8[6GG>KW+Q<B<B;"&Z>%A'-XCJ.7#EQZO\'D !4.    2W1EB9<-XBC=
M,]4H*G**H3@1.!W0O9F:414<B*U45%WT5#'Q?NAG$_E:RK;*I^=;0M1&JJ[[
MXMB+T;.HL43_ ,6=?AFHP^3+Z%B  LG:
M
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MG=&9075I6P?:+;A*2MM5!'330S,5SV*N:M7-N6^O&J%*D4X.+PRGJ*)42V2
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ME7^-N\O9JKTD%\<K)R^*5;H*Q>A70 *IP@?N*1\,K)(G*V1CD<UR;45-BGX
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M#,=%1%Y4?/Z@ &Y:
M
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M%%3>=+Q_TIO\ZH7H6:(86YG;X9I]JYLO7H  6#K
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MKHLGKXA1/RSC^2S@>2V7*CNE*E1;JJ*IA7[T;L\N1>)>13UDI<3364  #(
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M=.]R$<KZRHN%7+55LSYJB5=9[WKFJJ><J3M<OX//:G73N\EY(  B*0
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M$_E&ZML](_.EHG9RJB[SY?\ _.SG52M"I=/<\(\_Q#4<R>Q=%^0 "$YP
M           +[T,8G\JV=;55OSK*%J:BJN^^+8G5LYLBA#IX;O%18;U2W&E7
MTX79JW/>>WA:O.AO7/:\EG27NBQ2]/4U<#RVFX4]TMM/74;]>"=B/:O[+RIL
M/47CTZ::R@  9*FTX88\-3LO]&S[2)$CJD1-K?NNZ-B\BIQ%+FO:J"*JII:>
MH8DD,K58]B['(J9*AE_&N'Y<-X@J*!^:PHNO ]?OQKL7GX%Y44JW0P]R.%Q+
M3[9<V/1]?Y.$ " Y8+1T(X8\=N#[W5LSIZ5=6!%3UI./H1>M>0KRQVRHO-VI
MK?1MSFG>C4XFIPJO(B9J:EL=LI[-:::WT;<H8&(U.-R\*KRJN:DU,,O+.CP[
M3\R>^71?D]P +9Z    'ENM6V@M=95O]6"%\J_THJ_L>HB&EJM\2P)<<ER?/
MJP-Y=9R9_P"W,Q)X39';/9!R[(S?(]TCW/>N;G+FJ\:GY .>>2    )'@?"L
M^++A/2T\[*=(8O".D>U7)M1$3>Y^PFFXQ6^]Z;\IW>;JN4EE(L5Z6VR.Z$<H
MJ@%K[C%;[WIORG=YY*W0]>8F*ZEK:*H5/NJKF*O8J=HY4NQL]%>O\2LP>Z\6
MFNLU:ZDN=-)3SIOZKN%.-%V*G*AX30K--/#  !@_44CXI&21N5KV*CFN1<E1
M4V*:BP/>TQ!ABBKW*GAG-U)D3@D;O+U[>E#+9<N@"O5:6[T#W>BQS)VHO*BH
M[^UI-1+$L'1X9:XV[/1D0TQUWCF.JMB+FVF8R!.A-9>URD)/??JU;C>[A6YY
M^,3OD3F5RJG8> BD\MLI73WV2EW8 !@C /O04SZVNIZ6+_,GD;$WG<N2?J6A
MN,5OO>F_*=WFT8.70FJT]EV7!9P50"U]QBM][TWY3N\;C%;[WIORG=YMRI]B
M7P-_M_!5 +%O6B6]4-*^>CFIZY&)FL<>;7KS(N\O65VYJM<K7(J.1<E1> TE
M%QZD%E,ZGB:P?P &",'ZC>Z.1KXW*U[516N1<E14X3\@ U+@B\^7\,4->Y4\
M*]FK+E^-N\[M3/I.E=*^GM=OJ*VMD2.G@:KWN7]$Y5V%;: :MTEENE(JYI#.
MV1/ZFY?\3@Z;,3K6W%+'2/\ ^FI5UIU3[\G%S-3M5>(N<S$-QZ+Q>S3*U]?^
MD-QGB6JQ/>'U=0JMA;FV"'/>C9W\:G! *;>?-GGYR<VY2ZL  &H!]Z&DJ*^K
MBI:.)\U1*[58QB9JJEUX/T445)$RHQ"OC=4N_P" :JI&SD7+?<O9SF\(.?0L
M4::R]X@4<B*JY(BJO('-<U<G-5%Y4-;T-OHZ"-&4-)!3L3>RBC1J=A]*FF@J
MHECJ88YHUVMD:CD7H4E\/\SH?"7C]_\ K_V9#!=^/M&-)44LM=AR)(*MB*YU
M,WU)4_A3[J\FPI%45%5%145-Y44AG!P>&<Z_3SHEMD?P &I "PM#6)76F_I;
M:A^5%7JC$15WF2_=7IV=7$5Z?ICW1O:]CE:YJYHJ;44S&6UY1)38ZIJ:]#7X
M.3A*ZI>\-V^X9IKS1(K\N!Z;SNU%.L7T\^9ZR,E)*2]3.^F>N\;QQ41HN;:6
M)D*=6LO:Y2#'2Q)6^4L07*LSS2>H>]O,KER[,CFE&3RVSRET]]DI=V  :D0!
M^HV.D>UC$S<Y41$XU+LCT-6U8V^$N=8C\DULFMRSZC:,'+H3TZ:R_.Q="D07
MAN-6OWG6_"WN/E/H9HE:OB]WJ6.X%?$UR=BH;\F9/\.O[?[*4!.,4:-+U9(7
MU,*,KZ1B9N? BZS4XU;MZLR#D;BX]2I95.IXFL  &#0$@P-B*7#5_@K&*Y:=
MRZE1&GWV+MZ4VH1\&4\/*-H3<)*4>J-?02LGACFA<CXY&HYKDV*B[Z*?L@6A
M:[K<<(MII79S4+UAW]NHN^W]53H)ZJHB*JKDB%^+W+)ZNJQ6P4UZF=],U=XY
MCBHC1<VTL3($ZM9>URD&/??ZU;E?+A6JN:3SOD3F5RY=AX"A)Y;9Y:Z>^R4N
M[  ,$8-(Z)*'Q' EOS3)\^M.[EUG+E_M1#.$;'22-8Q,W.5$1.-36MJI&T%L
MI*1GJP0LB3^E$3]B?3KS;.KPJ&9REV1Z@ 6CN  _,CVQQN>]<FM155>) #.&
MEJN\=QU<,ES9!JP-_I;O]JJ0\]5UJW5]SK*M_K5$SY5_J<J_N>4Y\GEMGDK9
M[YN7=@ &",&BM#5#XG@:FD5,G54CYUZ]5.QJ&=D155$1,U7>1#6-BHDMECH*
M/>1*>!D:\Z-1%4GH7FV=3A4,V2EV1SL<8E@PQ8Y:R3)]0[T((E7UW]R;5,S7
M&MJ+C6S5=;*Z6HF<KGO=PJ2327B5V(\1ROB>JT-,JQ4Z<"HB[[NE=_FR(F:V
MSW/Y$&NU/.GA=$  1%( '<PEABX8GN'BU Q$C9DLLS_4C3EY>) EGR1M&+F]
ML5EG#/TUCG^JU7<R9FC<-Z.;#9HV+)3-KZI-LM2B.3/D;L3M7E)?%%'"Q&0Q
MLC8FQK4R0G5#]6=.OA4VLSEC_9D)45%R5,E/X:UN-KH+E$L=PHZ>I8O!+&CO
MUV%/:2=&T=KI9;K8$>M+'Z4U,JZRQI^)J[53C1=AB5+BLHCOX=.J.Z+RBJP
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M7ZB/8XT>NPK:&5TES94Z\R0I&D.KOJBKGGK+^$PZY)9:-9Z.Z$7*4?)?P00
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MG3@5,]]W2N_S9$=L]J*>MU')K\NKZ$6>]TCW/>Y7/<N:JJYJJ\9^0"D>:
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MN755.;?1>@H$OS3C=(J7"K*#63P]9*W)O#JM765>O53I*#*=W[CSW$L<[R[
M $1SP3;1K7+;J7$]2BY:EL?DO\2N1&]JD))!;G+38,O$G#5U$%,G*B:TCNUK
M.LVB\/)+1+;/<O3/X(^ #4B   )9HJH?'L=6QJIFR%RSNY-5%5.W(TJ4EH!H
M?"7>Z5RIO0PMB1>5[L_^':7:6Z%B)Z'AD-M.>[  )CH SWIIM45NQ>LU.U&L
MK8DG<B<#\U1W7DB]*FA#/&F6[1W/&,D<#D='1QI3YIL5R*JN[5RZ"&_&TYW$
M]O)\^N2"@ J'GP  "S]%5T2P81Q/=GY+J>#9$B_>DR=DG6Y"LYY9)YI)IGJ^
M61RO<Y=JJJYJI)+K*Z@P/:;<F;7ULK[A*G\/^7'_ &N7I0C!O)^218NF]L:^
MR_/F  :%< $IT:6)+]BRE@E;K4T/V\R+L5K>#I7).DREEX-JX.R2BO4M;1%A
M!EEM3;G6QIY2JV9IK)OQ1KL3G7:O0G 6$ 7XQ45A'JZJHU04(@ &20&=M,-E
M9:<7RRP-1L%:SQA$38CE54<G6F?2:)*C_P 0,"+36:HR])KY8UY45&K^Q%<L
MQ*'$8*5#?8IH %,\Z   7MH&KEGPS64CES6FJ,TY&N1%_5'$UQ;7>3<,72K1
M<G14[U:O\62HWM5"KO\ #[,J5MYASWG1QOZE<G[DITV5WBN"GPHN3JJ=D70F
M;E_M+<)8KR>@HMQH]W9,SX "H>?   ._@*A\H8QM%.J9M6H:]R<;6^DO8BFH
MBA-!=#XQBV:I5,VTM.Y47B<Y4:G9K%]ENA?IR=_A<,5.7=@ $QT@4+IFPO%9
M[I%<J&-(Z2M54>QJ9(R1-]<N)%3?Z%+Z(/IFI6U&!*N14S=3R1RMY];5_1RD
M=L<Q94UM2LI>?3S,[  I'F0  "T= 58L=]N5'GZ,U.DF7*UR)^CU+5QM7>3<
M)7:J1<G,IW(U?XG)JIVJA2NA-ZMQS$B?>@D1>K/]BP=.==XMA&.E:OI550UJ
MIQM;FY>U&EFN6*V=O2V[=')]LE!  K'$   )!H_H?*&,[13JF;?&&R.3D9Z2
M]B&H2AM!-#X?%535.3T::G7)>)SE1$[-8ODMT+$<G?X7#%3EW8 !,=(' Q_7
M>3L&7>H1<G>+NC:O*_T4[7'?*WT[5W@,*T]*U<G5-0F:<;6HJKVZIK-XBV0:
MF>RJ4OD4, "@>5   .Y@>A\I8MM-*J9M=4-<Y/X6KK+V(I>.EJ^K9<)3LA?J
MU58OB\>6U$7UEZLTYU0K?070^,8MEJG)Z-+3N<B\3G*C4[%<?S3?=EKL5-H6
M.SBH8T;E_&[TG=FJG03Q>VMON=.F7)TDI^LGC^_[*[ ! <P   ]EGMU1=KG3
M4%&W6GG>C&IP)RKR(F^:?PM8J7#MGAH*-J9-3.23+?D?PN4K/0-8D5:R]SLS
M5O\ T\"KUN7]$ZRXBU3#"W'>X;IU"',?5_@  G.F#\R,;)&YDC4<QR*US53-
M%1> _0 ,I8IMR6G$5QH&^I!.YK,_PY^CV9'++,T@8+Q!=,87*LH;8^6FE>U6
M/1[$ULFHF>^O&A'MSO%7NB3\QGU%%P>7A'E[=/8IM1B\9[$4!*]SO%7NB3\Q
MGU#<[Q5[HD_,9]1C9+L1^'M]K^S(O"]8I62-7)S7(Y.@UY$[7C8[\2(IFY-'
M.*E5,[2]$_\ NQ_4:1A;J1,;^%J(3T)K.3K<+KG#=N373_I^@ 6#K%7:?*[P
M5BMU$BY+/.LB\J,;E^KDZBCRR-.U=X?%--2-7T::G3-.)SE55[-4K<I6O,F>
M:U\]]\OEY  $93!:>@&A\)>;G7*F]# V)%Y7NS_1G:587WH*H?%\)SU3D]*J
MJ'*B\;6HC4[=8DI69%WA\-UZ^7F6, "Z>D!6&GU5\W+<GW?&]_X'%GD TWT:
MU."EE:F?BU0R5>9<V_\ )#2S]K*VL6:)8[&?0 43RX  !86B['D>&DDH+FQ[
MK?*_71[$S=$[8JY<*+DA>%HO-NN\*2VRM@J6Y9KX-Z*J<Z;4Z3)I^X99(9&R
M0R/CD;L<Q<E3I)87.*P=#3<0G3'8UE&O@9HM6D'$MMR2.YR31I]RH1),^E=_
MM)C:=,L[=5MVM<<B<+Z9ZM7X5S_4F5T7U.C7Q*F77R)IBW1[;L375*^LJJN*
M5(TCU8E:B9(J[^^B\9Q=QRR^WW'XF?2=ZQZ1,.796L;6^*S+_P!NJ3P:]?J]
MI+6N1S4<U45JIFBIL4VVPEYDJHT]S<TDRM-QRR^WW'XF?2-QRR^WW'XF?268
M#/+CV,^"H]I7EKT46BW7*EK8JVO=)3RME:URLR56KFF?H\A88!F,5'H35TPJ
M6(+  !L2 C6D*:ZMP[-!8:26HK:G[+6CR3P;5]9W/EO)S\A)08:RL&LX[XN.
M<9,R^86)_<U1UM[QYA8G]S5'6WO-- AY$>YS?A5?=F9?,+$_N:HZV]X\PL3^
MYJCK;WFF@.1'N/A5?=F9?,+$_N:HZV]X\PL3^YJCK;WFFCDXJO<.'[%57&HR
M7P3<F,S]=Z^JWK[,PZ(KSR8EPRJ*<G)X1EZYV^JM=8^DKX5AJ&9:T;E153-,
MTSR/*>BOK)J^MGJZIZR3S/5[W+PJJGG*IQ)8SY=   8   !?>AC#/DJRK=*I
MF597-169IOLBX.O;U%7Z-L-+B3$<44K56AI\I:A>-J+O-Z5WN;,TJUJ-:C6H
MB-1,D1. L40_R9U^&:?+YLOH?T %D[0  !$-)SKQ+A]U!8:.:HFJ\V2OCR3P
M<?#M7:NSFS*4\PL3^YJCK;WFF@13J4GELI7Z*-\MTFS,OF%B?W-4=;>\>86)
M_<U1UM[S30->1'N0?"J^[,R^86)_<U1UM[QYA8G]S5'6WO-- <B/<?"J^[,R
M^86)_<U1UM[QYA8G]S5'6WO-- <B/<?"J^[,R^86)_<U1UM[QYA8G]S5'6WO
M-- <B/<?"J^[,R^86)_<U1UM[QYA8G]S5'6WO-- <B/<?"J^[,R^86)_<U1U
MM[QYA8G]S5'6WO-- <B/<?"J^[,R^86)_<U1UM[QYA8G]S5'6WO-- <B/<?"
MJ^[,R^86)_<U1UM[QYA8G]S5'6WO-- <B/<?"J^[,R^86)_<U1UM[R8Z+K7B
M?#=^1*JU5+;=591S[,FK]U^W@_15+I!E4J+RF;U\.A7)3C)Y0 !,=$   XF,
MK#%B.P5-OER21R:T+U^Y(FQ?V7D53EZ,<+>;-A1M2Q$N%2J23JF_J\3,^1.U
M5)>#7:L[B)TP=G,QY@ &Q*      #+6.*[RCBZ[U*+FUU0YK5_A:NJG8B&F;
MS6);[16UCME/"^7J:JF2W*KG*YRJJJN:JI7O?1''XK/RC _@ *QQ@?J-J/D:
MUSD:BJB*Y=B<I^0 :5I,;85I:2&GBO%.D<3&QMWG;$3). ^WG[ACWS3]3NXS
M("?GOL=-<4L7^*--^?N&/?-/U.[CC7O2M8*&%WD]\MPGR]%L;%8W/E<Y$[$4
MSZ##OD8EQ2UK"21U<37ZMQ%=)*ZXO19')JM8W>;&W@:B<1R@"%O)SI2<GE]0
M  8!)<0PK;\,X?HG)JR3LDKY$_G5&L_VLSZ3QX0LDF(<04EOC1=1[LY7)]R-
M-]R]7;D=72K4LGQK6Q0HB04C64T;4V-1K4S3KS-DL1;)XPQ5*;]?+_I$0 :D
M   !=FA>LM=IPQ,^NN%'3U%3.K]669K':J(C4WE7C1Q/_.:Q>^;;\RSO*8T@
M8:\GX,PO7QLR<VG2&?>X79R)VJ].HKLL<QP_3@ZWC9Z5*K;T2-5^<UB]\VWY
MEG>>:KQEAVE8KIKU0JB<$<J2+U-S4RZ#'/?8P^*S](HN#&>EADE/)28:9(CG
MIJK5R)JY)_ W;GRKU%0.57.57*JJN^JKPG\!%*;EU*%U\[WF;  -2$'4PS9Y
M[]>Z6W4R+K3/R<[+U&_><O,AX*2FFJZF.GI8GRSR.U6,8F:N7D0T-HUP<S"M
ML?45FJZYSMSE<F^D;=NHB_JO"O,25PWLM:33.^?R74IK2/-')BVL@IDU::C1
MM)$W\+8VHW+K12,GHN%0M77U-2_UII72+SJJJ><T;R\D%DMTG+N  8- 7=H$
MM:0VBX7)[?3J)4A8J_A:F:]:KV%(FG='%$E!@BT199*Z!)EYW^E^Y-0LRR='
MAD-UV[LB2  MGH    5/_B!D1+?9X_O.ED<G0B=Y;!1NGNM26_V^C1<T@IU>
MO(KW=S4(K7B#*7$)8HD5@ "F>;   +5_P_HOEB[+P) U/]Q]_P#$!7:U3::!
MJ^HQ\[DYU1$_M<?;_#[3JD=ZJ53>58HT7FUE7]4(CI@KO',=5K47-E.UD#>A
M,U[54G;Q4=64MFA2[O\ Z0L $!R@  "[= -#X.T72N5-^:9L2+R,3/\ Y]A:
MA$M%-#XC@6VHJ9/F:Z=W+K.54[,B6EZM8BCU.DALIBOD  ;E@$-TOR)'@"Y(
MNUZQM3\QO<3(K+3U7)#AVAHD7TZBHUU3^%B+GVN::6/$65]7+;3)_(HL %$\
ML   3[0C$K\;M<G_ &Z>1WZ)^YU=/M=X2\VVA1=Z"%953E>N7Z-[3]: *37N
M]UK,MZ*!L6?\SL_^!$])]=X_CFZO1<V1R) WDU$1J]J*3=*_Y.BWLT27N?\
M?P18 $)S@  "\- 5#X*QW*M5,EGG2-%XT8F?ZN4M$BVB^A\0P-:F*F3I(UG7
MEUU5R=BH2DO5K$4CU.EALIBOD  ;E@%'Z?*[PM\MU$BYI! LB\[W9?HU.LO
MS/I0KO'\<W5Z+FV.1($Y-1-5>U%(;GB.#G<3GMIQW9%@ 5#SX  !=N@:D;36
M&Z7&7T4EF1FLOX6-SS_W+U%/7FN?<KO6UTF>M43.EYLU5<B\+5&MCT+/?ZLC
MZ)\F?+)GE_<A09+9Y12+^K_1577\L_<  B*  .IA:B2XXCME(Y,VS5,;7)_#
MK)GV9A+)F*W-)&D<#VM+/A2VT>KJO;"CI/YW>D[M53N '02PL'KH14(J*]
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M,C4\=GREJ%_B78WH3>Z^,E(!?2PL(]57!5Q48]$  9-P
M                                  "&Z7JWQ+ E>B+D^H5D#>EV:]B*
M9P+HT_UNK16F@1?7D?.Y/Y4R3^Y2ERG<\R/.\2GNNQV  (B@
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M[5Y-AI.:BO,@U&IA1',GY]CE:5<5IB*]I#1OUK=1YLB5-DCOO/\ V3D3E(0
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MR\(X'$M1OGRX]%^0 "$YH
M                 !T\-6>>_7NEMU-O.F=DYV7J-X7+S(:EMM%!;:"GHZ1F
MI! Q(V-Y$_<K[0IAKR=:'7>J9E55J91YIOMBX/B7?YD0LHMTPVK)Z'AVGY=>
M]]7^  "8Z /#?JU+=9+A6*N7B\#Y$YT:JH>XA6F&M\3P+6-1<G5+V0ITKFO8
MU363PFR.Z>RN4NR,Z*JJJJJYJI_ "@>2   )#H^H?*&-+1!EFWPZ2.3D9Z2]
MC34!0V@FA\/BJHJG)FVFIUR7B<Y41.S6+Y+="Q')W^%PQ4Y=V  3'2
M !^*B5L$$DTBY,C:KW+R(F8!FS2E7>/8ZNCD7-L3T@;R:B(B]J*10^]=4NK*
MVHJ9/7FD=([G557]SX'/;R\GD;)[YN7<  P: U3@ZA\G86M5*J9.CIV:R?Q*
MF:]JJ9FP]1>4K[;Z++-)YV1KS*Y,^PUBF\F2%C3KJSL<)AYRG]  "R=DSEI<
MM'DK&=4]C<H:Q$J6<6:YZW^Y%7I(67QISL_CF'(+C&W.2AD])?X'[R]NKVE#
ME*V.V3/,ZVKE7->C\P ",J T!H4O?E+"RT4KLYZ!W@]_:L:[[5_5.@S^3/1+
M>_(^+Z=LCLJ>L_Z>3/9FJ^BOQ9=:DE4MLBWH;N5<F^C\C1P +IZ8@.F+#CKS
MAWQRF9K5E!G(B(F^Z/[R=B+T+QF?#8*[Z9*4!I5P2^QUK[E;HE6USNS5&I_D
M/7@_E7@ZN+.O=#_)''XEIF__ #1^I7H *QQ@  #Z03RT\B24\KXI$V.8Y6JG
M2AU$Q3?T9J)>[EJ[,O&7]YQP,M&RE*/1GUJ:F>JE62IFDFD7:Z1RN7K4^0 -
M0    6IHRT<OK7Q76_Q*RD3)T-,],EEXG.3@;R</-MVC%R>$2TTRNEM@='0W
M@M8M2_W2+)ZI_P!)&Y-B+_W%_;KXBW B(B(B)DB;$0_,CVQ1OD>N3&HKE7B1
M"["*BL(]-13&B&R)F_2Q7>/8ZN2HN;(5; WDU4W^W,B!Z;G5.KKE5U;_ %IY
M7RKSN55_<\Q1D\ML\O;/?-R[L  P:             '[AB?-*R.%CI)'KJM:
MU,U5>)$+FT<:-/%'Q7/$<;73IDZ&D7?1B\"OXUY. VA!S>$3T:>=\ML3]Z(,
M$.H6,OEVBRJ7M_Z:)R;\;5^^O*J;.).?>M4 NQBHK"/2T4QIALB?*K@CJJ6:
MGF36BE8L;TXT5,E_4RC?;;-9[Q5V^H1?"4\BLSXTX%Z4R7I-9E8Z8\'ONE,E
MYML:NK*=F4\;4WY(TX4Y4_3F([H;EE%/B.G=L-T>J*, !4//@   _J*J;%R/
MX !M       /7:K=576OAHJ")TM1*[5:U/U7B3E!E)MX1W]&V&W8CQ)#%(Q5
MHJ=4EJ%X-5%WF]*[W-GQ&ET1$1$1,D0C^!\,T^%[*RDB5'U#_3GER]=_<FQ"
M0%VJ&Q'I-%I^17Y]7U!6FFS#3KC:8[O2LUJFB14E1$WW1;<_Z5W^95++/X]K
M7L<UZ(YKDR5%3-%0VE'<L,GNJ5T'!^IC\$ZTGX*DPY<'5=$Q76F=WH*F_P"!
M<OW%Y.)2"E&47%X9Y>VN54G"74  P1@_K'.8Y',<K7)L5%R/X #U.N%:YFJZ
MKJ%;Q+*[+]3RKO[0 &V^H    /M14L];514U)$^:>1VJQC$S55 2ST/I:Z"I
MNEP@HJ*-9:B9R-8U/UYC3F#L/P8:L4%!!DYZ>G-)E_F/7:O[)R(AQ-&N"(L,
M4:U%7JR769N3WIOI&GX&_NO"38MU5[?-]3T&@TG)6^?[G_H  F.B>"_UJ6ZQ
MW"M5<O 0/D3G1JJG:9-55555=]5-%Z8Z[Q/ M6Q%R=4R,@3KUE[&J9T*M[\\
M'"XK/-BCV0 ! <L'OL%$MQOEOHD3/P\[(UYE<B+V'@)MH<H?',=4CU3-M,Q\
MZ]":J=KD,Q66D24PWV1CW9HM$1$1$WD0 '0/6@  &8=(5E=8L65U,C=6![_#
M0\2L<JJF7-OIT$<-&:4L)><MG26D:GE*D171?_N-X6=W+SF=9&.C>YDC5:]J
MJCFN3)45.!2E9#:SS.LT[IL?9]#\@ C*@/U&]\3VOC<YCVKFCFKDJ'Y !(:7
M&F(Z5B-BO-9JILUWZ_\ =F?RKQGB.J8K)KS6:J[49)J9_#D1\&=S[DG.LQC<
M_N?I[W2/5[W*YSES557-5/R 8(P   6QH,PVZ6KEOU2S**)%BI\T]9R[SG)S
M)O=*\1#<"82J\4W-(HT='11*BU$^6\U.).-RFD[=14]NH8*.CC2*GA:C&-3@
M0GIAE[F=3AVE<Y<V71=#T  M'=      !QL87V+#E@J;A+DKV)JQ,7[\B^JG
M[KR(IV3/FF#$WEJ_K0TS\Z&A56)DN\^3[SOV3F7C-+)[45=7J.16VNKZ$'K*
MF6LJIJFI>LDTSU>]R[555S53X@%$\QU
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MEDF8V./P*N7),U5V>:)_"6"6:H[8^9V]!2ZJL26&P "4NGDN]#'<[75T,_\
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M5Y3V %@ZR22P@  9      (=I2Q-YNX=>E._*OJ\XH,MK?Q/Z$[50S>77CO
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MKP^KZ@ $A:
M
M
M
>                                     /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g942740g59d47.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g942740g59d47.jpg
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MW-*; _8U553+XCP=28-2.W"(RE$]'-*(]25J4IFOJPVVFN+4S9J93&D'5 (
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MG,TTDI^:;UD=F_\ ?4"O.RM]W6[W2YOM:]<KC<:VN.:.3(]JJ9)\?5CG@#W
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MDR-44&N72GT#E(RIJ07NYO36Z&HHY0'J9(Q%(%5OFV1I"P616'<*JG*DCEC
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MLCE7N<='%1EXPLZ5*0C#;Q#3 (WZEOS+>KO73<(99D+$]."C5@P'K@&,&5\
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M,M$U*&*+8%5,E&SHL;,2DD$E<6(-%# ,DGD2!S<6JW!>J>H@]BI'$JNRM/*
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MBXB)$>/DI QY7X-#!!L/$/N9_!#3:E>,^.G=W6-&D=@J(K.[$X"JH+,Q/N
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MJ9ZJ4_!F?G*B5Y7[FXY/F<^NFVM75&.U_K/7=#B,^8FE4:I5*,S[>&O5'UR
MCX<-66DJ6EO*APV\Y1A:L)SG.,*5X\YL&"-88(85^UBBCC7^C&@4?^ UKRUT
M<=NMENM\/^9H:&DHXNW',=-3QPH>.3C*H.V3CTR==PM7H0M7CSZ4J5X_^_IQ
MG/C_ -_'70G )^@9TN)P"?H&=)MVGMVR-OL]CMDOO#W9:T3TO8I1W]'&<^Y(
MS<@1)&N>57[*L^LDEU7G.?.?/G/X]5L]H:1WD:IRSLSL>CZLQ+'_ %OTDZQA
M5^'$E955-7-?<S551-4RGX-SF2>1I7/_ #A[V8G390NHJD3H@30YXN"Z,[J<
M75!(F6T-Y>K'V1;J2VTHS[B&G,QF/U?C*_9<].4YSE.,]6"*:,T@I",Q&G%.
M0.WS?3Z?;Z/+Z?1K7*V>C>PK8)%YT!M*VATP 6I/8Q1D =PI,7IZ\3C'II2L
M;MKG5Z;8D(G?) 4G!RC1D9(C:ZRP4(=&%I?#-'<1?O4R0.0RV^TM.?+;B$J3
MGSC&>J^^!BCY6J(9&R&$.""I[$?.]B",CZ-9#7PRDIYUDAO[1RP2AXI4MI5T
MDB<,DBL+AE65E#*0<@@$::ANNG*+RLX\0U"WE#"VB+N=0J\Q*D MYB"XZSNP
MXIB+-5WDN%O0,F$<00]'J0\4A SST8=B1C2C12I]+315]&L-4HD66-&8@<2L
MA4'J1^I1@22O<]B5;DI(.KJZRT&[-N0V^^PI515M'233-&.B\=484<55*07-
M/*DC,T>&<!6:*3J1.Z.HSS\X%Q/#6VIC8+94C>(:3;2=&,2U8&B)./#(5Y8#
M.D0YHL64)81G"73AXF(:(5C*T #8SZ,5Y=K4MMDXK.TJG!7D@5@#D@$AB&(Q
MW(50?O1Z:Q]XA;!AV55].GN<E?!+Q>)9J5898T?NJ22I.Z2LH[%UAA#'N(U]
M-2KV\NVK5.7RW[+=]H3M=K$$I@F5K5;K@7UB886ZA&1A+1(2I0L1G.5?G?75
MY164>4H0VO.'$][-98[EEY9WC1#YD1 689Q@2,Q"GZS&WYM._ASX94F\N557
M76HI:6GX/-2TU-'UYE8XX)5R2ND)_*-)-V]%![ZWXY8\8*16>"5FXTZ8;C]1
MTV4)JD4HF/B'9TG([%JB)^5+D,ORT:=,S%@<AFQ967D91TLA@AY+JG4);:1+
MJ^@B2U24--BGB8QKE5+' D1V+>92S/Q 9F8D@D'([:T'NW:U#2["J=L601V>
MBE:DA+1PFH;BM7#42O)RFBDGFJ# $FFEE9V5FY$C "]_W8'\</Z:?_T#J(&Q
M8!/M7H,_YC^^UG8^%F 3\.^@S_S7_B.IST?V9 MJRRF)+D25% "(^04T#JIE
MTLEE"DX6R.6_L3+(CJL*_*^X$:E&<?B.O]G2FEVV*AN]85 [D"GR2 ?0$S8!
M/TX./H.GRQ>"R7><I+N-X8TPSB.T@NZ]\JKM<>*$X[,4D ^].M\>)? ;CUPY
M")?UG FR]VE \ S>RK@0/+7$\/*D.NQH;XX@,; 0[C[:'7(Z#CP4F99%5+/2
M;X8S[<MM]HH[:"8$+2L.+3RD-(1G/$$!51<XR$49P.18@'6@MH>'VW-F1LUK
MIY)JZ5.$]SK62:MD0D$Q(RI'%3PE@"8X(X^?%#,TK(K#S>:_ 74'-JNQ3%R?
MD*C?ZLP2/3]D5\<8B4C!2E^\_#3,:2IH>QUUPG_:\1CQ()8967GHF5C%&R/S
M?ESM--<T42$QS1@B.= "R@_<LI[.F>_$D$'[5ERV>6^/#ZS;XIH5K6DH[A2*
MZT=SIU5I8D<\FAGB?"U-,7\_2+1NCY,,T7.7FFWR0X_?W?=CR6O_ +6_:[Z=
M(O@?5_H/T#WO9=RW[OP/K4U[?J\>KV_FK\?L]>?V]5M64OLDS1=3J8+#EQX9
MP<>G)O7\^L6[EL'Q=N<EN]K]LZ;LO6Z'L^<-C/3ZT^,^N.9_/K5GMX]J;6G(
M"/"VQM;8,Y+U.(/$R1K:$A$0.)MWPHA \I;L3AYR(ESVLLG"145&R3[3BOBS
M0#F,.=/]GL$%8JU%1,[1J5S B\.>1G#2ARP7W,%56(]'4]]6WX<>$ULW%%'>
M+M<9YJ.)T+6R" 4_78CF%EK.O(XA..,B10Q2LI\D\9[Z:/:J%58J;=#:KD*W
M2FJ^FIMU-,:)]GDUA,?])Q7\1'M?!S#_ $O'T_Z=EC(N0_\ 9\M9:SZ>IWTX
MQ'TN"]+AT^GQ'#I\>/#CZ<>/EXXQCMZ:U4*.D6C%O6F@%"*;V,48B3V84O3Z
M/LW1QT^ATOF^EQX</+C';2L/<E[7>L^.@1&W-3W>9B*G/R1GL:REH=,RU /X
MPDAUB'MBYD4Y4.CWL- @RD7)2 K3>,$31V<XRF!WNQP4*FIIY66-R<0,O+@?
M4A9.0/'OV#*S#WL=92\3/"NU[;C:\6BNGAI*B5^-KFA$XIV #%8:PSI(81RP
MD<L4LB >:>3W4FX3\(!^75V#JY>RGJ((K*WB2!JDW8B'&!TJ=>98]VR0S;#S
MS;:FVR'$$H86K#BAGTIRTMKM=L%QE$9F,(R<D1\S@=SCSI@GZ>^/7!]-0;8V
MQEWC7+2O<VMZ Y=EHQ4LRKR+!<U, 5F"D!B'"DY*L!@M\<5>(.F.'U%=I>I8
M4A),HX.5;+E..L'6^XR J'&QR)N29'%90*$EY],9#QPH41&X?)=&#P8:>678
ME!;J:W1=*G4Y;!DE?!DE8# +L !@9/%5 5<D@99B=B[3V=9-FT!H;1 P:4H]
M96SE9*RME0$*\\@55"("W2AB2.&+DY1 \DCOCKW0^)DCR*Y,-V@S9_V9#K>O
M*O4HJ%Q3LS26!6B9FP$$Y,^U<0E3I4A8"\J3@).4M-LH4ZYA"?3&[[0-65W,
MS\ D,<:KT^6 "SDYZB^K.?=]&J:\5-HR;DW.M6]T]E2FMM)1PP>Q=?BBO/4,
MQ?VN')>2I?/D& %&3@8O5VI..$=QST1=(QFQ_:R4MFSI"7/FLPF('* P*Y78
MZ-BL!XE9G+C8;B)$Q)"BTY6Y)NMX81AK"G':P4:T=)( _4:2=F+<>'94157'
M)LX(8YS]T1CMJ=^$NVHMMV"NB6I]KEJ[K)-)/T/9_)'2TT<47#JS9"'JN&Y]
MS*1Q&,F:^9_!/3_->J1<7?%2-:N5727]C-B5U RIN#2;[:RHPX0I.1)VO%O,
ML/DQ)2F'FWFLO1<C%D/DO/*KG:J:YQJLO))8\]*9,<TSC*D'LZ' RIP1ZJRD
MDZ?=[;"LV^*2*&X=2EK:7G[%<J8*9X ^"\3H_DJ*=RJLT+\6##E#)$S,S*3\
MA.%>-$;#DJ%C97VIQ'G.A8E<T[Z)EW#;JF_<R#]JI?T>?'GT?+7X_9ZO^?5>
MUMM]CF,76ZF"1RZ?#T^KJ-_ZZR#N+9/P!<9+?\)^U].;I=;V+H9[D<NG[7-C
MT].9_/K5S@;V@-0W:-KNZ-P7J8V%"-&H(#UD) -5:#++#]E]*+/+HG9F2FXI
M>7$^Y%Q[=?R\IO#9990;KX;K_:=O4\P6IJ96F0$$0!.FI([^=P[,R_DJ$S[R
M1D&W-@^#=FKHJ:]WFOGN, D#):TIUI('=,$"JF$\\L\)SWBB%,6( =V0LC,E
M!AB1X@H  HX(((S 800C+8P@8@S261A11V4H9'''90AIAEI"&VFD);;2E*<8
MQ-0         ,  =@ !V  [ #TUI=$2-$CC18XXU5$1%"HB* JHBJ JJJ@!5
M       UG3W.*Y;]BZ%%U'5[Q^C^/V).H&N$NS!KG#9*M0B&I%=;8;1-P>0Q
MI635'.R1&"7LD@ O13C"Q)(KIFOJ2348ITEZ2S.!(P7D61?-P'F7 9@I8Y[@
M%2,,=5OXHTU9<MOK9Z6O^#H[C4!:V98#.\M+ !(:90)X."S2](RL&/*.-H2I
M25]+L_=E_P ;/Z;_ .O>H;\#?RG^I_O=9Q^2_P#GS^S/\0T?=E_QL_IO_KWH
M^!OY3_4_WNCY+_Y\_LS_ !#1]V7_ !L_IO\ Z]Z/@;^4_P!3_>Z/DO\ Y\_L
MS_$-'W9?\;/Z;_Z]Z/@;^4_U/][H^2_^?/[,_P 0T?=E_P ;/Z;_ .O>CX&_
ME/\ 4_WNCY+_ .?/[,_Q#1]V7_&S^F_^O>CX&_E/]3_>Z/DO_GS^S/\ $-'W
M9?\ &S^F_P#KWH^!OY3_ %/][H^2_P#GS^S/\0T?=E_QL_IO_KWH^!OY3_4_
MWNCY+_Y\_LS_ !#6ZW:BX9U#C;1;W>43GVSOE[F\01%D>@T0>8FIP+0I T!'
M"9E9IQM)LL21)RY236TR*AX9EP1&8=EYZ5[?MT='#-+RZDLK\"Y7CQC0 A%'
M)O5B68Y\V%&/*";Z\)=E4>V:"OKQ/[;7W"?H-5- (.E24X1DIXTZTY >9GEF
1<..J5A5D^85CK=U(=6]K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jun. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000002969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Air Products & Chemicals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-275663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Jun. 11, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">3.250% Notes due 2032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">569,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 567,669,056.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 86,910.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering The filing fee is calculated and is being paid pursuant to Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, based on the maximum aggregate offering price of the 3.250% Notes due 2032 (the "2032 Notes"). The maximum aggregate offering price is calculated based on the public offering price of 99.661% of the principal amount of the 2032 Notes. The amount registered, maximum aggregate offering price and registration fee have been calculated by converting the amount registered from Euros to U.S. Dollars based upon the Euro to U.S. Dollar exchange rate at 9:00 a.m. (London time) on June 10, 2025 of Euro1.00 = $1.13920.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jun. 11, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 567,669,056.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">86,910.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 86,910.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="d942740dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d942740dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d942740dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d942740dexfilingfees.htm">d942740dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d942740dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d942740dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 20,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d942740dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d942740dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d942740dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d942740dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-138898-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-138898-xbrl.zip
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?9V9E97,N:'1M4$L%!@     !  $ 1@   /4)      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d942740dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000002969</identifier>
        </entity>
        <period>
            <startDate>2025-06-11</startDate>
            <endDate>2025-06-11</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000002969</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-11</startDate>
            <endDate>2025-06-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-206">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-207">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-208">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="rc" id="ixv-209">333-275663</ffd:RegnFileNb>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-210">0000002969</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-211">Air Products &amp; Chemicals, Inc.</dei:EntityRegistrantName>
    <ffd:FnlPrspctsFlg contextRef="rc" id="ixv-212">false</ffd:FnlPrspctsFlg>
    <ffd:FormTp contextRef="rc" id="ixv-237">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-238">Air Products &amp; Chemicals, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-239">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-240">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-241">3.250% Notes due 2032</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-242">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-243"
      unitRef="Shares">569600000</ffd:AmtSctiesRegd>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-244"
      unitRef="USD">567669056.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-245"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-246"
      unitRef="USD">86910.14</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-247" unitRef="USD">567669056.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-248" unitRef="USD">86910.14</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-249" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-250" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-251" unitRef="USD">86910.14</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-252">The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering The filing fee is calculated and is being paid pursuant to Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, based on the maximum aggregate offering price of the 3.250% Notes due 2032 (the "2032 Notes"). The maximum aggregate offering price is calculated based on the public offering price of 99.661% of the principal amount of the 2032 Notes. The amount registered, maximum aggregate offering price and registration fee have been calculated by converting the amount registered from Euros to U.S. Dollars based upon the Euro to U.S. Dollar exchange rate at 9:00 a.m. (London time) on June 10, 2025 of Euro1.00 = $1.13920.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
